Moorestown, New Jersey, United States
SEEKING BIOTECH ALPHA = BIOTECMAX THE HEART OF BIOTEC 6/25/2024
thank you for visiting biotecMAX / seeking biotech al
感谢您访问寻求生物技术 寻求 α
grazie per la visita alla ricerca di biotech alpha
biotecMAX™
“There is not a truth existing which I fear... or would wish unknown to the whole world.” Thomas Jefferson
BiotechSTORM™ novel coronavirus (2019-nCoV)/Monkeypox/Polio/RSV
I have added a tenth 10th! page on the BiotechSTORM™ , the novel coronavirus (2019-nCoV), aka, SARS-CoV2.
As of 11/27/2022, many people in China are rebelling against CCP lockdowns, and the strict Covid-19 protocols that are in place across many cities in China. https://biotecmax.com/biohazzard2023-10 https://biotecmax.com/biohazard2022-9-1
America has lost over 1,123,836 people due to Covid-19 related deaths since the start of this pandemic, most likely more. (JHU Has Stopped Collecting Data As Of 03 / 10 / 2023)
https://coronavirus.jhu.edu/map.html https://coronavirus.jhu.edu /https://www.worldometers.info/coronavirus/ https://www.worldometers.info/coronavirus/#countries
The world has lost over 6,881,955 million people due to Covid-19 https://coronavirus.jhu.edu/map.html
(JHU Has Stopped Collecting Data As Of 03 / 10 / 2023)
And many countries, including the USA/Canada are dealing with three respiratory illnesses all at once with Covid-19, flu, (increased influenza activity)and RSV (respiratory syncytial virus,) this fall as winter approaches.
And I am seeing increased ridicule and open hatred of all biotech/pharm companies/spokespeople on social media sites, like Twitter, e.g., during January 2023 twitter commentators denigrate both paxlovid https://www.paxlovid.com/ and veklury https://www.veklury.com/ while doctors in China are desperate to locate these meds and the CCP has no funds or even a desire to buy any meds for their people to fight Covid-19 aka the "Crown Virus", "New Coronary Pneumonia", "community-acquired pneumonia", "new crown infection".
China Now Wants the World to Live With the Virus. China’s Shortage of Antivirals Puts Vulnerable People at Risk
Many unreported deaths in China from the day they ended their painful/unsustainable "zero-covid" policy.
Deaths can not be a result of Covid-19 in China as the deceased can then not be buried/cremated.
The new CCP mantra= 对耗费资源的弱势群体弃掉，物竞天择，适者生存～
Abandon the vulnerable groups that consume resources, natural selection, survival of the fittest~
Unfortunately the pandemic is not over as of 12/22/2022. On this date I got my 2nd PFE/BNTX Covid-19 booster shot = The Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY®) = https://www.comirnaty.com/eua-bivalent
For now November 2023, I have decided to not get any more Covid-19 booster shots in 2023/24. All should review this document before getting any more booster shots, as there are risks =
Assessment of Myocardial 18F-FDG Uptake at PET/CT in Asymptomatic SARS-CoV-2-vaccinated and Nonvaccinated Patients
https://pubs.rsna.org/doi/10.1148/radiol.230743
As of 10/19/2023 as the 2024 US presidential election progresses "BIG Pharma" is being targeted from all politicos as the "enemy of the state". If you work or invest in any Pharma company take cover and just keep working on great new products and improve existing ones, 2024 will be a difficult year for all in biotech/healthcare/med-tech.
Also, as of 11/15/2023 there is a very negative perception of ALL vaccines based on the sudden deaths that have occurred with many who received Covid-19 shots and the higher the normal "excess deaths" occurring into 2021/2022/2023 worldwide. Based on what I am seeing/reading healthy people with good immune systems under 55 years of age should not have received the Covid-19 vaccine.
Excess deaths in 2023 Dr. John Campbell
https://www.youtube.com/watch?v=1uOxhYyfYw4
‘Excess mortality’ continuing surge causes concerns By Doug Bailey
https://insurancenewsnet.com/innarticle/excess-mortality-continuing-surge-causes-concerns
Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)
https://www.comirnaty.com/eua-bivalent https://www.comirnaty.com/
Monitoring Variant Proportions
And not to be forgotten is “the special military operation” aka a full-fledged WAR that Russia continues to wage against the people of Ukraine continues into the winter of 2022/2023. I keep track of the WAR here = https://twitter.com/MaxD56808233
And as more information keeps coming out supporting the belief that this SARS-CoV2 virus was made in the
#武汉病毒研究所 / #Wuhan Institute of Virology sometime in 2019.
I will continue to keep track of the information here = BiotecWARS™ https://biotecmax.com/biotecwars-1
The Lab Leak Will Haunt Us Forever DANIEL ENGBER
Each new revelation is a reminder of how little is actually known.
God bless all the healthcare professionals battling Covid-19 around the world, thank you.
GLTA & I pray that you have a peaceful sky above you.
Dan Watson
biotecNOVA® Medicines
Stand In Faith- BiotecHOPE™
Stand In Faith- BiotecHOPE™
Dec. 05, 2021 5:05 PM ET ABBV, BHVN,BMY,BNTX,GILD,JNJ,LLY,MRK,MRNA,PFE
Summary
- During the last 6 months of 2021 there has been significant gains in medicines that can fight Covid-19 beyond the vaccines.
- I continue to remain 100% invested in biotech companies and I am increasing my positions in (MRK)(ABBV)(GILD)(JNJ)(PFE)(MRNA)(LLY) as we move toward pandemic year 3.
- I have taken a new position in Biohaven Pharmaceuticals BHVN.
- I will stand in faith. Nothing's impossible, nothing's impossible.
Covid-19 Tracker
More Than 12.7 Billion Shots Given: Covid-19 Tracker
In the US, 613 million doses have been administered Updated: September 16, 2022 at 6:09 PM MDT
More Than 12.7 Billion Shots Given: Covid-19 Tracker
In the US, 611 million doses have been administered Updated: September 13, 2022 at 5:10 PM PDT
More Than 12.6 Billion Shots Given: Covid-19 Tracker
In the US, 611 million doses have been administered Updated: September 9, 2022 at 8:09 AM EDT
More Than 12.6 Billion Shots Given: Covid-19 Tracker
In the US, 610 million doses have been administered Updated: September 2, 2022 at 8:05 AM EDT
More Than 12.6 Billion Shots Given: Covid-19 Tracker
In the US, 609 million doses have been administered Updated: August 30, 2022 at 8:09 PM EDT
More Than 12.5 Billion Shots Given: Covid-19 Tracker
In the US, 608 million doses have been administered Updated: August 20, 2022 at 8:10 AM EDT
More Than 12.5 Billion Shots Given: Covid-19 Tracker
In the US, 606 million doses have been administered Updated: August 18, 2022 at 8:09 AM EDT
More Than 12.4 Billion Shots Given: Covid-19 Tracker
In the US, 606 million doses have been administered Updated: August 14, 2022 at 8:00 PM EDT
More Than 12.4 Billion Shots Given: Covid-19 Tracker
In the US, 604 million doses have been administered Updated: August 10, 2022 at 8:10 AM EDT
More Than 12.4 Billion Shots Given: Covid-19 Tracker
In the US, 599 million doses have been administered Updated: August 5, 2022 at 8:10 AM EDT
More Than 12.3 Billion Shots Given: Covid-19 Tracker
In the US, 599 million doses have been administered Updated: July 23, 2022 at 8:10 AM EDT
More Than 12.2 Billion Shots Given: Covid-19 Tracker
In the US, 599 million doses have been administered Updated: July 15, 2022 at 8:09 PM EDT
More Than 12.2 Billion Shots Given: Covid-19 Tracker
In the US, 598 million doses have been administered Updated: July 14, 2022 at 8:09 PM EDT
More Than 12.1 Billion Shots Given: Covid-19 Tracker
In the US, 598 million doses have been administered Updated: July 11, 2022 at 8:09 AM EDT
More Than 12.1 Billion Shots Given: Covid-19 Tracker
In the US, 596 million doses have been administered Updated: July 2, 2022 at 8:05 AM EDT
More Than 12.1 Billion Shots Given: Covid-19 Tracker
In the US, 594 million doses have been administered Updated: June 30, 2022 at 8:11 AM EDT
More Than 12 Billion Shots Given: Covid-19 Tracker
In the US, 594 million doses have been administered Updated: June 26, 2022, 8:09 PM EDT
More Than 12 Billion Shots Given: Covid-19 Tracker
In the US, 592 million doses have been administered Updated: June 17, 2022, 8:09 AM EDT
More Than 12 Billion Shots Given: Covid-19 Tracker
In the US, 591 million doses have been administered Updated: June 13, 2022, 8:03 AM EDT
More Than 11.9 Billion Shots Given: Covid-19 Tracker
In the US, 590 million doses have been administered Updated: June 8, 2022, 8:06 PM EDT
More Than 11.9 Billion Shots Given: Covid-19 Tracker
In the US, 588 million doses have been administered Updated: June 3, 2022, 8:12 AM EDT
More Than 11.9 Billion Shots Given: Covid-19 Tracker
In the US, 587 million doses have been administered Updated: May 30, 2022, 8:10 PM EDT
More Than 11.9 Billion Shots Given: Covid-19 Tracker
In the US, 585 million doses have been administered Updated: May 26, 2022, 8:11 PM EDT
More Than 11.8 Billion Shots Given: Covid-19 Tracker
In the US, 584 million doses have been administered Updated: May 22, 2022, 8:11 AM EDT
More Than 11.8 Billion Shots Given: Covid-19 Tracker
In the US, 583 million doses have been administered Updated: May 20, 2022, 8:11 PM EDT
More Than 11.8 Billion Shots Given: Covid-19 Tracker
In the US, 583 million doses have been administered Updated: May 19, 2022, 8:05 PM EDT
More Than 11.7 Billion Shots Given: Covid-19 Tracker
In the US, 582 million doses have been administered Updated: May 18, 2022, 8:06 AM EDT
More Than 11.7 Billion Shots Given: Covid-19 Tracker
In the U.S., 580 million doses have been administered Updated: May 10, 2022, 8:09 PM EDT
More Than 11.7 Billion Shots Given: Covid-19 Tracker
In the U.S., 578 million doses have been administered Updated: May 8, 2022, 8:10 AM EDT
More Than 11.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 578 million doses have been administered Updated: May 6, 2022, 8:11 PM EDT
More Than 11.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 576 million doses have been administered Updated: May 2, 2022, 8:04 AM EDT
More Than 11.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 574 million doses have been administered Updated: April 27, 2022, 8:10 PM EDT
More Than 11.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 574 million doses have been administered Updated: April 26, 2022, 8:05 PM EDT
More Than 11.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 572 million doses have been administered Updated: April 23, 2022, 8:11 AM EDT
More Than 11.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 571 million doses have been administered Updated: April 20, 2022, 8:09 PM EDT
More Than 11.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 568 million doses have been administered Updated: April 18, 2022, 8:10 AM EDT
More Than 11.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 568 million doses have been administered Updated: April 14, 2022, 8:10 PM EDT
More Than 11.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 567 million doses have been administered Updated: April 13, 2022, 8:11 AM EDT
More Than 11.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 565 million doses have been administered Updated: April 8, 2022, 8:11 PM EDT
More Than 11.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 563 million doses have been administered Updated: April 5, 2022, 8:11 PM EDT
More Than 11.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 561 million doses have been administered Updated: April 2, 2022, 8:06 AM EDT
More Than 11.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 560 million doses have been administered Updated: April 1, 2022, 8:11 PM EDT
More Than 11.2 Billion Shots Given: Covid-19 Tracker
In the U.S., 560 million doses have been administered Updated: March 29, 2022, 8:03 PM EDT
More Than 11.2 Billion Shots Given: Covid-19 Tracker
In the U.S., 559 million doses have been administered Updated: March 28, 2022, 8:10 AM EDT
More Than 11.1 Billion Shots Given: Covid-19 Tracker
In the U.S., 559 million doses have been administered Updated: March 21, 2022, 8:11 PM EDT
More Than 11.1 Billion Shots Given: Covid-19 Tracker
In the U.S., 558 million doses have been administered Updated: March 20, 2022, 8:10 PM EDT
More Than 11 Billion Shots Given: Covid-19 Tracker
In the U.S., 558 million doses have been administered Updated: March 18, 2022, 8:12 PM EDT
More Than 11 Billion Shots Given: Covid-19 Tracker
In the U.S., 557 million doses have been administered Updated: March 14, 2022, 8:11 PM EDT
More Than 10.9 Billion Shots Given: Covid-19 Tracker
In the U.S., 557 million doses have been administered Updated: March 13, 2022, 8:10 PM EDT
More Than 10.9 Billion Shots Given: Covid-19 Tracker
In the U.S., 556 million doses have been administered Updated: March 8, 2022, 8:10 PM EST
More Than 10.9 Billion Shots Given: Covid-19 Tracker
In the U.S., 555 million doses have been administered Updated: March 7, 2022, 8:10 PM EST
More Than 10.8 Billion Shots Given: Covid-19 Tracker
In the U.S., 555 million doses have been administered Updated: March 6, 2022, 8:10 AM EST
More Than 10.8 Billion Shots Given: Covid-19 Tracker
In the U.S., 554 million doses have been administered Updated: March 3, 2022, 8:11 AM EST
More Than 10.8 Billion Shots Given: Covid-19 Tracker
In the U.S., 553 million doses have been administered Updated: March 1, 2022, 8:11 AM EST
More Than 10.7 Billion Shots Given: Covid-19 Tracker
In the U.S., 553 million doses have been administered Updated: February 28, 2022, 8:10 PM EST
More Than 10.7 Billion Shots Given: Covid-19 Tracker
In the U.S., 552 million doses have been administered Updated: February 27, 2022, 8:10 AM EST
More Than 10.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 552 million doses have been administered Updated: February 24, 2022, 8:10 PM EST
More Than 10.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 551 million doses have been administered Updated: February 22, 2022, 8:28 PM EST
More Than 10.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 550 million doses have been administered Updated: February 21, 2022, 11:22 AM EST
More Than 10.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 550 million doses have been administered Updated: February 20, 2022, 8:27 AM EST
More Than 10.5 Billion Shots Given: Covid-19 Tracker
In the U.S., 549 million doses have been administered Updated: February 18, 2022, 8:27 AM EST
More Than 10.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 548 million doses have been administered Updated: February 17, 2022, 11:27 AM EST
More Than 10.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 548 million doses have been administered Updated: February 15, 2022, 8:27 PM EST
More Than 10.4 Billion Shots Given: Covid-19 Tracker
In the U.S., 547 million doses have been administered Updated: February 14, 2022, 5:28 PM EST
More Than 10.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 547 million doses have been administered Updated: February 12, 2022, 8:27 PM EST
More Than 10.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 546 million doses have been administered Updated: February 10, 2022, 8:27 PM EST
More Than 10.3 Billion Shots Given: Covid-19 Tracker
In the U.S., 545 million doses have been administered Updated: February 10, 2022, 8:27 AM EST
More Than 10.2 Billion Shots Given: Covid-19 Tracker
In the U.S., 544 million doses have been administered Updated: February 7, 2022, 8:27 PM EST
More Than 10.2 Billion Shots Given: Covid-19 Tracker
In the U.S., 543 million doses have been administered Updated: February 7, 2022, 11:28 AM EST
More Than 10.2 Billion Shots Given: Covid-19 Tracker
In the U.S., 542 million doses have been administered Updated: February 5, 2022, 11:27 AM EST
More Than 10.1 Billion Shots Given: Covid-19 Tracker
In the U.S., 541 million doses have been administered Updated: February 3, 2022, 8:28 AM EST
More Than 10.1 Billion Shots Given: Covid-19 Tracker
In the U.S., 540 million doses have been administered Updated: February 2, 2022, 8:27 AM EST
More Than 10.1 Billion Shots Given: Covid-19 Tracker
In the U.S., 537 million doses have been administered Updated: January 29, 2022, 8:27 AM EST
More Than 10.0 Billion Shots Given: Covid-19 Tracker
In the U.S., 536 million doses have been administered Updated: January 26, 2022, 9:21 AM EST
More Than 9.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 535 million doses have been administered Updated: January 25, 2022, 6:47 AM EST
More Than 9.94 Billion Shots Given: Covid-19 Tracker
In the U.S., 535 million doses have been administered Updated: January 24, 2022, 12:35 PM EST
More Than 9.92 Billion Shots Given: Covid-19 Tracker
In the U.S., 534 million doses have been administered Updated: January 23, 2022, 12:34 PM EST
More Than 9.91 Billion Shots Given: Covid-19 Tracker
In the U.S., 534 million doses have been administered Updated: January 23, 2022, 6:34 AM EST
More Than 9.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 533 million doses have been administered Updated: January 22, 2022, 9:30 AM EST
More Than 9.87 Billion Shots Given: Covid-19 Tracker
In the U.S., 533 million doses have been administered Updated: January 21, 2022, 6:35 PM EST
More Than 9.84 Billion Shots Given: Covid-19 Tracker
In the U.S., 530 million doses have been administered Updated: January 20, 2022, 3:34 PM EST
More Than 9.81 Billion Shots Given: Covid-19 Tracker
In the U.S., 529 million doses have been administered Updated: January 19, 2022, 3:34 PM EST
More Than 9.80 Billion Shots Given: Covid-19 Tracker
In the U.S., 529 million doses have been administered Updated: January 19, 2022, 12:35 PM EST
More Than 9.78 Billion Shots Given: Covid-19 Tracker
In the U.S., 529 million doses have been administered Updated: January 19, 2022, 6:36 AM EST
More Than 9.77 Billion Shots Given: Covid-19 Tracker
In the U.S., 527 million doses have been administered Updated: January 18, 2022, 11:03 AM EST
More Than 9.72 Billion Shots Given: Covid-19 Tracker
In the U.S., 527 million doses have been administered Updated: January 17, 2022, 9:34 AM EST
More Than 9.70 Billion Shots Given: Covid-19 Tracker
In the U.S., 527 million doses have been administered Updated: January 16, 2022, 12:34 PM EST
More Than 9.67 Billion Shots Given: Covid-19 Tracker
In the U.S., 526 million doses have been administered Updated: January 15, 2022, 9:34 AM EST
More Than 9.64 Billion Shots Given: Covid-19 Tracker
In the U.S., 524 million doses have been administered Updated: January 14, 2022, 12:36 PM EST
More Than 9.61 Billion Shots Given: Covid-19 Tracker
In the U.S., 524 million doses have been administered Updated: January 13, 2022, 8:34 PM EST
More Than 9.57 Billion Shots Given: Covid-19 Tracker
In the U.S., 521 million doses have been administered Updated: January 12, 2022, 6:34 PM EST
More Than 9.54 Billion Shots Given: Covid-19 Tracker
In the U.S., 521 million doses have been administered Updated: January 12, 2022, 6:34 AM EST
More Than 9.52 Billion Shots Given: Covid-19 Tracker
In the U.S., 520 million doses have been administered Updated: January 11, 2022, 6:34 PM EST
More Than 9.51 Billion Shots Given: Covid-19 Tracker
In the U.S., 520 million doses have been administered Updated: January 11, 2022, 9:34 AM EST
More Than 9.46 Billion Shots Given: Covid-19 Tracker
In the U.S., 519 million doses have been administered Updated: January 10, 2022, 9:34 AM EST
More Than 9.45 Billion Shots Given: Covid-19 Tracker
In the U.S., 519 million doses have been administered Updated: January 9, 2022, 6:34 PM EST
More Than 9.41 Billion Shots Given: Covid-19 Tracker
In the U.S., 517 million doses have been administered Updated: January 8, 2022, 12:35 PM EST
More Than 9.39 Billion Shots Given: Covid-19 Tracker
In the U.S., 515 million doses have been administered Updated: January 7, 2022, 6:34 PM EST
More Than 9.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 515 million doses have been administered Updated: January 7, 2022, 6:34 AM EST
More Than 9.35 Billion Shots Given: Covid-19 Tracker
In the U.S., 514 million doses have been administered Updated: January 6, 2022, 9:34 AM EST
More Than 9.29 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: January 5, 2022, 9:34 AM EST
More Than 9.26 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: January 4, 2022, 6:34 PM EST
More Than 9.23 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: January 3, 2022, 9:34 PM EST
More Than 9.20 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: January 2, 2022, 12:34 PM EST
More Than 9.19 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: January 1, 2022, 6:34 PM EST
More Than 9.17 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: December 31, 2021, 6:34 PM EST
More Than 9.16 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: December 31, 2021, 6:34 AM EST
More Than 9.12 Billion Shots Given: Covid-19 Tracker
In the U.S., 508 million doses have been administered Updated: December 30, 2021, 6:34 PM EST
More Than 9.11 Billion Shots Given: Covid-19 Tracker
In the U.S., 506 million doses have been administered Updated: December 30, 2021, 6:37 AM EST
More Than 9.00 Billion Shots Given: Covid-19 Tracker
In the U.S., 500 million doses have been administered Updated: December 27, 2021, 6:36 AM EST
More Than 8.95 Billion Shots Given: Covid-19 Tracker
In the U.S., 500 million doses have been administered Updated: December 25, 2021, 6:34 PM EST
More Than 8.91 Billion Shots Given: Covid-19 Tracker
In the U.S., 500 million doses have been administered Updated: December 24, 2021, 6:35 AM EST
More Than 8.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 500 million doses have been administered Updated: December 23, 2021, 6:34 PM EST
More Than 8.87 Billion Shots Given: Covid-19 Tracker
In the U.S., 499 million doses have been administered Updated: December 23, 2021, 12:34 PM EST
More Than 8.86 Billion Shots Given: Covid-19 Tracker
In the U.S., 499 million doses have been administered Updated: December 23, 2021, 6:37 AM EST
More Than 8.82 Billion Shots Given: Covid-19 Tracker
In the U.S., 497 million doses have been administered Updated: December 22, 2021, 9:35 AM EST
More Than 8.80 Billion Shots Given: Covid-19 Tracker
In the U.S., 497 million doses have been administered Updated: December 21, 2021, 6:31 PM EST
More Than 8.75 Billion Shots Given: Covid-19 Tracker
In the U.S., 495 million doses have been administered Updated: December 20, 2021, 12:36 PM EST
More Than 8.74 Billion Shots Given: Covid-19 Tracker
In the U.S., 495 million doses have been administered Updated: December 20, 2021, 9:29 AM EST
More Than 8.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 494 million doses have been administered Updated: December 19, 2021, 12:34 PM EST
More Than 8.69 Billion Shots Given: Covid-19 Tracker
In the U.S., 494 million doses have been administered Updated: December 19, 2021, 6:35 AM EST
More Than 8.66 Billion Shots Given: Covid-19 Tracker
In the U.S., 492 million doses have been administered Updated: December 18, 2021, 6:35 AM EST
More Than 8.65 Billion Shots Given: Covid-19 Tracker
In the U.S., 490 million doses have been administered Updated: December 17, 2021, 3:34 PM EST
More Than 8.61 Billion Shots Given: Covid-19 Tracker
In the U.S., 490 million doses have been administered Updated: December 17, 2021, 6:31 AM EST
More Than 8.59 Billion Shots Given: Covid-19 Tracker
In the U.S., 488 million doses have been administered Updated: December 16, 2021, 9:35 AM EST
More Than 8.56 Billion Shots Given: Covid-19 Tracker
In the U.S., 487 million doses have been administered Updated: December 15, 2021, 12:36 PM EST
More Than 8.53 Billion Shots Given: Covid-19 Tracker
In the U.S., 485 million doses have been administered Updated: December 14, 2021, 6:34 PM EST
More Than 8.49 Billion Shots Given: Covid-19 Tracker
In the U.S., 485 million doses have been administered Updated: December 13, 2021, 6:34 PM EST
More Than 8.48 Billion Shots Given: Covid-19 Tracker
In the U.S., 484 million doses have been administered Updated: December 13, 2021, 9:34 AM EST
More Than 8.45 Billion Shots Given: Covid-19 Tracker
In the U.S., 483 million doses have been administered Updated: December 12, 2021, 12:35 PM EST
More Than 8.38 Billion Shots Given: Covid-19 Tracker
In the U.S., 481 million doses have been administered Updated: December 11, 2021, 12:34 PM EST
More Than 8.37 Billion Shots Given: Covid-19 Tracker
In the U.S., 481 million doses have been administered Updated: December 10, 2021, 6:34 PM EST
More Than 8.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 477 million doses have been administered Updated: December 10, 2021, 9:34 AM EST
More Than 8.34 Billion Shots Given: Covid-19 Tracker
In the U.S., 477 million doses have been administered Updated: December 9, 2021, 6:35 PM EST
More Than 8.30 Billion Shots Given: Covid-19 Tracker
In the U.S., 476 million doses have been administered Updated: December 8, 2021, 6:34 PM EST
More Than 8.23 Billion Shots Given: Covid-19 Tracker
In the U.S., 462 million doses have been administered Updated: December 7, 2021, 6:35 AM EST
More Than 8.22 Billion Shots Given: Covid-19 Tracker
In the U.S., 462 million doses have been administered Updated: December 6, 2021, 3:34 PM EST
More Than 8.18 Billion Shots Given: Covid-19 Tracker
In the U.S., 462 million doses have been administered Updated: December 5, 2021, 6:34 PM EST
More Than 8.09 Billion Shots Given: Covid-19 Tracker
In the U.S., 462 million doses have been administered Updated: December 2, 2021, 6:34 PM EST
More Than 8.06 Billion Shots Given: Covid-19 Tracker
In the U.S., 462 million doses have been administered Updated: December 2, 2021, 6:35 AM EST
More Than 8.05 Billion Shots Given: Covid-19 Tracker
In the U.S., 461 million doses have been administered Updated: December 1, 2021, 6:34 PM EST
More Than 8.01 Billion Shots Given: Covid-19 Tracker
In the U.S., 461 million doses have been administered Updated: November 30, 2021, 6:34 PM EST
More Than 8 Billion Shots Given: Covid-19 Tracker
In the U.S., 459 million doses have been administered Updated: November 30, 2021, 6:34 AM EST
More Than 7.94 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 29, 2021, 9:33 AM EST
More Than 7.91 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 28, 2021, 12:34 PM EST
More Than 7.90 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 28, 2021, 6:34 AM EST
More Than 7.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 27, 2021, 6:35 AM EST
More Than 7.83 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 25, 2021, 12:34 PM EST
More Than 7.80 Billion Shots Given: Covid-19 Tracker
In the U.S., 454 million doses have been administered Updated: November 24, 2021, 6:35 PM EST
More Than 7.79 Billion Shots Given: Covid-19 Tracker
In the U.S., 453 million doses have been administered Updated: November 24, 2021, 12:34 PM EST
More Than 7.76 Billion Shots Given: Covid-19 Tracker
In the U.S., 453 million doses have been administered Updated: November 23, 2021, 9:32 AM EST
More Than 7.75 Billion Shots Given: Covid-19 Tracker
In the U.S., 451 million doses have been administered Updated: November 23, 2021, 6:34 AM EST
More Than 7.73 Billion Shots Given: Covid-19 Tracker
In the U.S., 451 million doses have been administered Updated: November 22, 2021, 3:34 PM EST
More Than 7.72 Billion Shots Given: Covid-19 Tracker
In the U.S., 451 million doses have been administered Updated: November 22, 2021, 6:34 AM EST
More Than 7.67 Billion Shots Given: Covid-19 Tracker
In the U.S., 445 million doses have been administered Updated: November 20, 2021, 3:34 PM EST
More Than 7.64 Billion Shots Given: Covid-19 Tracker
In the U.S., 445 million doses have been administered Updated: November 20, 2021, 6:34 AM EST
More Than 7.63 Billion Shots Given: Covid-19 Tracker
In the U.S., 445 million doses have been administered Updated: November 19, 2021, 9:34 AM EST
More Than 7.61 Billion Shots Given: Covid-19 Tracker
In the U.S., 445 million doses have been administered Updated: November 18, 2021, 3:34 PM EST
More Than 7.58 Billion Shots Given: Covid-19 Tracker
In the U.S., 443 million doses have been administered Updated: November 17, 2021, 6:34 PM EST
More Than 7.57 Billion Shots Given: Covid-19 Tracker
In the U.S., 443 million doses have been administered Updated: November 17, 2021, 12:58 PM EST
More Than 7.52 Billion Shots Given: Covid-19 Tracker
In the U.S., 441 million doses have been administered Updated: November 15, 2021, 3:34 PM EST
More Than 7.49 Billion Shots Given: Covid-19 Tracker
In the U.S., 439 million doses have been administered Updated: November 14, 2021, 3:34 PM EST
More Than 7.47 Billion Shots Given: Covid-19 Tracker
In the U.S., 439 million doses have been administered Updated: November 13, 2021, 6:25 PM EST
More Than 7.39 Billion Shots Given: Covid-19 Tracker
In the U.S., 434 million doses have been administered Updated: November 12, 2021, 6:35 AM EST
More Than 7.38 Billion Shots Given: Covid-19 Tracker
In the U.S., 434 million doses have been administered Updated: November 11, 2021, 10:34 AM EST
More Than 7.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 434 million doses have been administered Updated: November 11, 2021, 3:35 AM EST
More Than 7.35 Billion Shots Given: Covid-19 Tracker
In the U.S., 433 million doses have been administered Updated: November 10, 2021, 6:33 AM EST
More Than 7.32 Billion Shots Given: Covid-19 Tracker
In the U.S., 432 million doses have been administered Updated: November 9, 2021, 9:33 AM EST
More Than 7.30 Billion Shots Given: Covid-19 Tracker
In the U.S., 432 million doses have been administered Updated: November 8, 2021, 11:34 PM EST
More Than 7.26 Billion Shots Given: Covid-19 Tracker
In the U.S., 431 million doses have been administered Updated: November 7, 2021, 11:33 PM EST
More Than 7.25 Billion Shots Given: Covid-19 Tracker
In the U.S., 428 million doses have been administered Updated: November 7, 2021, 9:33 AM EST
More Than 7.23 Billion Shots Given: Covid-19 Tracker
In the U.S., 428 million doses have been administered Updated: November 6, 2021, 3:33 PM EDT
More Than 7.20 Billion Shots Given: Covid-19 Tracker
In the U.S., 427 million doses have been administered Updated: November 5, 2021, 12:33 PM EDT
More Than 7.16 Billion Shots Given: Covid-19 Tracker
In the U.S., 425 million doses have been administered Updated: November 4, 2021, 11:34 PM EDT
More Than 7.14 Billion Shots Given: Covid-19 Tracker
In the U.S., 425 million doses have been administered Updated: November 3, 2021, 11:34 PM EDT
More Than 7.12 Billion Shots Given: Covid-19 Tracker
In the U.S., 424 million doses have been administered Updated: November 2, 2021, 11:33 PM EDT
More Than 7.11 Billion ShotsGiven: Covid-19 Tracker
In the U.S., 423 million doses have been administered Updated: November 2, 2021, 12:33 PM EDT
More Than 7.08 Billion Shots Given: Covid-19 Tracker
In the U.S., 422 million doses have been administered Updated: November 1, 2021, 12:33 PM EDT
More Than 7.04 Billion Shots Given: Covid-19 Tracker
In the U.S., 421 million doses have been administered Updated: October 31, 2021, 11:33 PM EDT
More Than 7 Billion Shots Given: Covid-19 Tracker
In the U.S., 419 million doses have been administered Updated: October 30, 2021, 9:33 AM EDT
More Than 6.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 419 million doses have been administered Updated: October 29, 2021, 3:34 PM EDT
More Than 6.96 Billion Shots Given: Covid-19 Tracker
In the U.S., 416 million doses have been administered Updated: October 28, 2021, 12:34 PM EDT
More Than 6.94 Billion Shots Given: Covid-19 Tracker
In the U.S., 416 million doses have been administered Updated: October 27, 2021, 11:34 PM EDT
More Than 6.92 Billion Shots Given: Covid-19 Tracker
In the U.S., 415 million doses have been administered Updated: October 27, 2021, 6:34 AM EDT
More Than 6.90 Billion Shots Given: Covid-19 Tracker
In the U.S., 414 million doses have been administered Updated: October 26, 2021, 3:33 PM EDT
More Than 6.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 414 million doses have been administered Updated: October 25, 2021, 11:33 PM EDT
More Than 6.88 Billion Shots Given: Covid-19 Tracker
In the U.S., 414 million doses have been administered Updated: October 25, 2021, 9:33 AM EDT
More Than 6.86 Billion Shots Given: Covid-19 Tracker
In the U.S., 413 million doses have been administered Updated: October 24, 2021, 12:33 PM EDT
More Than 6.84 Billion Shots Given: Covid-19 Tracker
In the U.S., 412 million doses have been administered Updated: October 23, 2021, 12:33 PM EDT
More Than 6.83 Billion Shots Given: Covid-19 Tracker
In the U.S., 412 million doses have been administered Updated: October 23, 2021, 6:34 AM EDT
COVID-19 early treatment: real-time analysis of 1,157 studies
biotecMAX™
Covid-19 Vaccine Tracker
More Than 6.75 Billion Shots Given: Covid-19 Tracker
In the U.S., 410 million doses have been administered Updated: October 20, 2021, 11:34 PM EDT
More Than 6.66 Billion Shots Given: Covid-19 Tracker
In the U.S., 407 million doses have been administered Updated: October 17, 2021, 6:33 AM EDT
More Than 6.64 Billion Shots Given: Covid-19 Tracker
In the U.S., 405 million doses have been administered Updated: October 16, 2021, 6:33 AM EDT
More Than 6.62 Billion Shots Given: Covid-19 Tracker
In the U.S., 405 million doses have been administered Updated: October 15, 2021, 6:33 AM EDT
Dan Watson gets a Pfizer (PFE) /BioNTech (BNTX) Covid-19 booster jab at a Maple Shade NJ CVS on October 14, 2021
More Than 6.59 Billion Shots Given: Covid-19 Tracker
In the U.S., 404 million doses have been administered Updated: October 14, 2021, 6:33 AM EDT
More Than 6.58 Billion Shots Given: Covid-19 Tracker
In the U.S., 404 million doses have been administered Updated: October 13, 2021, 12:33 PM EDT
More Than 6.56 Billion Shots Given: Covid-19 Tracker
In the U.S., 402 million doses have been administered Updated: October 12, 2021, 12:33 PM EDT
More Than 6.53 Billion Shots Given: Covid-19 Tracker
In the U.S., 402 million doses have been administered Updated: October 11, 2021, 6:33 PM EDT
More Than 6.50 Billion Shots Given: Covid-19 Tracker
In the U.S., 402 million doses have been administered Updated: October 10, 2021, 6:33 PM EDT
More Than 6.49 Billion Shots Given: Covid-19 Tracker
In the U.S., 402 million doses have been administered Updated: October 10, 2021, 6:34 AM EDT
More Than 6.46 Billion Shots Given: Covid-19 Tracker
In the U.S., 401 million doses have been administered Updated: October 8, 2021, 6:33 PM EDT
More Than 6.44 Billion Shots Given: Covid-19 Tracker
In the U.S., 400 million doses have been administered Updated: October 7, 2021, 6:33 PM EDT
More Than 6.43 Billion Shots Given: Covid-19 Tracker
In the U.S., 399 million doses have been administered Updated: October 7, 2021, 12:33 PM EDT
More Than 6.40 Billion Shots Given: Covid-19 Tracker
In the U.S., 398 million doses have been administered Updated: October 6, 2021, 6:33 AM EDT
More Than 6.39 Billion Shots Given: Covid-19 Tracker
In the U.S., 398 million doses have been administered Updated: October 5, 2021, 6:33 PM EDT
More Than 6.38 Billion Shots Given: Covid-19 Tracker
In the U.S., 397 million doses have been administered Updated: October 5, 2021, 12:22 PM EDT
More Than 6.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 397 million doses have been administered Updated: October 4, 2021, 7:55 PM EDT
More Than 6.34 Billion Shots Given: Covid-19 Tracker
In the U.S., 396 million doses have been administered Updated: October 3, 2021, 9:22 PM EDT
More Than 6.33 Billion Shots Given: Covid-19 Tracker
In the U.S., 395 million doses have been administered Updated: October 2, 2021, 9:22 PM EDT
More Than 6.30 Billion Shots Given: Covid-19 Tracker
In the U.S., 394 million doses have been administered Updated: October 1, 2021, 3:22 PM EDT
More Than 6.27 Billion Shots Given: Covid-19 Tracker
In the U.S., 393 million doses have been administered Updated: September 30, 2021, 5:31 PM EDT
More Than 6.25 Billion Shots Given: Covid-19 Tracker
In the U.S., 392 million doses have been administered Updated: September 29, 2021, 6:22 PM EDT
More Than 6.19 Billion Shots Given: Covid-19 Tracker
In the U.S., 391 million doses have been administered Updated: September 28, 2021, 5:22 PM EDT
More Than 6.17 Billion Shots Given: Covid-19 Tracker
In the U.S., 390 million doses have been administered Updated: September 27, 2021, 9:29 PM EDT
More Than 6.13 Billion Shots Given: Covid-19 Tracker
In the U.S., 390 million doses have been administered Updated: September 26, 2021, 9:23 PM EDT
More Than 6.12 Billion Shots Given: Covid-19 Tracker
In the U.S., 389 million doses have been administered Updated: September 25, 2021, 9:22 PM EDT
More Than 6.10 Billion Shots Given: Covid-19 Tracker
In the U.S., 389 million doses have been administered Updated: September 25, 2021, 6:23 AM EDT
More Than 6.06 Billion Shots Given: Covid-19 Tracker
In the U.S., 388 million doses have been administered Updated: September 23, 2021, 5:48 PM EDT
More Than 6.03 Billion Shots Given: Covid-19 Tracker
In the U.S., 387 million doses have been administered Updated: September 22, 2021, 5:22 PM EDT
More Than 6.00 Billion Shots Given: Covid-19 Tracker
In the U.S., 387 million doses have been administered Updated: September 21, 2021, 6:22 PM EDT
More Than 5.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 386 million doses have been administered Updated: September 20, 2021, 5:22 PM EDT
More Than 5.95 Billion Shots Given: Covid-19 Tracker
In the U.S., 386 million doses have been administered Updated: September 19, 2021, 9:22 PM EDT
More Than 5.92 Billion Shots Given: Covid-19 Tracker
In the U.S., 385 million doses have been administered Updated: September 18, 2021, 6:22 PM EDT
More Than 5.85 Billion Shots Given: Covid-19 Tracker
In the U.S., 383 million doses have been administered Updated: September 16, 2021, 4:28 PM EDT
More Than 5.81 Billion Shots Given: Covid-19 Tracker
In the U.S., 382 million doses have been administered Updated: September 15, 2021, 4:22 PM EDT
More Than 5.79 Billion Shots Given: Covid-19 Tracker
In the U.S., 381 million doses have been administered Updated: September 14, 2021, 8:29 PM EDT
More Than 5.78 Billion Shots Given: Covid-19 Tracker
In the U.S., 381 million doses have been administered Updated: September 14, 2021, 10:22 AM EDT
More Than 5.76 Billion Shots Given: Covid-19 Tracker
In the U.S., 380 million doses have been administered Updated: September 13, 2021, 10:23 PM EDT
More Than 5.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 380 million doses have been administered Updated: September 12, 2021, 8:04 PM EDT
More Than 5.69 Billion Shots Given: Covid-19 Tracker
In the U.S., 379 million doses have been administered Updated: September 11, 2021, 8:24 PM EDT
More Than 5.66 Billion Shots Given: Covid-19 Tracker
In the U.S., 379 million doses have been administered Updated: September 10, 2021, 2:34 PM EDT
More Than 5.59 Billion Shots Given: Covid-19 Tracker
In the U.S., 377 million doses have been administered Updated: September 8, 2021, 3:37 PM EDT
More Than 5.56 Billion Shots Given: Covid-19 Tracker
In the U.S., 376 million doses have been administered Updated: September 7, 2021, 3:18 PM EDT
More Than 5.53 Billion Shots Given: Covid-19 Tracker
In the U.S., 374 million doses have been administered Updated: September 6, 2021, 11:12 PM EDT
More Than 5.48 Billion Shots Given: Covid-19 Tracker
In the U.S., 374 million doses have been administered Updated: September 5, 2021, 8:56 PM EDT
More Than 5.43 Billion Shots Given: Covid-19 Tracker
In the U.S., 374 million doses have been administered Updated: September 3, 2021, 3:49 PM EDT
More Than 5.39 Billion Shots Given: Covid-19 Tracker
In the U.S., 372 million doses have been administered Updated: September 2, 2021, 3:54 PM EDT
More Than 5.35 Billion Shots Given: Covid-19 Tracker
In the U.S., 371 million doses have been administered Updated: September 1, 2021, 3:34 PM EDT
More Than 5.31 Billion Shots Given: Covid-19 Tracker
In the U.S., 370 million doses have been administered Updated: August 31, 2021, 7:46 PM EDT
More Than 5.26 Billion Shots Given: Covid-19 Tracker
In the U.S., 370 million doses have been administered Updated: August 30, 2021, 3:16 PM EDT
More Than 5.22 Billion Shots Given: Covid-19 Tracker
In the U.S., 369 million doses have been administered Updated: August 29, 2021, 4:06 PM EDT
More Than 5.20 Billion Shots Given: Covid-19 Tracker
In the U.S., 368 million doses have been administered Updated: August 28, 2021, 10:46 PM EDT
More Than 5.11 Billion Shots Given: Covid-19 Tracker
In the U.S., 366 million doses have been administered Updated: August 26, 2021, 5:22 PM EDT
More Than 5.06 Billion Shots Given: Covid-19 Tracker
In the U.S., 365 million doses have been administered Updated: August 25, 2021, 8:08 PM EDT
More Than 5.02 Billion Shots Given: Covid-19 Tracker
In the U.S., 364 million doses have been administered Updated: August 24, 2021, 4:52 PM EDT
More Than 4.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 363 million doses have been administered Updated: August 23, 2021, 7:30 PM EDT
More Than 4.95 Billion Shots Given: Covid-19 Tracker
In the U.S., 363 million doses have been administered Updated: August 22, 2021, 6:54 PM EDT
More Than 4.85 Billion Shots Given: Covid-19 Tracker
In the U.S., 360 million doses have been administered Updated: August 19, 2021, 4:24 PM EDT
More Than 4.82 Billion Shots Given: Covid-19 Tracker
In the U.S., 359 million doses have been administered Updated: August 18, 2021, 5:24 PM EDT
More Than 4.78 Billion Shots Given: Covid-19 Tracker
In the U.S., 358 million doses have been administered Updated: August 17, 2021, 6:07 PM EDT
More Than 4.74 Billion Shots Given: Covid-19 Tracker
In the U.S., 357 million doses have been administered Updated: August 16, 2021, 7:14 PM EDT
More Than 4.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 356 million doses have been administered Updated: August 15, 2021, 7:18 PM EDT
More Than 4.64 Billion Shots Given: Covid-19 Tracker
In the U.S., 355 million doses have been administered Updated: August 13, 2021, 5:13 PM EDT
More Than 4.62 Billion Shots Given: Covid-19 Tracker
In the U.S., 354 million doses have been administered Updated: August 13, 2021, 5:32 AM EDT
More Than 4.56 Billion Shots Given: Covid-19 Tracker
In the U.S., 353 million doses have been administered Updated: August 11, 2021, 7:20 PM EDT
More Than 4.51 Billion Shots Given: Covid-19 Tracker
In the U.S., 353 million doses have been administered Updated: August 10, 2021, 4:45 PM EDT
More Than 4.48 Billion Shots Given: Covid-19 Tracker
In the U.S., 352 million doses have been administered Updated: August 9, 2021, 3:53 PM EDT
More Than 4.45 Billion Shots Given: Covid-19 Tracker
In the U.S., 351 million doses have been administered Updated: August 8, 2021, 6:13 PM EDT
More Than 4.41 Billion Shots Given: Covid-19 Tracker
In the U.S., 351 million doses have been administered Updated: August 7, 2021, 3:53 PM EDT
More Than 4.31 Billion Shots Given: Covid-19 Tracker
In the U.S., 349 million doses have been administered Updated: August 5, 2021, 2:50 PM EDT
More Than 4.27 Billion Shots Given: Covid-19 Tracker
In the U.S., 348 million doses have been administered Updated: August 4, 2021, 5:34 PM EDT
More Than 4.21 Billion Shots Given: Covid-19 Tracker
In the U.S., 347 million doses have been administered Updated: August 3, 2021, 4:31 PM EDT
More Than 4.16 Billion Shots Given: Covid-19 Tracker
In the U.S., 347 million doses have been administered Updated: August 2, 2021, 3:51 PM EDT
More Than 4.13 Billion Shots Given: Covid-19 Tracker
In the U.S., 346 million doses have been administered Updated: August 1, 2021, 5:53 PM EDT
More Than 4.10 Billion Shots Given: Covid-19 Tracker
In the U.S., 346 million doses have been administered Updated: July 31, 2021, 4:58 PM EDT
More Than 4.06 Billion Shots Given: Covid-19 Tracker
In the U.S., 345 million doses have been administered Updated: July 30, 2021, 2:50 PM EDT
More Than 4.02 Billion Shots Given: Covid-19 Tracker
In the U.S., 344 million doses have been administered Updated: July 29, 2021, 5:47 PM EDT
More Than 3.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 343 million doses have been administered Updated: July 28, 2021, 3:00 PM EDT
More Than 3.93 Billion Shots Given: Covid-19 Tracker
In the U.S., 343 million doses have been administered Updated: July 27, 2021, 3:40 PM EDT
More Than 3.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 342 million doses have been administered Updated: July 26, 2021, 4:14 PM EDT
More Than 3.82 Billion Shots Given: Covid-19 Tracker
In the U.S., 341 million doses have been administered Updated: July 24, 2021, 3:11 PM EDT
More Than 3.78 Billion Shots Given: Covid-19 Tracker
In the U.S., 340 million doses have been administered Updated: July 23, 2021, 4:53 PM EDT
More Than 3.74 Billion Shots Given: Covid-19 Tracker
In the U.S., 340 million doses have been administered Updated: July 22, 2021, 4:40 PM EDT
More Than 3.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 339 million doses have been administered Updated: July 21, 2021, 2:20 PM EDT
More Than 3.67 Billion Shots Given: Covid-19 Tracker
In the U.S., 338 million doses have been administered Updated: July 20, 2021, 9:17 PM EDT
More Than 3.64 Billion Shots Given: Covid-19 Tracker
In the U.S., 338 million doses have been administered Updated: July 19, 2021, 3:51 PM EDT
More Than 3.62 Billion Shots Given: Covid-19 Tracker
In the U.S., 338 million doses have been administered Updated: July 18, 2021, 6:28 PM EDT
More Than 3.6 Billion Shots Given: Covid-19 Tracker
In the U.S., 337 million doses have been administered Updated: July 17, 2021, 6:04 PM EDT
More Than 3.57 Billion Shots Given: Covid-19 Tracker
In the U.S., 337 million doses have been administered Updated: July 16, 2021, 3:27 PM EDT
More Than 3.54 Billion Shots Given: Covid-19 Tracker
In the U.S., 336 million doses have been administered Updated: July 15, 2021, 3:26 PM EDT
More Than 3.51 Billion Shots Given: Covid-19 Tracker
In the U.S., 335 million doses have been administered Updated: July 14, 2021, 4:44 PM EDT
More Than 3.46 Billion Shots Given: Covid-19 Tracker
In the U.S., 335 million doses have been administered Updated: July 13, 2021, 5:59 PM EDT
More Than 3.44 Billion Shots Given: Covid-19 Tracker
In the U.S., 335 million doses have been administered Updated: July 12, 2021, 4:58 PM EDT
More Than 3.41 Billion Shots Given: Covid-19 Tracker
In the U.S., 334 million doses have been administered Updated: July 11, 2021, 4:45 PM EDT
More Than 3.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 333 million doses have been administered Updated: July 9, 2021, 3:19 PM EDT
More Than 3.35 Billion Shots Given: Covid-19 Tracker
In the U.S., 332 million doses have been administered Updated: July 8, 2021, 3:33 PM EDT
More Than 3.32 Billion Shots Given: Covid-19 Tracker
In the U.S., 332 million doses have been administered Updated: July 7, 2021, 8:35 PM EDT
More Than 3.26 Billion Shots Given: Covid-19 Tracker
In the U.S., 331 million doses have been administered Updated: July 6, 2021, 3:52 PM EDT
More Than 3.22 Billion Shots Given: Covid-19 Tracker
In the U.S., 331 million doses have been administered Updated: July 5, 2021, 7:39 PM EDT
More Than 3.17 Billion Shots Given: Covid-19 Tracker
In the U.S., 330 million doses have been administered Updated: July 3, 2021, 2:49 PM EDT
More Than 3.14 Billion Shots Given: Covid-19 Tracker
In the U.S., 329 million doses have been administered Updated: July 2, 2021, 3:06 PM EDT
More Than 3.10 Billion Shots Given: Covid-19 Tracker
In the U.S., 328 million doses have been administered Updated: July 1, 2021, 2:59 PM EDT
More Than 3.01 Billion Shots Given: Covid-19 Tracker
In the U.S., 325 million doses have been administered Updated: June 29, 2021, 3:33 PM EDT
More Than 2.97 Billion Shots Given: Covid-19 Tracker
In the U.S., 324 million doses have been administered Updated: June 28, 2021, 4:12 PM EDT
More Than 2.92 Billion Shots Given: Covid-19 Tracker
In the U.S., 323 million doses have been administered Updated: June 27, 2021, 2:12 PM EDT
More Than 2.89 Billion Shots Given: Covid-19 Tracker
In the U.S., 322 million doses have been administered Updated: June 26, 2021, 3:05 PM EDT
More Than 2.85 Billion Shots Given: Covid-19 Tracker
In the U.S., 321 million doses have been administered Updated: June 25, 2021, 5:27 PM EDT
More Than 2.80 Billion Shots Given: Covid-19 Tracker
In the U.S., 321 million doses have been administered Updated: June 24, 2021, 5:24 PM EDT
More Than 2.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 319 million doses have been administered Updated: June 22, 2021, 6:17 PM EDT
More Than 2.66 Billion Shots Given: Covid-19 Tracker
In the U.S., 319 million doses have been administered Updated: June 21, 2021, 7:03 PM EDT
More Than 2.62 Billion Shots Given: Covid-19 Tracker
In the U.S., 318 million doses have been administered Updated: June 20, 2021, 3:45 PM EDT
More Than 2.51 Billion Shots Given: Covid-19 Tracker
In the U.S., 315 million doses have been administered Updated: June 17, 2021, 4:59 PM EDT
More Than 2.47 Billion Shots Given: Covid-19 Tracker
In the U.S., 313 million doses have been administered Updated: June 16, 2021, 4:52 PM EDT
More Than 2.42 Billion Shots Given: Covid-19 Tracker
In the U.S., 312 million doses have been administered Updated: June 15, 2021, 5:29 PM EDT
More Than 2.39 Billion Shots Given: Covid-19 Tracker
In the U.S., 311 million doses have been administered Updated: June 14, 2021, 10:18 PM EDT
More Than 2.35 Billion Shots Given: Covid-19 Tracker
In the U.S., 309 million doses have been administered Updated: June 13, 2021, 6:07 PM EDT
More Than 2.33 Billion Shots Given: Covid-19 Tracker
In the U.S., 308 million doses have been administered Updated: June 12, 2021, 7:40 PM EDT
More Than 2.30 Billion Shots Given: Covid-19 Tracker
In the U.S., 307 million doses have been administered Updated: June 11, 2021, 5:21 PM EDT
More Than 2.26 Billion Shots Given: Covid-19 Tracker
In the U.S., 306 million doses have been administered Updated: June 10, 2021, 5:26 PM EDT
More Than 2.23 Billion Shots Given: Covid-19 Tracker
In the U.S., 305 million doses have been administered Updated: June 9, 2021, 6:38 PM EDT
More Than 2.19 Billion Shots Given: Covid-19 Tracker
In the U.S., 304 million doses have been administered Updated: June 8, 2021, 6:30 PM EDT
More Than 2.12 Billion Shots Given: Covid-19 Tracker
In the U.S., 300 million doses have been administered Updated: June 6, 2021, 3:16 PM EDT
More Than 2.02 Billion Shots Given: Covid-19 Tracker
In the U.S., 298 million doses have been administered Updated: June 4, 2021, 12:17 PM EDT
More Than 2.01 Billion Shots Given: Covid-19 Tracker
In the U.S., 298 million doses have been administered Updated: June 3, 2021, 4:59 PM EDT
More Than 2.00 Billion Shots Given: Covid-19 Tracker
In the U.S., 297 million doses have been administered Updated: June 3, 2021, 11:03 AM EDT
More Than 1.98 Billion Shots Given: Covid-19 Tracker
In the U.S., 297 million doses have been administered Updated: June 2, 2021, 3:11 PM EDT
More Than 1.94 Billion Shots Given: Covid-19 Tracker
In the U.S., 295 million doses have been administered Updated: June 1, 2021, 2:31 PM EDT
More Than 1.91 Billion Shots Given: Covid-19 Tracker
In the U.S., 295 million doses have been administered Updated: May 31, 2021, 5:46 PM EDT
More Than 1.86 Billion Shots Given: Covid-19 Tracker
In the U.S., 295 million doses have been administered Updated: May 30, 2021, 2:52 PM EDT
More Than 1.81 Billion Shots Given: Covid-19 Tracker
In the U.S., 292 million doses have been administered Updated: May 28, 2021, 3:16 PM EDT
More Than 1.78 Billion Shots Given: Covid-19 Tracker
In the U.S., 291 million doses have been administered Updated: May 27, 2021, 6:37 PM EDT
More Than 1.74 Billion Shots Given: Covid-19 Tracker
In the U.S., 289 million doses have been administered Updated: May 26, 2021, 4:39 PM EDT
More Than 1.71 Billion Shots Given: Covid-19 Tracker
In the U.S., 288 million doses have been administered Updated: May 25, 2021, 6:17 PM EDT
More Than 1.68 Billion Shots Given: Covid-19 Tracker
In the U.S., 287 million doses have been administered Updated: May 24, 2021, 4:43 PM EDT
More Than 1.65 Billion Shots Given: Covid-19 Tracker
In the U.S., 286 million doses have been administered Updated: May 23, 2021, 2:46 PM EDT
More Than 1.63 Billion Shots Given: Covid-19 Tracker
In the U.S., 284 million doses have been administered Updated: May 22, 2021, 5:59 PM EDT
More Than 1.60 Billion Shots Given: Covid-19 Tracker
In the U.S., 282 million doses have been administered Updated: May 21, 2021, 9:00 PM EDT
More Than 1.54 Billion Shots Given: Covid-19 Tracker
In the U.S., 277 million doses have been administered Updated: May 19, 2021, 6:45 PM EDT
More Than 1.51 Billion Shots Given: Covid-19 Tracker
In the U.S., 276 million doses have been administered Updated: May 18, 2021, 4:39 PM EDT
More Than 1.48 Billion Shots Given: Covid-19 Tracker
In the U.S., 274 million doses have been administered Updated: May 17, 2021, 9:54 PM EDT
Biden to Send U.S.-Authorized Vaccines Abroad for First Time
More Than 1.45 Billion Shots Given: Covid-19 Vaccine Tracker
More Than 1.45 Billion Shots Given: Covid-19 Tracker
In the U.S., 274 million doses have been administered Updated: May 16, 2021, 3:26 PM EDT
More Than 1.43 Billion Shots Given: Covid-19 Tracker
In the U.S., 271 million doses have been administered Updated: May 15, 2021, 6:04 PM EDT
More Than 1.41 Billion Shots Given: Covid-19 Tracker
In the U.S., 268 million doses have been administered Updated: May 14, 2021, 4:54 PM EDT
More Than 1.38 Billion Shots Given: Covid-19 Tracker
In the U.S., 267 million doses have been administered Updated: May 13, 2021, 6:18 PM EDT
More Than 1.36 Billion Shots Given: Covid-19 Tracker
In the U.S., 265 million doses have been administered Updated: May 12, 2021, 5:34 PM EDT
More Than 1.34 Billion Shots Given: Covid-19 Tracker
In the U.S., 263 million doses have been administered Updated: May 11, 2021, 5:19 PM EDT
More Than 1.31 Billion Shots Given: Covid-19 Tracker
In the U.S., 262 million doses have been administered Updated: May 10, 2021, 5:16 PM EDT
More Than 1.29 Billion Shots Given: Covid-19 Tracker
In the U.S., 260 million doses have been administered Updated: May 9, 2021, 3:07 PM EDT
More Than 1.28 Billion Shots Given: Covid-19 Tracker
In the U.S., 257 million doses have been administered Updated: May 8, 2021, 3:26 PM EDT
More Than 1.25 Billion Shots Given: Covid-19 Tracker
In the U.S., 255 million doses have been administered Updated: May 7, 2021, 5:14 PM EDT
More Than 1.23 Billion Shots Given: Covid-19 Tracker
In the U.S., 252 million doses have been administered Updated: May 6, 2021, 5:11 PM EDT
More Than 1.21 Billion Shots Given: Covid-19 Tracker
In the U.S., 250 million doses have been administered Updated: May 5, 2021, 5:38 PM EDT
More Than 1.19 Billion Shots Given: Covid-19 Tracker
In the U.S., 248 million doses have been administered Updated: May 4, 2021, 7:49 PM EDT
More Than 1.17 Billion Shots Given: Covid-19 Tracker
In the U.S., 247 million doses have been administered Updated: May 3, 2021, 5:16 PM EDT
More Than 1.16 Billion Shots Given: Covid-19 Tracker
In the U.S., 247 million doses have been administered Updated: May 3, 2021, 2:16 PM EDT
More Than 1.10 Billion Shots Given: Covid-19 Tracker
In the U.S., 237 million doses have been administered Updated: April 29, 2021, 4:25 PM EDT
More Than 1.08 Billion Shots Given: Covid-19 Tracker
In the U.S., 235 million doses have been administered Updated: April 28, 2021, 4:28 PM EDT
More Than 1.06 Billion Shots Given: Covid-19 Tracker
In the U.S., 232 million doses have been administered Updated: April 27, 2021, 9:48 PM EDT
More Than 1.04 Billion Shots Given: Covid-19 Tracker
In the U.S., 231 million doses have been administered Updated: April 26, 2021, 5:12 PM EDT
More Than 1.02 Billion Shots Given: Covid-19 Tracker
In the U.S., 231 million doses have been administered Updated: April 26, 2021, 1:39 PM EDT
More Than 1 Billion Shots Given: Covid-19 Tracker
In the U.S., 229 million doses have been administered Updated: April 25, 2021, 3:46 PM EDT
More Than 1 Billion Shots Given: Covid-19 Tracker
In the U.S., 226 million doses have been administered Updated: April 24, 2021, 4:01 PM EDT
More Than 993 Million Shots Given: Covid-19 Tracker
In the U.S., 222 million doses have been administered Updated: April 23, 2021, 5:01 PM EDT
More Than 966 Million Shots Given: Covid-19 Tracker
In the U.S., 219 million doses have been administered Updated: April 23, 2021, 7:00 AM EDT
More Than 944 Million Shots Given: Covid-19 Tracker
In the U.S., 216 million doses have been administered Updated: April 21, 2021, 5:13 PM EDT
More Than 925 Million Shots Given: Covid-19 Tracker
In the U.S., 213 million doses have been administered Updated: April 20, 2021, 8:10 PM EDT
More Than 910 Million Shots Given: Covid-19 Tracker
In the U.S., 212 million doses have been administered Updated: April 19, 2021, 5:22 PM EDT
More Than 894 Million Shots Given: Covid-19 Tracker
In the U.S., 209 million doses have been administered Updated: April 18, 2021, 3:56 PM EDT
More Than 848 Million Shots Given: Covid-19 Tracker
In the U.S., 198 million doses have been administered Updated: April 15, 2021, 4:07 PM EDT
More Than 832 Million Shots Given: Covid-19 Tracker
In the U.S., 195 million doses have been administered Updated: April 14, 2021, 4:44 PM EDT
More Than 814 Million Shots Given: Covid-19 Tracker
In the U.S., 192 million doses have been administered; rollout goes global Updated: April 14, 2021, 8:48 AM EDT
More Than 801 Million Shots Given: Covid-19 Tracker
In the U.S., 192 million doses have been administered; rollout goes global Updated: April 13, 2021, 2:25 PM EDT
More Than 781 Million Shots Given: Covid-19 Tracker
In the U.S., 187 million doses have been administered; rollout goes global Updated: April 11, 2021, 8:27 PM EDT
More Than 768 Million Shots Given: Covid-19 Tracker
In the U.S., 183 million doses have been administered; rollout goes global Updated: April 10, 2021, 9:16 PM EDT
More Than 748 Million Shots Given: Covid-19 Tracker
In the U.S., 179 million doses have been administered; rollout goes global Updated: April 9, 2021, 5:01 PM EDT
More Than 704 Million Shots Given: Covid-19 Tracker
In the U.S., 171 million doses have been administered; rollout goes global Updated: April 7, 2021, 4:49 PM EDT
More Than 689 Million Shots Given: Covid-19 Tracker
In the U.S., 169 million doses have been administered; rollout goes global Updated: April 6, 2021, 9:28 PM EDT
More Than 673 Million Shots Given: Covid-19 Tracker
In the U.S., 167 million doses have been administered; rollout goes global Updated: April 5, 2021, 4:55 PM EDT
More Than 662 Million Shots Given: Covid-19 Tracker
In the U.S., 167 million doses have been administered; rollout goes global Updated: April 5, 2021, 2:38 PM EDT
More Than 658 Million Shots Given: Covid-19 Tracker
In the U.S., 165 million doses have been administered; rollout goes global Updated: April 4, 2021, 3:16 PM EDT
More Than 652 Million Shots Given: Covid-19 Tracker
In the U.S., 162 million doses have been administered; rollout goes global Updated: April 3, 2021, 3:55 PM EDT
More Than 628 Million Shots Given: Covid-19 Tracker
In the U.S., 158 million doses have been administered; rollout goes global Updated: April 2, 2021, 4:25 PM EDT
More Than 608 Million Shots Given: Covid-19 Tracker
In the U.S., 154 million doses have been administered; rollout goes global Updated: April 1, 2021, 5:20 PM EDT
More Than 590 Million Shots Given: Covid-19 Tracker
In the U.S., 150 million doses have been administered; rollout goes global Updated: March 31, 2021, 9:32 PM EDT
More Than 577 Million Shots Given: Covid-19 Tracker
In the U.S., 150 million doses have been administered; rollout goes global Updated: March 31, 2021, 1:50 PM EDT
More Than 574 Million Shots Given: Covid-19 Tracker
In the U.S., 148 million doses have been administered; rollout goes global Updated: March 30, 2021, 7:49 PM EDT
More Than 559 Million Shots Given: Covid-19 Tracker
In the U.S., 146 million doses have been administered; rollout goes global Updated: March 29, 2021, 5:11 PM EDT
More Than 546 Million Shots Given: Covid-19 Tracker
In the U.S., 143 million doses have been administered; rollout goes global Updated: March 28, 2021, 3:05 PM EDT
More Than 535 Million Shots Given: Covid-19 Tracker
In the U.S., 143 million doses have been administered; rollout goes global Updated: March 28, 2021, 3:05 PM EDT
More Than 528 Million Shots Given: Covid-19 Tracker
In the U.S., 140 million doses have been administered; rollout goes global Updated: March 27, 2021, 8:06 PM EDT
More Than 521 Million Shots Given: Covid-19 Tracker
In the U.S., 140 million doses have been administered; rollout goes global Updated: March 27, 2021, 1:50 PM EDT
More Than 518 Million Shots Given: Covid-19 Tracker
In the U.S., 137 million doses have been administered; rollout goes global Updated: March 26, 2021, 4:31 PM EDT
More Than 501 Million Shots Given: Covid-19 Tracker
In the U.S., 133 million doses have been administered; rollout goes global Updated: March 25, 2021, 5:16 PM EDT
More Than 486 Million Shots Given: Covid-19 Tracker
In the U.S., 130 million doses have been administered; rollout goes global Updated: March 24, 2021, 4:26 PM EDT
More Than 470 Million Shots Given: Covid-19 Tracker
In the U.S., 130 million doses have been administered; rollout goes global Updated: March 24, 2021, 1:57 PM EDT
More Than 468 Million Shots Given: Covid-19 Tracker
In the U.S., 128 million doses have been administered; rollout goes global Updated: March 23, 2021, 4:41 PM EDT
More Than 458 Million Shots Given: Covid-19 Tracker
In the U.S., 127 million doses have been administered; rollout goes global Updated: March 22, 2021, 5:02 PM EDT
More Than 449 Million Shots Given: Covid-19 Tracker
In the U.S., 127 million doses have been administered; rollout goes global Updated: March 22, 2021, 12:58 PM EDT
More Than 447 Million Shots Given: Covid-19 Tracker
In the U.S., 124 million doses have been administered; rollout goes global Updated: March 21, 2021, 8:38 PM EDT
More Than 410 Million Shots Given: Covid-19 Tracker
In the U.S., 116 million doses have been administered; rollout goes global Updated: March 18, 2021, 6:24 PM EDT
More Than 400 Million Shots Given: Covid-19 Tracker
In the U.S., 113 million doses have been administered; rollout goes global Updated: March 17, 2021, 4:39 PM EDT
More Than 391 Million Shots Given: Covid-19 Tracker
In the U.S., 111 million doses have been administered; rollout goes global Updated: March 16, 2021, 4:48 PM EDT
More Than 381 Million Shots Given: Covid-19 Tracker
In the U.S., 109 million doses have been administered; rollout goes global Updated: March 15, 2021, 4:32 PM EDT
More Than 374 Million Shots Given: Covid-19 Tracker
In the U.S., 109 million doses have been administered; rollout goes global Updated: March 15, 2021, 2:10 PM EDT
More Than 359 Million Shots Given: Covid-19 Tracker
In the U.S., 107 million doses have been administered; rollout goes global Updated: March 14, 2021, 4:25 PM EDT
More Than 354 Million Shots Given: Covid-19 Tracker
In the U.S., 106 million doses have been administered; rollout goes global Updated: March 13, 2021, 6:07 PM EST
More Than 345 Million Shots Given: Covid-19 Tracker
In the U.S., 101 million doses have been administered; rollout goes global Updated: March 12, 2021, 4:09 PM EST
More Than 326 Million Shots Given: Covid-19 Tracker
In the U.S., 95.7 million doses have been administered; rollout goes global Updated: March 10, 2021, 5:27 PM EST
More Than 319 Million Shots Given: Covid-19 Tracker
In the U.S., 93.7 million doses have been administered; rollout goes global Updated: March 9, 2021, 4:44 PM EST
More Than 313 Million Shots Given: Covid-19 Tracker
In the U.S., 93.7 million doses have been administered; rollout goes global Updated: March 9, 2021, 1:43 PM EST
More Than 312 Million Shots Given: Covid-19 Tracker
In the U.S., 92.1 million doses have been administered; rollout goes global Updated: March 8, 2021, 4:09 PM EST
More Than 304 Million Shots Given: Covid-19 Tracker
In the U.S., 90.4 million doses have been administered; rollout goes global Updated: March 7, 2021, 4:08 PM EST
More Than 299 Million Shots Given: Covid-19 Tracker
In the U.S., 87.9 million doses have been administered; rollout goes global Updated: March 6, 2021, 4:28 PM EST
More Than 279 Million Shots Given: Covid-19 Tracker
In the U.S., 82.6 million doses have been administered; rollout goes global Updated: March 4, 2021, 5:17 PM EST
More Than 273 Million Shots Given: Covid-19 Tracker
In the U.S., 82.6 million doses have been administered; rollout goes global Updated: March 4, 2021, 1:48 PM EST
More Than 271 Million Shots Given: Covid-19 Tracker
In the U.S., 80.5 million doses have been administered; rollout goes global Updated: March 3, 2021, 5:19 PM EST
More Than 265 Million Shots Given: Covid-19 Tracker
In the U.S., 78.6 million doses have been administered; rollout goes global Updated: March 2, 2021, 6:13 PM EST
More Than 245 Million Shots Given: Covid-19 Tracker
In the U.S., 76.9 million doses have been administered; rollout goes global Updated: March 1, 2021, 4:53 PM EST
More Than 241 Million Shots Given: Covid-19 Tracker
In the U.S., 75.2 million doses have been administered; rollout goes global Updated: February 28, 2021, 3:44 PM EST
More Than 236 Million Shots Given: Covid-19 Tracker
In the U.S., 72.8 million doses have been administered; rollout goes global Updated: February 27, 2021, 4:10 PM EST
More Than 231 Million Shots Given: Covid-19 Tracker
In the U.S., 70.5 million doses have been administered; rollout goes global Updated: February 26, 2021, 4:56 PM EST
More Than 225 Million Shots Given: Covid-19 Tracker
In the U.S., 68.3 million doses have been administered; rollout goes global Updated: February 25, 2021, 6:08 PM EST
More Than 218 Million Shots Given: Covid-19 Tracker
In the U.S., 66.5 million doses have been administered; rollout goes global Updated: February 24, 2021, 6:56 PM EST
More Than 213 Million Shots Given: Covid-19 Tracker
In the U.S., 65 million doses have been administered; rollout goes global Updated: February 23, 2021, 6:12 PM EST
More Than 209 Million Shots Given: Covid-19 Tracker
In the U.S., 64.2 million doses have been administered; rollout goes global Updated: February 22, 2021, 6:27 PM EST
More Than 206 Million Shots Given: Covid-19 Tracker
In the U.S., 64.2 million doses have been administered; rollout goes global Updated: February 22, 2021, 1:37 PM EST
More Than 205 Million Shots Given: Covid-19 Tracker
In the U.S., 63.1 million doses have been administered; rollout goes global Updated: February 21, 2021, 5:34 PM EST
More Than 202 Million Shots Given: Covid-19 Tracker
In the U.S., 61.3 million doses have been administered; rollout goes global Updated: February 20, 2021, 8:49 PM EST
More Than 199 Million Shots Given: Covid-19 Tracker
In the U.S., 60.5 million doses have been administered; rollout goes global Updated: February 19, 2021, 8:12 PM EST
More Than 193 Million Shots Given: Covid-19 Tracker
In the U.S., 59.1 million doses have been administered; rollout goes global Updated: February 18, 2021, 6:43 PM EST
More Than 186 Million Shots Given: Covid-19 Tracker
In the U.S., 57.4 million doses have been administered; rollout goes global Updated: February 17, 2021, 7:12 PM EST
More Than 181 Million Shots Given: Covid-19 Tracker
In the U.S., 56.1 million doses have been administered; rollout goes global Updated: February 16, 2021, 7:01 PM EST
U.S. Vaccine Supply Increasing to 13.5 Million Doses a Week
By Jordan Fabian and Josh Wingrove February 16, 2021, 9:30 AM PST Updated on February 16, 2021, 10:11 AM PST
- Pharmacy program vaccine shipments will double as of next week
- Bad weather could slow vaccine shipments over next few days
U.S. Vaccine Supply Increasing to 13.5 Million Doses a Week
More Than 176 Million Shots Given: Covid-19 Tracker
In the U.S., 54.6 million doses have been administered; rollout goes global Updated: February 15, 2021, 3:19 PM PST
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
Dan Watson gets a 2nd jab of the Pfizer (PFE)/BioNTech (BNTX) Covid-19 vaccine on February 15, 2021
at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus) Mega Site
More Than 138 Million Shots Given: Covid-19 Tracker
In the U.S., 44.4 million doses have been administered; rollout goes global Updated: February 9, 2021, 5:26 PM EST
More Than 134 Million Shots Given: Covid-19 Tracker
In the U.S., 43.1 million doses have been administered; rollout goes global Updated: February 8, 2021, 6:07 PM EST
More Than 131 Million Shots Given: Covid-19 Tracker
In the U.S., 42 million doses have been administered; rollout goes global Updated: February 7, 2021, 4:18 PM EST
More Than 128 Million Shots Given: Covid-19 Tracker
In the U.S., 40.5 million doses have been administered; rollout goes global Updated: February 6, 2021, 5:01 PM EST
More Than 124 Million Shots Given: Covid-19 Tracker
In the U.S., 38.5 million doses have been administered; rollout goes global Updated: February 5, 2021, 5:55 PM EST
More Than 119 Million Shots Given: Covid-19 Tracker
In the U.S., 36.7 million doses have been administered; rollout goes global Updated: February 4, 2021, 7:16 PM EST
More Than 108 Million Shots Given: Covid-19 Tracker
In the U.S., 35 million doses have been administered; rollout goes global Updated: February 3, 2021, 6:36 PM EST
More Than 104 Million Shots Given: Covid-19 Tracker
In the U.S., 33.7 million doses have been administered; rollout goes global Updated: February 2, 2021, 6:06 PM EST
Covid-19 Vaccinations Surpass 100 Million Doses Worldwide
In the U.S., 32.8 million doses have been administered: Covid-19 Vaccine Tracker Updated: February 1, 2021, 6:33 PM EST
More Than 98.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 31.8 million doses; vaccine campaign goes global Updated: January 31, 2021, 8:05 PM EST
More Than 97.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 31.8 million doses; vaccine campaign goes global Updated: January 31, 2021, 5:37 PM EST
More Than 94.4 Million Shots Given: Covid-19 Tracker
The U.S. has administered 30.5 million doses; vaccine campaign goes global Updated: January 30, 2021, 5:12 PM EST
More Than 90.8 Million Shots Given: Covid-19 Tracker
The U.S. has administered 28.9 million doses; vaccine campaign goes global Updated: January 29, 2021, 5:13 PM EST
More Than 86.4 Million Shots Given: Covid-19 Tracker
The U.S. has administered 27.3 million doses; vaccine campaign goes global Updated: January 28, 2021, 8:03 PM EST
More Than 82.5 Million Shots Given: Covid-19 Tracker
The U.S. has administered 25.6 million doses; vaccine campaign goes global Updated: January 27, 2021, 5:05 PM EST
More Than 71.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 24.5 million doses; vaccine campaign goes global Updated: January 27, 2021, 12:35 AM EST
More Than 68.1 Million Shots Given: Covid-19 Tracker
The U.S. has administered 23.5 million doses; vaccine campaign goes global Updated: January 25, 2021, 6:49 PM EST
More Than 67.8 Million Shots Given: Covid-19 Tracker
The U.S. has administered 23.1 million doses; vaccine campaign goes global Updated: January 25, 2021, 6:12 PM EST
More Than 65.6 Million Shots Given: Covid-19 Tracker
The U.S. has administered 22.4 million doses; vaccine campaign goes global Updated: January 24, 2021, 6:01 PM EST
Dan Watson gets a 1st jab of the Pfizer (PFE)/BioNTech (BNTX) Covid-19 vaccine on January 24, 2021
at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus) Mega Site
More Than 63 Million Shots Given: Covid-19 Tracker
The U.S. has administered 21.1 million doses; vaccination campaign goes global Updated: January 23, 2021, 5:54 PM EST
More Than 60.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 19.8 million doses; Europe’s rollout begins Updated: January 22, 2021, 5:55 PM EST
More Than 56.7 Million Shots Given: Covid-19 Tracker
The U.S. has administered 18.4 million doses; Europe’s rollout begins Updated: January 21, 2021, 6:42 PM EST
More Than 54.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 17.2 million doses; Europe’s rollout begins Updated: January 20, 2021, 6:34 PM EST
More Than 51.9 Million Shots Given: Covid-19 Tracker
The U.S. has administered 16.3 million doses; Europe’s rollout begins Updated: January 20, 2021, 9:16 AM EST
More Than 46.2 Million Shots Given: Covid-19 Tracker
The U.S. has administered 15.6 million doses; Europe’s rollout begins Updated: January 19, 2021, 6:05 PM EST
More Than 44 Million Shots Given: Covid-19 Tracker
The U.S. has administered 14.7 million doses; Europe’s rollout begins Updated: January 18, 2021, 5:13 PM EST
More Than 42.2 Million Shots Given: Covid-19 Tracker
The U.S. has administered 14.3 million doses; Europe’s rollout begins Updated: January 17, 2021, 5:31 PM EST
More Than 39.7 Million Shots Given: Covid-19 Tracker
The U.S. has administered 13.7 million doses; Europe’s rollout begins Updated: January 16, 2021, 7:08 PM EST
More Than 37.9 Million Shots Given: Covid-19 Tracker
The U.S. has administered 13 million doses; Europe’s rollout begins Updated: January 16, 2021, 1:47 AM EST
More Than 35 Million Shots Given: Covid-19 Tracker
The U.S. has administered 11.9 million doses; Europe’s rollout begins Updated: January 14, 2021, 10:13 PM EST
More Than 34.5 Million Shots Given: Covid-19 Tracker
The U.S. has administered 11.3 million doses; Europe’s rollout begins Updated: January 14, 2021, 7:29 PM EST
More Than 32.4 Million Shots Given: Covid-19 Tracker
The U.S. has administered 10.8 million doses; Europe’s rollout begins Updated: January 13, 2021, 5:41 PM EST
More Than 30.5 Million Shots Given: Covid-19 Tracker
The U.S. has administered 9.94 million doses; Europe’s rollout begins Updated: January 12, 2021, 5:29 PM EST
More Than 29 Million Shots Given: Covid-1 Tracker
The U.S. has administered 9.27 million doses; Europe’s rollout begins Updated: January 11, 2021, 6:49 PM EST
More Than 26 Million Shots Given: Covid-19 Tracker
The U.S. has administered 8.07 million doses; Europe’s rollout begins Updated: January 11, 2021, 11:13 AM EST
More Than 25 Million Shots Given: Covid-19 Tracker
The U.S. has administered 8.02 million doses; Europe’s rollout begins Updated: January 10, 2021, 5:07 PM EST
More Than 24 Million Shots Given: Covid-19 Tracker
The U.S. has administered 7.73 million doses; Europe’s rollout begins Updated: January 9, 2021, 8:30 PM EST
More Than 18.9 Million Shots Given: Covid-19 Tracker
The U.S. has administered 7.05 million doses; Europe’s rollout begins Updated: January 8, 2021, 5:23 PM EST
More Than 17.5 Million Shots Given: Covid-19 Tracker
The U.S. has administered 6.25 million doses; Europe’s rollout begins Updated: January 7, 2021, 6:56 PM EST
More Than 15.9 Million Shots Given: Covid-19Tracker
The U.S. has administered 5.48 million doses; Europe’s rollout begins Updated: January 6, 2021, 8:27 PM EST
More Than 15 Million Shots Given: Covid-19 Tracker
The U.S. has administered 5.05 million doses; Europe’s rollout begins Updated: January 5, 2021, 6:31 PM EST
More Than 13 Million Shots Given: Covid-19 Tracker
The U.S. has administered 4.66 million doses; Europe’s rollout begins Updated: January 4, 2021, 4:32 PM EST
More Than 12.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 4.33 million doses; Europe’s rollout begins Updated: January 3, 2021, 8:04 PM EST
More Than 12 Million Shots Given: Covid-19 Tracker
The U.S. has administered 4.28 million doses; Europe’s rollout begins Updated: January 2, 2021, 4:59 PM EST
More Than 10.8 Million Shots Given: Covid-19 Tracker
The U.S. has administered 3.49 million doses; Europe’s rollout begins Updated: January 1, 2021, 5:21 PM EST
More Than 10.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 3.17 million doses; Europe’s rollout begins Updated: December 31, 2020, 5:29 PM EST
More Than 6 Million Shots Given: Covid-19 Tracker
The U.S. has administered 3.05 million doses—the most of any country so far Updated: December 30, 2020, 11:16 PM EST
More Than 4.2 Million Shots Given: Covid-19 Tracker
The U.S. has administered 1.94 million doses, according to the CDC Updated: December 26, 2020, 3:52 PM EST
More Than 3.3 Million Shots Given: Covid-19 Tracker
The U.S. has administered 1.23 million doses, according to Bloomberg’s count Updated: December 24, 2020, 1:42 PM EST
COVID-19 CoV Genetics
What there is to know about the Covid-19 vaccines roll out in Hong Kong
•Jan 4, 2021
South China Morning Post South China Morning Post
https://www.nytimes.com/live/2021/01/07/world/covid-19-coronavirus
L.A. County first responders told not to bring patients to hospital if survival chances are low
By Antonia Noori Farzan, Erin Cunningham, Marisa Iati, Miriam Berger, Brittany Shammas and Taylor Telford Jan. 5, 2021 at 1:55 p.m. EST
https://www.washingtonpost.com/nation/2021/01/05/coronavirus-covid-live-updates-us/
Prognosis
One Person in 50 in England Now Has Covid, Government Says
N.Y. Seeking More Vaccine Supply Ahead of Distribution Increase
Covid Spike in U.S. South Dwarfs All Earlier Regional Hot Spots
More Than 13 Million Shots Given: Covid-19 Vaccine Tracker
New UK variant is 50% more transmissible than original strain of COVID-19
•Jan 5, 2021
ABC News
Global Vaccination Efforts Roll Out Slower Than Promised
Countries are falling short of the inoculation targets set by leaders. There are more than twice as many Covid-19 patients in California hospitals now as there were a month ago.
Merkel announces an extension of the lockdown in Germany.
https://www.nytimes.com/live/2021/01/05/world/covid-19-coronavirus
LIVE UPDATES
UPDATED TUE, JAN 5 20211:19 PM EST
Covid live updates: U.S. likely to see more virus strains, Biden advisor says; FDA responds to UK vaccine delays
CNBC.com staff
https://www.cnbc.com/2021/01/05/covid-live-updates.html
miracle on ice milagro sobre hielo 冰上的奇迹
The World’s Most Loathed Industry Gave Us a Vaccine in Record Time
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
By Drew Armstrong
Coronavirus: BMJ urges NYT to correct vaccine 'mixing' article
The editor of the British Medical Journal has asked the New York Times to correct an article that says UK guidelines allow two Covid-19 vaccines to be mixed.
Prognosis
PFIZER AND BIONTECH TO SUPPLY THE EUROPEAN UNION WITH 100 MILLION ADDITIONAL DOSES OF COMIRNATY®
Tuesday, December 29, 2020 - 01:11pm
- European Union orders 100 million additional doses of COMIRNATY® bringing total doses to 300 million for 27 EU member states
- All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
PFIZER AND BIONTECH RECEIVE AUTHORIZATION IN THE EUROPEAN UNION FOR COVID-19 VACCINE
Monday, December 21, 2020 - 02:09pm
- COMIRNATY® (also known as BNT162b2) receives conditional marketing authorization from the European Commission; this milestone represents a global joint effort to advance the first authorized mRNA vaccine
- Pfizer and BioNTech are ready to immediately ship initial doses to the 27 EU member states
- Pfizer and BioNTech previously announced an agreement with the European Commission to supply 200 million vaccine doses to EU member states; the EU also has an option to purchase an additional 100 million doses in 2021
- The vaccine has now been granted a conditional marketing authorization, emergency use authorization, or temporary authorization in more than 40 countries worldwide, including all 27 EU member states
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the European Commission (EC) has granted a conditional marketing authorization (CMA) to Pfizer and BioNTech for COMIRNATY® (also known as BNT162b2), for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus, in individuals 16 years of age and older. This follows the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) positive opinion to authorize the vaccine earlier today. The EC granted this CMA in the interest of public health to help address the COVID-19 pandemic. The CMA is valid in all 27 member states of the European Union (EU).
PFIZER AND BIONTECH TO SUPPLY THE U.S. WITH 100 MILLION ADDITIONAL DOSES OF COVID-19 VACCINE
Wednesday, December 23, 2020 - 07:00am
- U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 Vaccine bringing total doses for U.S. to 200 million
- All 200 million doses expected to be delivered by July 31, 2021, allowing for 100 million people in the U.S. to be vaccinated
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 Vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
UK rolls out Oxford-AstraZeneca vaccine as it battles against Covid surge
PUBLISHED MON, JAN 4 20213:01 AM ESTUPDATED MON, JAN 4 20217:22 AM ESTHolly Ellyatt@HOLLYELLYAT
UK to roll out Oxford/AstraZeneca vaccine in January: reports
Regulator could approve the jab by midweek, according to local media.
BY LAURENS CERULUS December 27, 2020 11:11 am
Oxford-AstraZeneca Covid vaccine approved by UK regulator
PUBLISHED WED, DEC 30 20201:57 AM ESTUPDATED WED, DEC 30 20207:34 AM ESTMatt Clinch@MATTCLINCH81Holly Ellyatt@HOLLYELLYATTKEY POINTS
- The Oxford-AstraZeneca vaccine is cheaper than others and does not need to be kept at the ultra-low temperatures required by the Pfizer and Moderna vaccines.
- The shot is expected to be rolled out next week.
- A vaccine by Pfizer-BioNTech has been given to 600,000 people in the U.K., according to government statistics.
AstraZeneca and Government of Canada announce agreement to supply up to 20 million doses of the AZD1222 COVID-19 vaccine
PUBLISHED25 September 2020
JANUARY 1, 20215:38 PM
AstraZeneca expects to supply two million doses of COVID-19 vaccine every week in UK -The Times
By Reuters Staff
South Africa to import 1.5M doses of the AstraZeneca vaccine
Today, 7:02 AM
Merck Announces Supply Agreement with U.S. Government for Initial Doses of Investigational Biological Therapy for the Treatment of Patients with Severe and Critical COVID-19
December 23, 2020 6:45 am EST KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE: MRK),
Coronavirus: India approves AstraZeneca vaccine; Singapore bans visitors from South Africa
The shots could start to be transported from cold storage to Indian states as early as Saturday
All long-term pass holders and short-term visitors with travel history to South Africa within the last 14 days will not be allowed entry into Singapore
Agencies Published: 1:15pm, 1 Jan, 2021
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 Vaccine for Persons 18 Years and Older
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA
Statement on Variants of the SARS-CoV-2 Virus
December 23, 2020 at 4:10 PM ESTPDF Version
The Moderna COVID-19 Vaccine expresses the full-length Spike protein of the SARS-COV-2 virus, allowing for the generation of neutralizing antibody responses to multiple domains of the protein. The full-length Spike protein is 1,273 amino acids long, so while recent variants involve multiple mutations, for instance up to 8 amino acid changes in the spike protein of the B1.1.7 strain, these represent less than a 1% difference from the spike protein encoded by Moderna’s vaccine.
Health Canada Authorizes Moderna COVID-19 Vaccine in Canada
December 23, 2020 at 11:20 AM EST PDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico
December 18, 2020
Lilly to begin pragmatic study of neutralizing antibody bamlanivimab (LY-CoV555) for COVID-19 in New Mexico
December 18, 2020 Tags | Product
Study will provide real-world data and insight on various infusion setting experiences Plan to study bamlanivimab in a diverse group of participants, including Native American communities INDIANAPOLIS , Dec. 18, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced plans to begin
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
December 11, 2020
Data from ACTT-2 Trial of Baricitinib in Hospitalized COVID-19 Patients Supportive of the EUA Published in New England Journal of Medicine
December 11, 2020 Tags | Product
INDIANAPOLIS , Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy
NDIANAPOLIS, Dec. 11, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) announced today that The New England Journal of Medicine has published peer-reviewed results from the Adaptive COVID-19 Treatment Trial (ACTT-2) sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). The Phase 3 study included 1,033 patients from 67 trial sites in eight countries. These results support the emergency use authorization (EUA) issued by the U.S. Food and Drug Administration (FDA) on Nov. 19 for baricitinib in combination with remdesivir in hospitalized patients with COVID-19 requiring supplemental oxygen.
Dec 31, 2020 02:58 PM WORLD
Singapore Begins Covid Vaccinations as One of Asia’s First
About Veklury®
Veklury® (remdesivir) is a nucleotide analog invented by Gilead, building on more than a decade of the company’s antiviral research. Veklury has broad-spectrum antiviral activity both in vitro and in vivo in animal models against multiple emerging viral pathogens, including Ebola, SARS, Marburg, MERS and SARS-CoV-2, the virus that causes COVID-19.
https://www.gilead.com/purpose/advancing-global-health/covid-19/about-veklury
December 29, 2020 at 4:30 PM EST
REGENERON ANNOUNCES ENCOURAGING INITIAL DATA FROM COVID-19 ANTIBODY COCKTAIL TRIAL IN HOSPITALIZED PATIENTS ON LOW-FLOW OXYGEN
TARRYTOWN, N.Y., Dec. 29, 2020 /PRNewswire/ --
Phase 3 program in hospitalized patients to continue based on passing futility analysis on ability to reduce incidence of death or mechanical ventilation
As in earlier outpatient trial, immune status when patients entered the trial was a strong predictor of viral load and clinical outcomes
First antibody therapy to demonstrate anti-viral effect in patients hospitalized with COVID-19
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)
December 17, 2020 at 5:00 PM EST Back
NEW ENGLAND JOURNAL OF MEDICINE PUBLISHES POSITIVE INITIAL REGENERON ANTIBODY COCKTAIL RESULTS IN NON-HOSPITALIZED PATIENTS WITH COVID-19
TARRYTOWN, N.Y., Dec. 17, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the New England Journal of Medicine (NEJM) has published initial clinical data from an ongoing seamless Phase 1/2/3 trial of the antibody cocktail casirivimab and imdevimab in non-hospitalized patients with COVID-19.
Hong Kong fourth wave: city finally secures enough Covid-19 vaccines to cover all residents after striking deal with AstraZeneca
Government has now procured 22.5 million doses, city leader Carrie Lam reveals as she urges everyone to get shots
Indemnity fund to provide help to those who develop rare and serious responses after being vaccinated, but officials say the programme is safe
Phila Siu , Lilian Cheng and Elizabeth Cheung
China promises free jabs for all as Sinopharm’s Covid-19 vaccine approved
The approval comes with conditions but regulator is confident the vaccine is safe and effective
National Health Commission says the shot is a ‘public good’ and will be provided to national inoculation programme
Zhuang Pinghui in Beijing and Simone McCarthy Published: 12:00pm, 31 Dec, 2020
China grants conditional market approval for its first homemade COVID-19 vaccine
By Leng Shumei, Hu Yuwei and Zhang Hui Published: Dec 31, 2020 10:11 AM Updated: Dec 31, 2020 04:11 PM
Coronavirus: Turkey says China’s CoronaVac vaccine 91.25 per cent effective
Health minister says results are first to be released for the Sinovac product; the firm recently delayed an announcement to consolidate data from global trials
Turkey is expecting a shipment of 3 million doses on Monday, as part of a deal for 50 million doses
Associated Press Published: 2:44am, 25 Dec, 2020
Covid: Post-exposure antibody protection trialled
By Rachel Schraer
Health reporter
Ten people have been given antibodies as a form of emergency protection after being exposed to coronavirus, in the first trial of its kind.
https://www.bbc.com/news/health-55438758
To the participants in our COVID-19 vaccine trial around the world: Thank You.
DECEMBER 23, 20203:23 PMUPDATED 17 HOURS AGO
Federal judge blocks Trump administration drug pricing rule
By Brendan Pierson (Reuters) -
Coronavirus: what we know so far about the new strain of Covid-19
•Dec 23, 2020
South China Morning Post South China Morning Post
Coronavirus updates: Third state identifies more transmissible variant as U.S. cases surpass 20 million
By Marisa Iati Jan. 1, 2021 at 1:49 p.m. EST
https://www.washingtonpost.com/nation/2021/01/01/coronavirus-covid-updates/
#ABCNews #COVID19 #NewCoronavirusVariant
What we know about new COVID-19 variant detected in UK l GMA
•Dec 24, 2020
ABC News ABC News
Prognosis
New Virus Strain Fears; Tokyo Battles Spread: Virus Update
Bloomberg News December 30, 2020, 6:15 PM EST Updated on December 31, 2020, 7:54 AM EST
Jan 02, 2021 07:34 PM
China Confirms First British Covid-19 Variant in Shanghai
By Lu Zhenhua
The U.S. needs to identify mutant strains faster: Dr. Peter Hotez
•Jan 4, 2021
CNBC Television Dr. Peter Hotez, co-director of the Center for Vaccine Development at Texas Children’s Hospital, says he is conducting research to neutralize a new South African Covid-19 variant. He says the U.S. needs to identify mutant strains faster to tackle this problem.
What You Need to Know About Getting Tested for Coronavirus Long lines, slow results and inconsistent advice have left many of us confused about when and how to get tested. We talked to the experts to answer your questions.
By Tara Parker-Pope and Katherine J. Wu Dec. 9, 2020
https://www.nytimes.com/2020/12/09/well/live/covid-coronavirus-testing.html
https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/?srnd=premium
Johns Hopkins experts in global public health, infectious disease, and emergency preparedness have been at the forefront of the international response to COVID-19.
This website is a resource to help advance the understanding of the virus, inform the public, and brief policymakers in order to guide a response, improve care, and save lives.
This Project is supported by Bloomberg Philanthropies and the Stavros Niarchos Foundation (SNF). https://coronavirus.jhu.edu/
COVID-19 Vaccinations in the United States
By Marisa Iati QuickTake
What You Need to Know About Allergic Reactions to Covid Vaccines
By John Lauerman December 31, 2020, 12:01 AM EST
NEW JERSEY COVID-19 Information Hub
Call (General COVID-19 Questions): 2-1-1 (24/7) Call (Medical COVID-19 Questions): 1-800-962-1253 (24/7)
Call (Vaccine Appointment Support): 1-855-568-0545 (8a-8p) Text NJCOVID to 898-211 to receive alerts
Download COVID Alert NJ app here https://covid19.nj.gov/
States in the West and South have the highest shares of residents hospitalized as Los Angeles hospitals turned away ambulances. By Fenit Nirappil and William Wan
Astra-Oxford Covid-19 Vaccine Gets U.K. Clearance
•Dec 30, 2020
Bloomberg Markets and Finance Bloomberg Markets and Finance
How the Pfizer-BioNTech COVID-19 vaccine was developed
•Dec 20, 2020
60 Minutes 60 Minutes
Dr Li Wenliang
Dr. Li Wenliang
Coronavirus: tributes pour in for Li Wenliang, the Chinese doctor who first warned of a deadly disease
‘I hope in the future there will be fewer dead heroes, and more normal, great, everyday people,’ social media user says
‘Our attention then was still on saving the sufferers, we didn’t expect that someone as young as him wouldn’t be able to survive,’ Wuhan doctor Ai Fen says
William Langley Published: 11:30pm, 30 Dec, 2020
Prior news-reports below
Coronavirus: Wuhan police apologise to family of whistle-blowing doctor Li Wenliang
- Medic’s death sparked national outrage after he was disciplined for warning colleagues about early cases of Covid-19
- City’s force says two officers have been disciplined after a report by a team from Beijing blamed a local station for mishandling the case
Keegan Elmer in Beijing Published: 8:18pm, 19 Mar, 2020
Li Wenliang: Coronavirus kills Chinese whistleblower doctor
- 7 February 2020
https://www.bbc.com/news/world-asia-china-51403795
BACKCHANNEL05.01.2020 07:00 AM
Inside the Early Days of China’s Coronavirus Coverup
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
Coronavirus: Whistle-blower Dr Li Wenliang confirmed dead of the disease at 34, after hours of chaotic messaging from hospital
- Li was one of the first doctors who tried to share information about the coronavirus only to be reprimanded by Wuhan police
- Wuhan Central Hospital initially denied reports he was dead, saying he was in ‘critical condition’, before finally confirming he had died
Cissy Zhou Published: 12:05am, 7 Feb, 2020
Li Wenliang: an ‘ordinary hero’ at the centre of the coronavirus storm
- In a self-criticism to his employer, Li said he had no authority to ‘release inaccurate information’
- He promised to keep in line with the Communist Party ‘in thought and action’
Guo Rui in Guangzhou and Jane Cai
Published: 11:00am, 15 Feb, 2020
Chinese doctor who sounded the alarm on coronavirus dies of the illness
BY SOPHIE LEWIS
FEBRUARY 6, 2020 / 4:09 PM / CBS NEWS
China Announces That It Will Expel American Journalists
The announcement comes weeks after President Trump limited the number of Chinese citizens who can work in the United States for five state-run Chinese news organizations.
SHAWN YUAN BACKCHANNEL05.01.2020 07:00 AM
Inside the Early Days of China’s Coronavirus Coverup
The dawn of a pandemic—as seen through the news and social media posts that vanished from China’s internet.
That day, a Wuhan doctor named Li Wenliang—a whistleblower who had raised alarms about the virus in late December, only to be reprimanded for “spreading rumors”—died of Covid-19.
Within hours, his death sparked a spectacular outpouring of collective grief on Chinese social media—an outpouring that was promptly snuffed out, post by post, minute by minute. With that, grief turned to wrath, and posts demanding freedom of speech erupted across China’s social media platforms as the night went on.
biotecMAX™
Crashing In - BiotecWARS Sep. 19, 2021 7:35 PM ET
Crashing In - BiotecWARS
Sep. 19, 2021 7:35 PM ET ABBV, AMGN, BGNE, BMY, GILD, JNJ, MRK
Summary
- I should be more upbeat as COVID-19 subsides in America and elsewhere, but I am not.
- throughout the summer of 2021 I continued to add positions in (ABBV) (AMGN) (GILD) (MRK) (JNJ) (BMY) whenever I can with quarterly dividends.
- “Among the richest men in China, few have good endings.” - Jack Ma.
- Politicos/Central Governments now dominate the business backdrop in many countries
- https://seekingalpha.com/instablog/5205071-danwatson888/5641043-crashing-in-biotecwars
Confirmed Covid-19 cases
https://multimedia.scmp.com/widgets/china/wuhanvirus/#
Coronavirus in the U.S.: Latest Map and Case Count
Updated Sept. 26, 2021
https://www.nytimes.com/interactive/2021/us/covid-cases.html
miracle on ice milagro sobre hielo 冰上的奇迹
The World’s Most Loathed Industry Gave Us a Vaccine in Record Time
At least one thing went right in 2020: Pharmaceutical companies came through. Thank you, science.
PHOTOGRAPHER: IAN LORING SHIVER FOR BLOOMBERG BUSINESSWEEK; PROP STYLIST: DAVID PROBASCO
By Drew Armstrong
COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
Tracking the Spread of the
Coronavirus Outbreak in the U.S.
https://www.bloomberg.com/graphics/2020-united-states-coronavirus-outbreak/?srnd=coronavirus
Confirmed Covid-19 cases
https://multimedia.scmp.com/widgets/china/wuhanvirus/#
#nanographics #visualization #biology
What does a virus actually look like?
•Jan 18, 2021
Too Dope for Microscope
Real SARS-CoV-2 virion in 3D
What does a virus actually look like?
This is the first time you can see real (flash-frozen) coronavirus in 3D. We used machine learning and advanced visualization algorithms to show you the most detailed view of a real SARS-CoV-2 virion, in 3D, directly from Cryo-ET data.
The Cryo-ET data were provided by Sai Li of Tsinghua University, Beijing, China.
https://nanographics.at/projects/coronavirus-3d/
ENGAGING, INTERACTIVE VISUAL EXPERIENCES
Nanographics turns your ideas, concepts, and data into images, animations, or interactive visuals. We focus on both understandability and aesthetics, so that you are able to efficiently deliver the message to your audience. Besides creating visualizations for you, we also specialize in software development, where the visual output plays a crucial role.
First 3D scan of the real coronavirus revealed
•Jan 25, 2021
South China Morning Post South China Morning Post
https://www.youtube.com/watch?v=W87C-1JFVIQ&feature=emb_logo
First 3D scan of the real coronavirus revealed
Jan 25, 2021 South China Morning Post
Austrian company Nanographics made the first 3 dimensional image of the SARS-CoV-2 virus. The real image, not a computer graphic or model of it, was unveiled by researchers from China's Tsinghua University, King Abdullah University of Science and Technology, and the Austrian company Nanographics. The 3D scan of the virus that causes Covid-19 was released on January 19, 2021.
A Look Back At Covering The Coronavirus Pandemic: ‘Unlike Anything I’d Experienced’ | Sunday TODAY
•Dec 27, 2020
TODAY
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
Sep. 11, 2020 7:23 PM ET|
About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
https://seekingalpha.com/instablog/5205071-danwatson888/5496262-biotecmax-you-keep-hope-alive
Pfizer-BioNTech COVID-19 vaccine
PFIZER AND BIONTECH TO SUPPLY THE EUROPEAN UNION WITH 100 MILLION ADDITIONAL DOSES OF COMIRNATY®
Tuesday, December 29, 2020 - 01:11pm
- European Union orders 100 million additional doses of COMIRNATY® bringing total doses to 300 million for 27 EU member states
- All 300 million doses expected to be delivered in 2020 and 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they will supply an additional 100 million doses of COMIRNATY®, the companies’ COVID-19 Vaccine, to the 27 European Union (EU) member states in 2021. This announcement is a result of the European Commission’s decision to exercise its option to purchase an additional 100 million doses under its Advanced Purchase Agreement signed on November 11, 2020. This agreement brings the total number of doses to be delivered to the EU to 300 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201229005380/en/
PFIZER AND BIONTECH CELEBRATE HISTORIC FIRST AUTHORIZATION IN THE U.S. OF VACCINE TO PREVENT COVID-19
Friday, December 11, 2020 - 11:12pm
- U.S. FDA authorizes COVID-19 mRNA vaccine for emergency use; companies are prepared to deliver first doses in the U.S. immediately
- Pfizer and BioNTech previously announced an agreement with the U.S. Government to supply doses in 2020 & 2021
- In collaboration with Operation Warp Speed, Pfizer and BioNTech, as well as other vaccine companies are expected to deliver hundreds of millions of vaccine doses to Americans by the end of 2021
- Historic science-driven efforts will seek to help bring an end to the most devastating pandemic in a century
- Pfizer and BioNTech expect to file a Biologics License Application for possible full regulatory approval in 2021
NEW YORK & MAINZ, Germany--(BUSINESS WIRE)-- Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against COVID-19 in individuals 16 years of age or older. The vaccine is now authorized under an Emergency Use Authorization (EUA) while Pfizer and BioNTech gather additional data and prepare to file a planned Biologics License Application (BLA) with the FDA for a possible full regulatory approval in 2021.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201211005640/en/
Pfizer and BioNTech to Supply the U.S. with 100 Million Additional Doses of COVID-19 Vaccine
- U.S. government orders 100 million additional doses of the Pfizer-BioNTech COVID-19 vaccine bringing total doses for U.S. to 200 million
- All 200 million doses will be produced by U.S. manufacturing facilities and are expected to be delivered by July 31, 2021, allowing for 100 million people in the U.S. to be vaccinated
NEW YORK and MAINZ, GERMANY, December 23, 2020 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced a second agreement with the U.S. government to supply an additional 100 million doses of the companies’ COVID-19 vaccine from production facilities in the U.S. This agreement brings the total number of doses to be delivered to the U.S. to 200 million. The companies expect to deliver the full 200 million doses to Operation Warp Speed (OWS) by July 31, 2021. Consistent with the original agreement announced in July 2020, the U.S. government will pay $1.95 billion for the additional 100 million doses.
https://seekingalpha.com/symbol/PFE
https://seekingalpha.com/symbol/BNTX
Prognosis
The bloc is pursuing a deal that could double its Pfizer shot supply.
Prognosis
NEWS/ An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission
AN IN VITRO STUDY SHOWS PFIZER-BIONTECH COVID-19 VACCINE ELICITS ANTIBODIES THAT NEUTRALIZE SARS-COV-2 WITH A MUTATION ASSOCIATED WITH RAPID TRANSMISSION
Friday, January 08, 2021 - 12:00am
New York, NY and Mainz, Germany, January 8, 2021 — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced results from an in vitro study conducted by Pfizer and the University of Texas Medical Branch (UTMB) that shows the antibodies from people who have received the Pfizer-BioNTech COVID-19 vaccine effectively neutralize SARS-CoV-2 with a key mutation that is also found in two highly transmissible strains. The results were published on the preprint server bioRxiv and are available here.
Prognosis
Asia Today: Australia OKs Pfizer vaccine, to begin in Feb.
Sun January 24, 2021 9:43 PM|Associated Press|About: AZN, BNTX, PFE
SYDNEY (AP) — Australia’s medical regulator has approved use of its first coronavirus vaccine, paving the way for inoculations to begin next month.
https://seekingalpha.com/pr/18162304-asia-today-australia-oks-pfizer-vaccine-to-begin-in-feb
To the participants in our COVID-19 vaccine trial around the world: Thank You.
Thank you for making a difference.
We are grateful to the tens of thousands of courageous people who chose to volunteer for the COVID-19 Vaccine Study.
https://www.covidvaccinestudy.com/participants?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link&__cf_chl_jschl_tk__=pmd_g1zZMaCx_mWM_x7W3fg8tpYq819m7j3OaSM8.KwtHf0-1631621060-0-gqNtZGzNAqWjcnBszQjR
Pfizer/BioNTech to speed up vaccination of placebo arm in COVID-19 trial
Jan. 02, 2021 2:54 AM ET Pfizer Inc. (PFE) By: Dulan Lokuwithana, SA News Editor19 Comments
Moderna COVID-19 Vaccine (mRNA-1273 SARS-CoV-2 vaccine)
Moderna COVID-19 Vaccine
GO TO FULL UNITED STATES SITE HERE:
For US Vaccination ProvidersFor US Vaccine Recipients
- The Moderna COVID‑19 Vaccine has not been approved or licensed by the US Food and Drug Administration (FDA), but has been authorized for emergency use by FDA, under an Emergency Use Authorization (EUA), to prevent Coronavirus Disease 2019 (COVID‑19) for use in individuals 18 years of age and older. There is no FDA-approved vaccine to prevent COVID‑19.
- The EUA for the Moderna COVID‑19 Vaccine is in effect for the duration of the COVID‑19 EUA declaration justifying emergency use of the product, unless the declaration is terminated or the authorization is revoked sooner.
- https://www.modernatx.com/
Health Canada Authorizes Moderna COVID-19 Vaccine in Canada
December 23, 2020 at 11:20 AM ESTPDF Version
Authorization under Health Canada's Interim Order
Canadian government has secured 40 million doses
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 23, 2020-- Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines to create a new generation of transformative medicines for patients, today announced that Health Canada has authorized its vaccine against COVID-19 for the immunization of people 18 years of age and older under an Interim Order.
U.S. CDC Advisory Committee on Immunization Practices Recommends Vaccination with Moderna’s COVID-19 Vaccine for Persons 18 Years and Older
December 19, 2020 at 9:44 PM ESTPDF Version
Recommendation follows yesterday’s U.S. FDA authorization for emergency use of the Moderna COVID-19 Vaccine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 19, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted today to recommend the use of the Moderna COVID-19 vaccine in people 18 years of age and older under the Emergency Use Authorization (EUA) issued by the U.S. Food and Drug Administration (FDA). The committee is comprised of independent health experts. 11 ACIP members voted in favor of the vaccine and 0 members voted against.
https://seekingalpha.com/symbol/MRNA
Contracts For Dec. 28, 2020
Moderna US Inc., Cambridge, Massachusetts, was awarded a $1,966,598,000 modification (P00003) to contract W911QY20C0100 for purchase of an additional 100 million filled drug production doses of SARS-CoV-2 mRNA-1273 vaccine utilizing Option 1 and acetate efforts on the base and option. Work will be performed in Cambridge, Massachusetts, with an estimated completion date of June 30, 2021. Fiscal 2021 research, development, test and evaluation funds in the amount of $1,966,598,000 were obligated at the time of the award. U.S. Army Contracting Command, Aberdeen Proving Ground, Maryland, is the contracting activity. (Awarded Dec. 11, 2020)
Moderna secures $1.97B Army contract modification for COVID-19 vaccine doses
Dec. 28, 2020 11:43 PM ETModerna, Inc. (MRNA)By: Mamta Mayani, SA News Editor17 Comments
- Moderna (NASDAQ:MRNA
Prognosis
Moderna COVID-19 Vaccine Retains Neutralizing Activity Against Emerging Variants First Identified in the U.K. and the Republic of South Africa
January 25, 2021 at 8:28 AM ESTPDF Version
Out of an abundance of caution, Moderna launches clinical program to boost immunity to emerging variants
Manuscript posted to preprint server; company to host conference call once manuscript is available
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 25, 2021-- Moderna Inc. (Nasdaq: MRNA),
Moderna's COVID-19 jab retains neutralizing activity against emerging virus variants
Jan. 25, 2021 9:02 AM ET Moderna, Inc. (MRNA)
By: Aakash Babu, SA News Editor9 Comments
- Moderna (NASDAQ:MRNA)
Dan Watson gets a 1st jab of the Pfizer (PFE) Covid-19 Vaccine on January 24, 2021 at Rowan College of South Jersey (RCSJ) Sewell NJ (Gloucester Main Campus)
Thank you to all at Pfizer (PFE) & BioNTech (BNTX) & moderna (MRNA) &
AstraZeneca (AZN) & Novavax (NVAX) & Johnson & Johnson (JNJ) –
Bless you all.
COVID-19 Vaccine
Vaccinations are underway across New Jersey.
biotecHOPE™ Won’t Stop Now
biotecHOPE™ Won’t Stop Now
Aug. 26, 2020 5:37 PM ET
|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
"I know breakthrough is coming, By faith I see a miracle
My God made me a promise, And it won't stop now"
https://seekingalpha.com/instablog/5205071-danwatson888/5489657-biotechope-won-t-stop-now
biotecNOVA™ - Let The Light In
biotecNOVA™ - Let The Light In
Jul. 11, 2020 12:00 PM ET
|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
https://seekingalpha.com/instablog/5205071-danwatson888/5471018-biotecnova-let-light-in
biotecMAX™
BiotecHOPE™ New Day
BiotecHOPE™ New Day
Mar. 14, 2021 3:08 PM ET AZN, BNTX, JNJ, LLY, MRK, MRNA, NVAX, PFE, VIR
Summary
- The vaccine and therapeutic news and updates coming on the Covid-19 disease has been nothing less than remarkable.
- For once HOPE, and specifically www.biotecHOPE.com is in the air.
- Unfortunately, the www.biohazard2020.com is not over, the virus continues to mutate and is still an issue to those who are susceptible and/or at risk.
- I am increasing my long positions in the following companies – (MRK), (ABBV), (AMGN), (JNJ), (GILD), (BMY), (LLY) and will consider adding the following (MRNA), (BNTX), (NVAX), (VIR).
- even with all the positive vaccine news, I am not feeling as upbeat as I thought I would regarding my personal life and the lives of my family.
https://seekingalpha.com/instablog/5205071-danwatson888/5566982-biotechope-new-day
2019
2020
2021
2021 & 2020
Take Me On A Ride – BiotecWARS™
Take Me On A Ride – BiotecWARS™
Feb. 8, 2021 7:38 AM ET
|About: AbbVie Inc. (ABBV), ABMD, AGN, AMGN, AMRN, BGNE, BIIB, BMY, CELG, GILD, IMMU, JNJ, KPTI, REGN, SGEN, VIR, ISRG
Summary
On January 29, 2021 I increased my positions in (JNJ) on a down day for (JNJ)??, when they released their findings on their vaccine.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV)(AZN) since September 2020.
Our markets look foolish and more like gambling/gaming then investing.
For more a comprehensive perspective on Covid-19 I now view other information sources from around the world.
“OK Boomer” or even “Boomer” – does not mean anything positive now.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5552661-take-me-on-ride-biotecwar
Revival’s In The Air–BiotecWARS™ Jan. 20, 2021 7:10 PM ET|
Revival’s In The Air–BiotecWARS™
Jan. 20, 2021 7:10 PM ET| About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the "SeekingBiotechAlpha" portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
COVID-19 Vaccinations in the United States
Maps, charts, and data provided by the CDC, updated daily by 8 pm ET
biotecMAX™
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Biotech-WAR$™-God, Turn It Around 上帝，把它转过来
Dec. 8, 2020 8:08 PM ET| About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
Thank you for visiting biotecALPHA™
Thank you fior visiting biotecHEART™
BiotecNOVA™ Running to the LIGHT
BiotecNOVA™ Running To The Light
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY,
Summary
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
Thank you for visiting biotecNOVA™
Thank you for visiting biotecDATA™
See A Victory – BiotecMAX™
See A Victory – BiotecMAX™
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
Thank you for visiting biotecMAX™
On August 1, 2020 I started the third full page of information and updates on Covid-19/SARS CoV2.
I never thought that this www.BioHazard2020.com would result in a third full page, but it does.
My first virus posting on this site was on January 11, 2020 ( https://seekingbiotechalpha.com/2020-1 ) =
https://www.scmp.com/news/hong-kong/health-environment/article/3045750/wuhan-pneumonia-hong-kong-set-develop-new-test and https://www.caixinglobal.com/2020-01-11/first-death-from-new-sars-like-virus-reported-in-central-chinas-wuhan-101503267.html
Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
BiotecHOPE™
There are many new medicines in testing, development and clinical trials that are currently not available or recently approved to the marketplace and many are having encouraging and positive results. There are also many approved meds that are in tests involved for other ailments/conditions that might work, where these new trials will determine. BiotecHOPE™ will seek to highlight these trials/efforts many of which are from smaller/newer biotech companies and/or are being developed by/with Universities or Hospitals.
Welcome to BiotecHOPE™ and thank you for visiting www.biotechope.com.
Thank you for visiting biotecMAX ™
biotecMAX™ Run To The Father
Sep. 28, 2020 9:38 AM ET| About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
https://seekingalpha.com/instablog/5205071-danwatson888/5512633-see-victory-biotecmax
Thank you for visiting biotech-WARS™
Thank you for visiting biotechVORTEX™
BioHazard2020 biotech-WARS™ biotecNOVA™ (Danwatsonblogs)
BiotecHOPE™ New Day
Revival’s In The Air–BiotecWARS™
Take Me On A Ride – BiotecWARS™
BiotecHOPE™ New Day
Mar. 14, 2021 3:08 PM ETAZN, BNTX, JNJ, LLY, MRK, MRNA, NVAX, PFE, VIR
Summary
- The vaccine and therapeutic news and updates coming on the Covid-19 disease has been nothing less than remarkable.
- For once HOPE, and specifically www.biotecHOPE.com is in the air.
- Unfortunately, the www.biohazard2020.com is not over, the virus continues to mutate and is still an issue to those who are susceptible and/or at risk.
- I am increasing my long positions in the following companies – (MRK), (ABBV), (AMGN), (JNJ), (GILD), (BMY), (LLY) and will consider adding the following (MRNA), (BNTX), (NVAX), (VIR).
- even with all the positive vaccine news, I am not feeling as upbeat as I thought I would regarding my personal life and the lives of my family.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Take Me On A Ride – BiotecWARS™
Revival’s In The Air–BiotecWARS™
Take Me On A Ride – BiotecWARS™
Take Me On A Ride – BiotecWARS™
Feb. 8, 2021 7:38 AM ET|
About: AbbVie Inc. (ABBV), ABMD, AGN, AMGN, AMRN, BGNE, BIIB, BMY, CELG, GILD, IMMU, JNJ, KPTI, REGN, SGEN, VIR, ISRG
Summary
On January 29, 2021 I increased my positions in (JNJ) on a down day for (JNJ)??, when they released their findings on their vaccine.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV)(AZN) since September 2020.
Our markets look foolish and more like gambling/gaming then investing.
For more a comprehensive perspective on Covid-19 I now view other information sources from around the world.
“OK Boomer” or even “Boomer” – does not mean anything positive now.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5552661-take-me-on-ride-biotecwars
Revival’s In The Air–BiotecWARS™
Revival’s In The Air–BiotecWARS™
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Revival’s In The Air–BiotecWARS™
Jan. 20, 2021 7:10 PM ET|
About: AbbVie Inc. (ABBV), AZN, BGNE, BMRN, BMY, BNTX, JNJ, LLY, MRK, MRNA, PFE, RHHBY, SGEN
Summary
After a storm sometimes skies become clearer.
Many companies are now considering or have already concluded that they will no longer fund politicos, either all of them, or some of them.
“The World’s Most Loathed Industry Gave Us a Vaccine in Record Time”.
I have been adding long positions in (MRK) (GILD) (AMGN) (JNJ) (ABBV) (AZN) since September 2020 to the SeekingBiotechAlpha portfolio.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
https://seekingalpha.com/instablog/5205071-danwatson888/5545353-revival-s-in-air-biotecwars
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
Biotech-WAR$™-God, Turn It Around 上帝，把它转过来
Dec. 8, 2020 8:08 PM ET|About: AbbVie Inc. (ABBV), AMGN, AZN, BGNE, GILD, GSK, JNJ, MRK, PFE
Summary
The unfortunate truth is the biotech-WAR$ are never-ending.
I have been adding long positions in (MRK)(GILD)(AMGN)(JNJ)(ABBV) since September.
The worldwide response to this virus has been a colossal failure. America's response to this virus has been horrific.
hyperinflation is already here.
https://seekingalpha.com/instablog/5205071-danwatson888/5529720-biotech-war-god-turn-around
BiotecNOVA™ Running to the LIGHT
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecNOVA™ Running to the LIGHT
BiotecNOVA™ Running To The Light
Nov. 15, 2020 7:57 AM ET| About: Amgen Inc. (AMGN), AZN, BMY, BNTX, GSK, JNJ, LLY, MRK, MRNA, NVS, PFE, RHHBY, SNY
Summary
“When you get on a plane everyone routes for the pilot”.
Pfizer (PFE) and Lilly (LLY) remain two of my top holdings.
Unfortunately for the state of Georgia, they will be subjected to countless new political ads for those competing for the two GA Senate races that will determine which party controls.
There have been many positive news articles on successful meds directed to cancer and other ailments just within the past 3 weeks.
See A Victory – BiotecMAX™
BiotecWAR$™-God, Turn It Around 上帝，把它转过来
BiotecNOVA™ Running to the LIGHT
See A Victory – BiotecMAX™
Oct. 24, 2020 3:08 PM ET |About: AbbVie Inc. (ABBV), AMGN, AZN, BMRN, BMY, BNTX, DXCM, EXEL, GILD, GLPG, GSK, JNJ, LLY, MDT, MRK, MRNA, PFE, SGEN
Summary
Unfortunately the Covid-19 virus is not over.
During the recent downturn I voted to increase my positions in (AMGN) (ABBV) (JNJ) (GILD) (MRK).
We all need to understand BSL-4 Labs and confirmation of the origins of the Covid-19 virus.
I remain hopeful that politicos will go after bigger fish before they target the biotech/pharma companies.
biotecMAX™ Run To The Father
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecMAX™ Run To The Father
Sep. 28, 2020 9:38 AM ET|
About: Johnson & Johnson (JNJ)
Summary
And just like that the biotech-WAR$™ are back in full force.
(JNJ) is one of my top holdings and I have been adding shares during this recent downturn.
There have been many positive and encouraging biotech news events during this one month = September 2020.
Abortion is a forever and lasting evil. Abortion is total annihilation.
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
biotecMAX™ You Keep Hope Alive
Sep. 11, 2020 7:23 PM ET|About: AbbVie Inc. (ABBV), Includes: ABT, AMGN, AZN, BGNE, BMY, BNTX, GSK, JNJ, LLY, MDT, MRK, MRNA, NVS, PFE, RHHBY, SNY, TMO
Summary
politicos have started again to bash biotech/pharma/healthcare companies all in an effort to gain votes and yes even during a pandemic.
Meanwhile, Biotech/pharma/med-tech companies have made significant progress in non-covid-19 medicines covering many other ailments.
AbbVie is one of my top holdings and I have been adding shares during the recent September downturn.
noteworthy positive news events over the last 2 months regarding both Covid-19 and non-Covid-19 partnerships, collaborations, mergers and acquisitions are in progress.
Inside the Clash Between Powerful Business Leaders and N.Y.C.’s Mayor
The tensions burst into the open when 163 executives joined to criticize Bill de Blasio’s leadership. Others think their portrait of the city is overly bleak.
By J. David Goodman, Emma G. Fitzsimmons and Jeffery C. Mays
Sept. 12, 2020Updated 10:29 a.m. ET
https://www.nytimes.com/2020/09/12/nyregion/coronavirus-business-nyc-reopen.html
biotecHOPE™ Won’t Stop Now
biotecMAX™ You Keep Hope Alive
biotecNOVA™ - Let The Light In
biotecHOPE™ Won’t Stop Now
Aug. 26, 2020 5:37 PM ET|About: AstraZeneca PLC (AZN), BNTX, CYDY, GILD, GSK, MRK, NVAX, PFE, SNY
Summary
"The country behaved like a horror-movie character who believes the danger is over, even though the monster is still at large."
there is encouraging news coming from biotech/pharma companies with regard to vaccines and therapies to fight this virus.
biotecNOVA™ - Let The Light In
Biotech-WAR$™ Biohazard2020 Peace Be Still
biotecNOVA™ - Let The Light In
biotecNOVA™ - Let The Light In
Jul. 11, 2020 12:00 PM ET|About: Amgen Inc. (AMGN), BGNE, GILD, GSK, NVAX, PFE, AZN, JNJ
Summary
some encouraging biotech news events and hopeful USA investments in vaccine
development and anti-viral development.
The number of Covid-19 cases in the USA is the highest in the world and getting worse.
a temporary truce between politicos and the biopharma community.
if there is a business sector that can unite Americans, Europeans and Chinese more than any other sector it is the biotech sector.
BioHazard2020 I Will Fear No More
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
BioHazard2020 I Will Fear No More
Jun. 9, 2020 5:29 PM ET|About: AbbVie Inc. (ABBV), AZN, BMY, GILD, GSK, MRK, MRNA, RHHBY
Summary
We seem to have entered into what I’ll call the “404 Pandemic”.
significant positive product news on the medical biotech front during May & June 2020.
The Camden NJ waterfront and the city of Camden NJ has come a long way from where it was, but it has taken many years to achieve it’s current level.
Many segments of American cities population were already disconnected from the economic growth and success in America.
The Importance of Placemaking.
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
Biotech-WAR$™ Biohazard2020 Peace Be Still
May 11, 2020 1:11 PM ET|About: Amgen Inc. (AMGN), BGNE, BMY, LLY, REGN, VIR, WXXWY
Summary
staggering and growing rift between the world’s 2 economic powerhouses.
there are some China based biotech companies that should be considered as strong investments going forward.
biotech investments are critical and important for the health of all countries.
at this point I do not think the origins of the virus matter much as the USA/China relationship could not get much worse.
BIOTECH$TORM™ BIOTECH-WAR$™ BiotecHEART™ (Danwatsonblogs)
BioHazard2020 Won’t Stop Now
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 Won’t Stop Now
May 05, 2020 5:34 AM ET
AZN, BNTX, GSK, JNJ, PFE, SNY
Summary
- The unfortunate truth is that the COVID-19 virus, will not just go away.
- many vaccine candidates are in progress/development/clinical trials.
- The virus continues to work its utmost damage among us all.
- there is a now a new Biotech-War$ emerging and it is more complicated then the original.
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
Apr. 23, 2020 2:02 PM ET| About: Incyte Corporation (INCY), Includes: A, ABBV, AMGN, BDX, BMY, GILD, IMMU, LH, LLY, MDT, MRK, MRNA, NVO, NVS, RHHBY, SGEN, TMO, VIR
Summary
11 states should create a new entity = Biotechnology States of America.
Covid-19 remains a riddle, wrapped in a mystery, inside an enigma.
The political storm created by the Covid-19 virus is very real.
The economic and human loses from this event will impact America and the world for a long time.
Ruxolitinib (Jakafi®) may help prevent another complication of Covid-19.
Long Only, Deep Value, Dividend Growth Investing, Healthcare
BioHazard2020™ Weapon
BioHazard2020 & Biotech-WAR$™ Graves Into Gardens
Biohazard2020™ Not Done Yet
BioHazard2020™ Weapon
Apr. 14, 2020 6:24 AM ET|
About: Gilead Sciences, Inc. (GILD), JNJ, PFE
Summary
there is no evidence that the novel coronavirus (2019-nCoV) now known as = COVID-19 is or was created from a biological weapons lab or any virology lab anywhere.
There is hope with one new med previously intended for another disease – Ebola.
Remdesivir (GS-5734, Nuc inhibitor).
Thankfully there are many companies that are developing vaccines for COVID-19.
The virus is “simply a piece of bad news wrapped up in protein,”.
https://seekingalpha.com/instablog/5205071-danwatson888/5433549-biohazard2020-weapon
Long Only, Deep Value, Dividend Growth Investing, Healthcare
Biohazard2020™ Not Done Yet
Biotech-Wars™ – Hunger + Thirst
Biohazard2020™ Not Done Yet
Biohazard2020™ Not Done Yet
Apr. 5, 2020 9:48 AM ET |About: Abbott Laboratories (ABT), GILD, MDT
Summary
Politico's continue to offer confusion, misinformation, and misdirection.
Hope = Remdesivir.
One of the more intriguing news events during this virus pandemic is the simultaneous crisis in the oil sector.
New Jersey governor calls for 'postmortem' of federal response to coronavirus.
Biohazard2020™ Not Done Yet
Apr. 5, 2020 9:48 AM ET|About: Abbott Laboratories (ABT), GILD, MDT
https://seekingalpha.com/instablog/5205071-danwatson888/5429826-biohazard2020-not-done-yet
Biotech-War$ Burn The Ships
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
Summary
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
The virus was the pin the popped the highly leveraged and overconfident market that many were indicating/predicting needed some adjustment. But not many were forecasting a -37% “pin” reduction vs.Jan.
an antiviral drug is a virus suppressant that blocks the chemical compounds that the virus needs for replication, its goal is to reduce the number of virus counts in the body to a manageable state.
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Feb. 29, 2020 12:46 PM ET
|About: AbbVie Inc. (ABBV), GILD, JNJ, MRNA, REGN, VIR, WXXWY
Summary
the news coming from China since January 11, 2020 was never positive even if the actual reported statistical data was suspect.
everyone, including everyone in China, has a right to be angry about COVID-19.
too much single source product manufacturing located in China.
politicos are now creating “Anti-Endorsements” lists that identify successful USA citizens.
BiotecHeart™ - See The Light
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ - See The Light
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ “Joy Unto The World”
BiotecHeart™ Joy Unto The World
Dec. 24, 2019 6:27 AM ET
Summary
this has been the “Biotech Decade” 2010-2019.
this year has been the “Biotech Year”.
Based on the current political environment it has been a spectacular year for the healthcare sector, and for many biotech companies.
|About: AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Biotech-WAR$™-Biohazard 2020
BiotecHeart™ “Joy Unto The World”
Biotech-WAR$™-Biohazard 2020
Biotech-WAR$™-Biohazard 2020
Dec. 15, 2019 4:18 PM ET|
Summary
the biotech sector is essentially avoided, at least publicly, as a recommended investment sector.
the 2020 political BiotechSTORM is coming.
I guess that If you can’t get anyone on TV to make positive comments on biotech companies then the sector must not be well liked or a good investment?
I guess the biotech/medtech successes for the past 10 years are and will remain a secret success story and a bewildering anomaly?
There has been “Nothing Else” but biotech success stories this December 2019 as there have been the entire year of 2019.
This has been the BIOTECH DECADE -2010-2019.
Biotech-WAR$™-Biohazard 2020
Dec. 15, 2019 4:18 PM ET|About: AbbVie Inc. (ABBV), ABMD, AMGN, AMRN, AZN, BIIB, BLUE, BMY, CELG, GILD, IBB,
BiotecNOVA™ All That Matters
Biotech-War$ - The “Morally” Correct Mandate
Biotech-WAR$™-Biohazard 2020
BiotecNOVA™ All That Matters
Dec. 31, 2019 4:20 PM ET
Summary
this has been the BIOTECH Decade.
10 years of phenomenal clinical success stories in many areas and that is “All That Matters".
And this year 2019 has been a great year for the entire biotech sector.
AbbVie Inc. (ABBV), ABMD, ABT, AMGN, AMRN, AZN, BGNE, BIIB, BLUE, BMRN, BMY, GILD, ISRG, JNJ, LLY, MDT, MRK, NVS, PFE, REGN, RHHBY, SGEN, SRPT, VRTX
Biotech-Wars™ Counteroffensive
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Biotech-Wars™ Counteroffensive
Sep. 18, 2019 2:46 PM ET|About: Johnson & Johnson (JNJ)
Summary
politicos have made a massive mistake vilifying the biotech sector.
politicos continue to see the biotech sector as easy targets in an effort to gain votes and win elections.
It is time for all biotech companies to take counteroffensive measures.
In a year that the biotech sector has been totally maligned by politicos, biotech companies will again achieve outstanding medical success as they did in 2018. I remain 100% invested in biotech and medtech companies as of 9/18/2019. And I remain long (JNJ).
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Biotech-War$ - The “Morally” Correct Mandate
Sep. 9, 2019 10:10 AM ET|About: Johnson & Johnson (JNJ)
Summary
candidates now see political socialism as the “morally” correct mandate,
a significant block of voters seem to want much more and expect much more from their government.
Nevertheless, and while under attack, biotech companies continue to bring successful products to market.
I am re-investing my biotech dividends back into additional shares of the following companies; (PFE), (JNJ), (LLY), (MRK), (AMGN), (BMY), (AZN), (ABBV), (MDT), (CELG), (GILD), (NVS), (OTCQX:RHHBY)
BIOTECH$TORM™ BIOTECH-WAR$™ BiotecHEART™ (Danwatsonblogs)
Biotech-War$-Champions Of The World
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$-Champions Of The World
Biotech-War$-Champions Of The World
Sep. 4, 2019 12:51 PM ET
|About: Amgen Inc. (AMGN), AZN, BMY, JNJ, MRK, PFE, Includes: ABBV, LLY
Merck Foundation Launches Five-Year Initiative to Reduce Disparities in HIV Care for Vulnerable and Underserved Southeastern US Communities.
Janssen Announces U.S. FDA Breakthrough Therapy Designation for Investigational Prophylactic Vaccine for the Prevention of Respiratory Syncytial Virus in Older Adults Leiden, The Netherlands, September 3, 2019
–.
European Commission Approves Merck’s KEYTRUDA® (pembrolizumab) in Combination with Inlyta® (axitinib) as First-Line Treatment for Patients with Advanced Renal Cell Carcinoma (RCC).
BiotecHEART™-Breakthrough
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$-Champions Of The World
BiotecHEART™-Breakthrough
Dec. 9, 2019 8:35 AM ET|About: AbbVie Inc. (ABBV), ALPMY, BMY, CELG, JNJ, MRK, PFE, RHHBY, SGEN
Summary
There is no impossible.
2019, has been a breakthrough year for all who need medicine.
many clinical tests involving combinations of successful medicines.
many approvals this year in China for successful medicines.
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$™-Be Fine & Dream-Dream-Dream
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™-Be Fine & Dream-Dream-Dream
Dec. 4, 2019 2:20 PM ET|About: Alphabet Inc. (GOOGL), Includes: BMY, JNJ, MRK, PFE, RHHBY, SGEN
Summary
politicos miss the real underlying support for the companies in the biotech/drug sector = medicine that brings about positive and encouraging outcomes, medicine that brings about successful outcomes.
The biotech/medtech success stories for all of November & early December 2019 are remarkable.
But it is not just the biotech sector that is under attack, big USA tech companies remain targets.
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Nov. 23, 2019 8:40 PM ET|About: Bristol-Myers Squibb Company (BMY), CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY
Summary
For me the world is upside down when success and profit and shareholders and new medicines and new medical devises and new products are vilified, this is insanity.
New Jersey is the “Biotech State”.
Unfortunately, the Biotech-War$™ continue in November 2019 and continue to expand at a high speed towards encompassing many other WAR$ against new business sectors.
But please don’t tell any Politicos about these biotech victories below they would not understand these remarkable events – just read them At Your Whisper, shhh….
“Let’s show them we are better”.
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-WAR$ - ZOMBIES TARGET ALPHA & HOPE
Nov. 14, 2019 9:50 PM ET|About: Amarin Corporation plc (AMRN), BMY, MRK, PFE
Summary
“POLITICAL ZOMBIES” and are now fully targeting ALPHA.
Zombies create “Irrational FEAR”, they thrive on “Irrational FEAR”
.
HOPE is a mechanism developed by the human brain to cope with contexts and situations unfavorable to survival.
HOPEFUL news events, many are even remarkable, in the Biotech and MedTech sectors in just the first 14 days of November 2019 and they WON'T STOP NOW.
Biotech-War$™ - Raise A Hallelujah
Biotech-War$™ ZOMBIES TARGET ALPHA & SUCCESS & HOPE
Biotech-War$™ - ZOMBIES TARGET ALPHA & HOPE
Biotech-WAR$ - Raise A Hallelujah
Nov. 9, 2019 6:45 PM ET|About: AbbVie Inc. (ABBV), ABMD, ABT, AGN, AMGN, AMRN, AZN, BGNE, BIIB, BMRN, BMY, CELG, GILD, ILMN, ISRG, JNJ, LLY, MDT, MRK, NVO, NVS, PFE, REGN, RHHBY, SGEN, VAR, VRTX
Summary
Politicos are now simultaneously spearheading Biotech-WAR$™, Tech WARS, and now Class WARS.
The biotech/medtech sectors continue to succeed and are on track to have another banner 2019 both in product development and financial success.
Billionaire Leon Cooperman has had enough and is fighting back.
Google and Facebook and Twitter should all fight back as should every Biotech company, every Bank, every business in the America.
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Biotech-Wars – I See A Victory
Oct. 14, 2019 2:38 PM ET|About: Amgen Inc. (AMGN), AZN, BMY, GILD, JNJ, LLY, MRK, PFE, RHHBY, SGEN, MDT
Summary
I see the power of many “Biotech Victory's”. every day.
promote the power of a “Biotech Victory”.
politicos have made a grave mistake vilifying the biotech sector.
Bio-Tech & China, China, China
Biotech-War$™ – I See A Victory
Biotech-War$™ – I See A Victory
Mar. 14, 2018 1:14 PM ET|About: Amgen Inc. (AMGN), AZN, BGNE, CELG, NVS, Includes: ABMD, BMY, LLY, MDT, MRK, NVO
Summary
China Bio-Tech growth is accelerating now.
China needs better healthcare in every province.
China will welcome all bio-technology partnerships.
China is on the verge of major investment changes.
https://seekingalpha.com/instablog/5205071-danwatson888/5127900-bio-tech-china-china-china
Biotech War$-Enemy Of The $Tate
Biotech-War$™ – I See A Victory
Biotech War$-Enemy Of The $Tate
Biotech War$-Enemy Of The $Tate
Oct. 18, 2019 12:50 PM ET|About: AbbVie Inc. (ABBV), AMGN, JNJ, LLY, MRK, VRTX, Includes: AMRN
Summary
Are successful USA based companies now the “enemy of the state”?
Cambridge, Mass. is in my view the epicenter of the biotech industry.
The attacks on all biotech companies will only benefit biotech hubs in Shanghai, China, Basel, Switzerland and Dublin, Ireland all highly supportive biotech centers.
“The inherent vice of capitalism is the unequal sharing of blessings; the inherent virtue of socialism is the equal sharing of miseries.” Winston Churchill
BioTECH! ZONE
BiotecHeart™ - See The Light
Biotech War$-Enemy Of The $Tate
Apr. 2, 2019 8:20 PM ET|About: AstraZeneca PLC (AZN), BMY, CELG, Includes: AMRN, JNJ, MRK, NVO, NVS, PFE, RHHBY, SNY
Summary
“TINSTAAFL” = “There is no such thing as a free lunch”.
Princeton NJ/Central Jersey – is for me the best example of a successful BioTECH Zone.
Ireland's Life Sciences sector has grown from very humble beginnings in the 1960s to reach global significance. Collaborative clusters in Pharmaceutical, Biotechnology, Medical Devices and Diagnostics have been a key.
AstraZeneca is spearheading the creation of a new life sciences park, in Wuxi, China, that aims to nurture innovation.
Cambridge, Mass, is one of the best examples of a successful BioTECH Zone.
HOSANNA
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
HOSANNA
Nov. 2, 2019 8:29 AM ET|2 comments |About: Amgen Inc. (AMGN), BGNE, BMY, GILD, PFE, SGEN, VRTX, VAR, NVO
Summary
The progress and product successes being achieved in the Biotech sector this September and October 2019 is nothing less than remarkable.remarkable Biotech/MedTech gains in September 2019 and October 2019.In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
In the Hebrew Bible hôšîʿâ-nā is used only in verses such as "help" or "save, I pray" (Psalms 118:25).
https://seekingalpha.com/instablog/5205071-danwatson888/5369912-hosanna
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
BiotecHeart™ - See The Light
Feb. 20, 2020 10:20 AM ET|About: Amarin Corporation plc (AMRN), BMY, DBX, GILD, JNJ, MRK, NVO, NVS, PFE, RHHBY, ABBV
Summary
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
SARS-CoV2 - BioHazard2020
The Start of the Coronavirus infection = novel coronavirus (2019-nCoV) = SARS-CoV2 = Covid-19= BioHazard2020
Below is the first section, a 1/2 page, and the start of my coverage of the SARS-CoV2 virus from January 2020 to early April 2020. It was during late February 2020 and early March that I was coming to conclusion that this virus was going to be a worldwide issue for some time - and I started www.biohazard2020.com and dedicated full page sections to the virus. The first date that I became aware of the virus was on January 11, 2020 via three posts noted below, 2 from SCMP and 1 from Caixin Global =
Wuhan pneumonia: Hong Kong set to develop new test for mystery virus after obtaining genetic sequence from mainland China
A team of experts will also fly over to the mainland city to be briefed on the situation and learn about control measures
News comes after China confirms first death from novel coronavirus strain
Ng Kang-chung Published: 8:35pm, 12 Jan, 2020
Wuhan pneumonia: new strain ‘bears close similarity to Sars’ as Hong Kong health minister assures public city is prepared
Secretary for Food and Health Sophia Chan says Hong Kong has plenty of beds and protective gear, but appeals to retailers not to jack up prices of masks
Victor Ting Published: 2:21pm, 11 Jan, 2020
Jan 11, 2020 08:31 PM ENVIRONMENT
First Death From New SARS-like Virus Reported in Central China’s Wuhan
By Isabelle Li
After the following 2 articles, originally both published on January 20, 2020, 1 from SCMP and 1 from Caixin, I started to keep track of all information on this virus, which at that point was only identified as a Coronavirus infection =
Wuhan virus kills fourth patient, infects hospital staff amid fear of ‘super-spreader’
Priority now to stop emergence of ‘super-spreader’, with one carrier already infecting more than a dozen medical staff, specialist says
Authorities in Wuhan, the epicenter of the virus outbreak, report a fourth death and 15 infections among hospital staff
Gigi Choy and Alice Yan Published: 9:40pm, 20 Jan, 2020
The central Chinese city of Wuhan reported more than 130 cases of the virus over the weekend alone.
Feb 02, 2020 10:35 AM SOCIETY & CULTURE
Coronavirus Latest (Jan. 15 - Feb. 1): China Infections Reach 14,411, Apple Closes All Mainland Stores
By Flynn Murphy, Lin Jinbing, Han Wei, Dave Yin, Matthew Walsh, Denise Jia, Mo Yelin and Timmy Shen
We start a new virus daily update in February. Please follow us here.
SARS-CoV2 - BioHazard2020-1 page 1
SARS-CoV2 - BioHazard2020-2 page 2
SARS-CoV2 - BioHazard2020-3 page 3
SARS-CoV2 - BioHazard2021-4 page 4
SARS-CoV2 - BioHazard2021-6 page 6
SARS-CoV2 - BioHazard2021-5 page 5
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
COVID‑19 Information & Resources
COVID‑19 Information & Resources
COVID‑19 Information & Resources
Coronavirus disease (COVID‑19)
Also called: 2019-nCov, 2019 Novel Coronavirus
Coronavirus symptoms: What are they and how do I protect myself?
By James GallagherHealth and science correspondent 30 March 2020
https://www.bbc.com/news/health-51048366
Coronavirus symptoms: what are the common signs of Covid-19?
- As the pandemic continues its deadly spread across the globe there are some common indicators to watch out for
- Emergency warning signs include persistent chest pain or pressure, mental confusion and a bluish tinge to lips or face
Published: 4:29pm, 3 Apr, 2020
Tracking Covid-19 cases in the US
Since January, novel coronavirus has spread to nearly every state and territory
By Sergio Hernandez, Sean O’Key, Amanda Watts, Byron Manley and Henrik Pettersson, CNN
Last updated: March 30, 2020 at 8:00 p.m. ET
https://www.cnn.com/interactive/2020/health/coronavirus-us-maps-and-cases/
This map is your interactive guide to confirmed cases, recoveries and deaths from the coronavirus around the state, nation and world. It combines data from the World Health Organization, U.S. and European CDCs, and the National Health Commission of China.
https://data.courierpostonline.com/coronavirus/
https://covidtracking.com/data/
https://coronavirus.1point3acres.com/en
Coronavirus Live Updates: Despite Pushback, Trump Suggests Testing No Longer an Issue
Maryland and Virginia issued statewide stay-at-home orders, and the F.D.A. approved two malaria drugs to treat coronavirus patients. Macy’s said it would furlough most of its 125,000 workers.
RIGHT NOW
President Trump said the United States soon will be producing so many ventilators and other medical equipment that the government will be sending supplies to hard-hit Europe.
https://www.nytimes.com/2020/03/30/world/coronavirus-live-news-updates.html
Coronavirus Live Updates: U.S. Leads the World in Known Cases
https://www.nytimes.com/2020/03/26/world/coronavirus-news.html
Coronavirus in the U.S.: Latest Map and Case Count
By Mitch Smith, Karen Yourish, Sarah Almukhtar, Keith Collins, Danielle Ivory, Allison McCann, Jin Wu and Amy HarmonUpdated March 26, 2020, 5:27 P.M. E.T.
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
https://coronavirus.jhu.edu/map.html
Mar 27, 2020 04:02 AMSOCIETY & CULTURE
Keys in Fighting Covid-19 Are Testing, Tracing, Isolation, WHO Says
By Tian Jiawei, Zeng Jia and Han Wei
Coronavirus symptoms: A list and when to seek help
By Sandee LaMotte, CNN
Updated 11:00 AM ET, Fri March 20, 2020
https://www.cnn.com/2020/03/20/health/coronavirus-symptoms-list-what-to-do-wellness/index.html
Mar 23, 2020 09:32 PM
Despite Official Figures, Wuhan Continues to Find New Asymptomatic Covid-19 Cases Daily
By Zhao Jinzhao and Dave Yin
Mar 23, 2020 09:46 PMSOCIETY & CULTURE
Coronavirus Live Updates (Monday): China’s Ambassador to U.S. Criticizes Coronavirus Conspiracy Theories
Hong Kong appeared to have the coronavirus under control, then it let its guard down
Analysis by James Griffiths, CNN
Updated 4:37 AM ET, Mon March 23, 2020
https://www.cnn.com/2020/03/23/asia/hong-kong-coronavirus-quarantine-intl-hnk/index.html
New York launches use of malaria drug to treat Covid-19
Mar. 23, 2020 1:26 PM ET|About: Tekla World Healthcare... (THW)|By: Douglas W. House, SA News Editor
https://seekingalpha.com/news/3554308-new-york-launches-use-of-malaria-drug-to-treat-covidminus-19
New York governor: "We haven't flattened the curve ... the curve is actually increasing"
Coronavirus pandemic changes life as we know it
By Jessie Yeung, Helen Regan, Adam Renton, Emma Reynolds, Mike Hayes and Meg Wagner, CNN
Updated 1:10 p.m. ET, March 24, 2020
Cuomo Says Virus Cases Increasing Rapidly Despite Lockdown
By Keshia ClukeyMarch 24, 2020, 11:16 AM EDT Updated on March 24, 2020, 11:41 AM EDT
- New York has 10 times more cases than California, Cuomo says
- Lack of ventilators seen as a huge problem once N.Y. hits apex
Mar 25, 2020 07:18 PM
High Elderly Population, Limited Testing May Underlie Italy’s High Covid-19 Death Rate: Paper
By Zeng Yukun, Ma Danmeng and Yang Ge
The George Washington University Hospital
Important Coronavirus Update
Coronavirus Disease 2019, or COVID-19
https://www.gwhospital.com/health-alert
Coronavirus: loss of smell or taste could be a symptom, growing evidence suggests
- Studies and observations in several countries indicate significant numbers of patients experience a loss of smell
- Identifying these symptoms could allow testing and isolation of people who would otherwise infect others, doctors say
Published: 4:58pm, 25 Mar, 2020
Mar 27, 2020 09:24 PMSOCIETY & CULTURE
New Study Indicates Coronavirus Spreads Easily Even When Symptoms Are Mild
By Wen Simin and Timmy Shen
Under Intense Criticism, Trump Says Government Will Buy More Ventilators
In another day of mixed messages, the president criticized G.M. and authorized the use of the Defense Production Act to force it to make ventilators after the company had already announced it was going to.
By David E. Sanger, Maggie Haberman and Annie Karni March 27, 2020
https://www.nytimes.com/2020/03/27/us/politics/coronavirus-trump-ventilators-gm-ventec.html
Coronavirus Live Updates: Pelosi Accuses Trump of ‘Deadly’ Denial and Governors Plead for Help; New York Mayor Says Medical Supplies Will Run Out in a Week
https://www.nytimes.com/2020/03/29/world/coronavirus-news.html
Coronavirus: China ramps up Covid-19 test kit exports amid global shortage, as domestic demand dries up
- More than 100 Chinese companies are selling coronavirus testing kits to Europe, but most are not licensed to sell in China
- A global shortage of kits has sparked a scramble for resources, but the specialist nature of the production process provides limitations
Finbarr Bermingham, Sidney Leng and Echo Xie in Beijing
Published: 6:00am, 30 Mar, 2020
Biotech-War$ Burn The Ships
COVID‑19 Information & Resources
COVID‑19 Information & Resources
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
Summary
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
Politicos from every country have failed to understand and to effectively battle the Covid-19 virus.
The virus was the pin the popped the highly leveraged and overconfident market that many were indicating/predicting needed some adjustment. But not many were forecasting a -37% “pin” reduction vs.Jan.
an antiviral drug is a virus suppressant that blocks the chemical compounds that the virus needs for replication, its goal is to reduce the number of virus counts in the body to a manageable state.
Biotech-War$ Burn The Ships
Mar. 27, 2020 3:47 PM ET|About: Gilead Sciences, Inc. (GILD), Includes: JNJ, MRNA, RHHBY, VIR
https://seekingalpha.com/instablog/5205071-danwatson888/5426472-biotech-war-burn-ships
https://seekingbiotechalpha.com/biotechstorm
History's verdict on Trump will be devastating
By Michael D'Antonio
Updated 6:14 PM ET, Mon March 30, 2020
https://www.cnn.com/2020/03/30/opinions/history-verdict-on-trump-devastating-dantonio/index.html
Trauma physician treating coronavirus patients worries ''we are slowly descending into chaos'
By Holly Yan, Madeline Holcombe and Steve Almasy, CNN
Updated 7:52 PM ET, Mon March 30, 2020
https://www.cnn.com/2020/03/30/health/us-coronavirus-updates-monday/index.html
Nurses Die, Doctors Fall Sick and Panic Rises on Virus Front Lines
The pandemic has begun to sweep through New York City’s medical ranks, and anxiety is growing among normally dispassionate medical professionals.
- March 30, 2020, 5:00 a.m. ET
https://www.nytimes.com/2020/03/30/nyregion/ny-coronavirus-doctors-sick.html
Shielding the Fetus From the Coronavirus
New studies suggest the virus can cross the placenta, but newborns have been mildly affected if at all.
By Apoorva Mandavilli March 27, 2020
https://www.nytimes.com/2020/03/27/health/shielding-the-fetus-from-the-coronavirus.html
Some U.S. Cities Could Have Coronavirus Outbreaks Worse Than Wuhan’s
By Nate Cohn, Josh Katz, Margot Sanger-Katz and Kevin QuealyMarch 27, 2020
https://www.nytimes.com/interactive/2020/03/27/upshot/coronavirus-new-york-comparison.html
What it's like for health care workers on the front lines of the coronavirus pandemic
By Dakin Andone, CNN
Updated 8:04 PM ET, Sat March 28, 2020
https://www.cnn.com/2020/03/27/us/inside-hospitals-coronavirus-vignettes/index.html
Coronavirus death toll in the US passes 2,000 as Trump says New York quarantine 'will not be necessary'
By Dakin Andone and Christina Maxouris, CNN
Updated 9:28 PM ET, Sat March 28, 2020
https://www.cnn.com/2020/03/28/health/us-coronavirus-weekend-saturday/index.html
By Michael D. Shear, Abby Goodnough, Sheila Kaplan, Sheri Fink, Katie Thomas and Noah Weiland March 28, 2020
https://www.nytimes.com/2020/03/28/us/testing-coronavirus-pandemic.html
N.Y.C.’s 911 System Is Overwhelmed. ‘I’m Terrified,’ a Paramedic Says.
With coronavirus cases mounting, emergency workers are making life-or-death decisions about who goes to a hospital, and who is left behind.
By Ali Watkins March 28, 2020
https://www.nytimes.com/2020/03/28/nyregion/nyc-coronavirus-ems.html
Coronavirus in the U.S.: Latest Map and Case Count
By Mitch Smith, Karen Yourish, Sarah Almukhtar, Keith Collins, Danielle Ivory, Allison McCann, Jin Wu and Amy HarmonUpdated March 29, 2020, 8:02 A.M. E.T.
https://www.nytimes.com/interactive/2020/us/coronavirus-us-cases.html
Let’s ‘Kick Coronavirus’s Ass’
In this nightmarish moment, we’re feeling warm and fuzzy about the cold and calculating Andrew Cuomo.
By Maureen Dowd Opinion Columnist
March 27, 2020
https://www.nytimes.com/2020/03/27/opinion/sunday/cuomo-new-york-coronavirus.html
Mar 29, 2020 12:47 PMSOCIETY & CULTURE
Zhejiang Covid-19 Infection Highlights Threat from Asymptomatic Carriers
By Zhang Erchi and Guo Yingzhe
New Chinese research may point to possible role of children in coronavirus spread
- Covid-19 symptoms tend to be milder in kids, according to studies in Zhejiang and Wuhan, with asymptomatic infections ‘not uncommon’
- But health experts say more investigation into the chain of transmission is needed
Published: 10:00am, 29 Mar, 2020
Coronavirus: China can’t suppress it, US military can’t kill it. Covid-19 is the real Godzilla
- The truth to emerge from the pandemic is that all humans share a common destiny, and we are embroiled in our biggest battle since World War II
- Only when the human race chooses to share, help, care, cooperate and support each other can we beat this enemy from nature
Published: 11:30am, 29 Mar, 2020
Decoding Covid-19
Seven human coronaviruses in seven graphics
Mar 29, 2020 06:41 PMOPINION
As U.S. Sits on Ample Ventilator Supply, China Wages Must-Win Battle to Contain Covid-19 in Hubei
By Wang Shuo
US could see millions of coronavirus cases and 100,000 or more deaths, Fauci says
By Devan Cole, CNN
Updated 1:27 PM ET, Sun March 29, 2020
https://www.cnn.com/2020/03/29/politics/coronavirus-deaths-cases-anthony-fauci-cnntv/index.html
Coronavirus: social distancing could save millions of lives, study says
- Researchers from Imperial College in London say that without steps such as social distancing Covid-19 could have killed 40 million people this year
- Study warns governments will have to make ‘challenging decisions’ but limiting social contacts could halve the death toll
Published: 7:00am, 31 Mar, 2020
Doctors on frontline of China’s battle with coronavirus tell of race to respond to onset of new disease
- One doctor in Wuhan describes the emotional toll of trying to care for Covid-19 patients and warns that the most serious cases are still struggling to make it
- Medical staff had to learn on the job when treating the previously unknown disease, which may have cost some patients their lives
Zhuang Pinghui in Beijing
Published: 7:00am, 1 Apr, 2020
Remdesivir (GS-5734)
COVID‑19 Information & Resources
the FDA has exercised “enforcement discretion” with respect to LDTs.
remdesivir
Gilead Expands Emergency Access to Experimental Coronavirus Drug
By Jason GaleMarch 28, 2020, 6:21 PM EDT Updated on March 29, 2020, 4:49 AM EDT
- Remdesivir given to over 1,000 patients for compassionate use
- Multiple clinical trials may report initial results in weeks
01-Apr-2020
GILEAD SCIENCES ANNOUNCES TWO PHASE 3 RANDOMISED STUDIES TO EVALUATE THE SAFETY AND ANTIVIRAL ACTIVITY OF REMDESIVIR (GS-5734™) IN PARTICIPANTS WITH MODERATE TO SEVERE COVID-19
- Remdesivir is an investigational agent – it is not approved anywhere globally and has not been demonstrated to be safe or effective for any use.
- The UK is one of the countries where Gilead is running clinical trials to evaluate remdesivir for the treatment of COVID-19
London, April 1st 2020 – Gilead Sciences
Gilead Sciences Statement on Request to Rescind Remdesivir Orphan Drug Designation
Gilead CEO: We're on track to have initial data in the coming weeks
Mar. 28, 2020 6:19 PM ET|About: Gilead Sciences, Inc. (GILD)|By: SA Eli Hoffmann, SA News Editor
https://seekingalpha.com/news/3556087-gilead-ceo-on-track-to-initial-data-in-coming-weeks
An Open Letter from our Chairman and CEO
Daniel O’Day - March 28, 2020
https://www.gilead.com/stories/articles/an-open-letter-from-our-chairman-and-ceo
Three coronavirus patients in Taiwan see fevers subside after taking remdesivir
Remdesivir in clinical trials to assess effectiveness in treating COVID-19
9636
By George Liao, Taiwan News, Staff Writer
2020/03/26 21:24
https://www.taiwannews.com.tw/en/news/3905171
Gilead to withdraw Orphan Drug tag for remdesivir;
Mar. 25, 2020 1:24 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
Covid Report: Gilead Asks FDA To Rescind Key Status For Coronavirus Drug
ALLISON GATLIN 04:15 PM ET 03/25/2020
Gilead's Remdesivir receives orphan drug status for coronavirus
Mar. 23, 2020 4:34 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Stephen Alpher, SA News Editor
https://seekingalpha.com/news/3554448-gileads-remdesivir-receives-orphan-drug-status-for-coronavirus
Gilead Sciences Update On The Company’s Ongoing Response To COVID-19
https://www.gilead.com/purpose/advancing-global-health/covid-19
https://seekingalpha.com/symbol/GILD
Gilead Mulls Hiring Remdesivir OEMs in China if Drug Passes Clinical TrialsTANG SHIHUADATE : MAR 25 2020/SOURCE : YICAI
Coronavirus Patients in Limbo as Gilead Suspends Emergency Drug Access
The company says it will switch to a broader approach for its experimental drug, remdesivir. But it was overwhelmed by demand for a potential treatment promoted by President Trump.
By Katie Thomas March 23, 2020
https://www.nytimes.com/2020/03/23/health/coronavirus-drugs-remdesivir.html
Coronavirus treatment: Palo Alto woman recovers from coronavirus after being treated with remdesivir
By David Louie
Wednesday, March 25, 2020 8:50PM
PALO ALTO, Calif. (KGO)
The race is on in the drug battle against the coronavirus
- Researchers are looking to repurpose existing pharmaceuticals to target a disease that has already killed thousands around the world
- Some have potential in helping those at greatest risk, virologist says
Published: 8:00am, 24 Mar, 2020
https://www.scmp.com/news/china/society/article/3076502/race-drug-battle-against-coronavirus
Coronavirus in NJ: Going to 'get worse before it gets better' says hospital chief
Michael L. Diamond, Asbury Park PressPublished 5:00 a.m. ET March 24, 2020 | Updated 7:44 a.m. ET March 24, 2020
Coronavirus updates: U.S. could become new coronavirus epicenter, WHO says
UPDATED ON: MARCH 24, 2020 / 2:29 PM / CBS NEWS
https://www.cbsnews.com/live-updates/coronavirus-disease-covid-19-latest-news-deaths-2020-03-24/
Coronavirus patients may be most infectious in first week of symptoms, study finds
- Researchers find viral load highest in first seven days after patients start showing signs of the disease
- Self-collected saliva samples could be safer than throat and nasal swabs taken by medical professionals, they say
Mandy Zuo in Shanghai and Holly Chik
Published: 8:30pm, 25 Mar, 2020
Opinion
Dale Fisher
Why Singapore’s coronavirus response worked – and what we can all learn
- It’s really about leadership being organised enough to get the messaging right. People will feel more comfortable and are more likely to follow the rules
- In Singapore, we want life to go on as normal. We want businesses, churches, restaurants and schools to stay open. This is what success looks like
Published: 12:42pm, 25 Mar, 2020
WHO chooses Malaysia to run trials on new drug to fight Covid-19
PUBLISHED
MAR 28, 2020, 3:00 PM SGT
PETALING JAYA (THE STAR/ASIA NEWS NETWORK)
Funeral parlour report fans fears over Wuhan death toll from coronavirus
- Magazine quotes truck driver saying he delivered thousands of funeral urns to facilities in the city last week
- Relatives of deceased only able to collect ashes in last week as centres in the city began clearing backlog
The comment came after reports that funeral homes in Wuhan have ordered thousands more urns than the official death tally of coronavirus patients in the city.
In a report on the weekend, Caixin magazine quoted a truck driver as saying he delivered about 5,000 urns on Wednesday and Thursday to the funeral parlour in Hankou district – one of eight such facilities in the city.
Published: 11:00pm, 30 Mar, 2020
the FDA has exercised “enforcement discretion” with respect to LDTs.
Coronavirus update U.S., Trump administration response under scrutiny
the FDA has exercised “enforcement discretion” with respect to LDTs.
EYE ON THE NEWS
A Self-Inflicted Crisis
Overregulation has played a dangerous role in America’s coronavirus outbreak.Roger D. KleinMarch 4, 2020 Health Care
For those without known exposures, CDC only recommends testing for severely affected patients. In theory, doctors could have tested any individuals in whom they suspected coronavirus, and Vice President Pence on March 3rd encouraged this; however, the unavailability of testing has been a major obstacle in practice. On February 4, following Health and Human Services Secretary Alex Azar’s declaration of a public-health emergency, the Food and Drug Administration issued an Emergency Use Authorization (EUA) to the CDC, allowing it to distribute test kits to designated public-health laboratories. The CDC began shipping the kits on February 5, but laboratories could not validate them because they contained a defective reagent.
Prognosis
U.S. Will Miss Coronavirus Test Rollout Goal, Senators Say
By Daniel Flatley, John Tozzi, and Shira SteinMarch 5, 2020, 9:48 AM EST Updated on March 5, 2020, 12:10 PM EST
- GOP senators says kits to be in mail by end of this week
- Distribution, training ‘going to take time,’ Lankford says
Mar 07, 2020 08:25 AMSOCIETY & CULTURE
Covid-19 Relapse Mystery May Be Linked to Controversial Treatment, Researchers Say
By Zhang Yang, Huang Shulun and Denise Jia
Facts about novel coronavirus and how to prevent COVID-19
March 6, 2020 at 7:19 am Updated March 7, 2020 at 11:08 am
By
Seattle Times graphics editor
Prognosis
Virus Testing Blitz Appears to Keep Korea Death Rate Low
By Heejin Kim, Sohee Kim, and Claire CheMarch 4, 2020, 4:00 PM EST Updated on March 5, 2020, 1:18 AM EST
- Country is testing at fastest global pace as cases top 5,000
- Faulty, limited testing in Japan, U.S., could worsen outbreak
How South Korea Scaled Coronavirus Testing While the U.S. Fell Dangerously Behind
By learning from a MERS outbreak in 2015, South Korea was prepared and acted swiftly to ramp up testing when the new coronavirus appeared there. Meanwhile, the U.S., plagued by delay and dysfunction, wasted its advantage.
by Stephen Engelberg, Lisa Song and Lydia DePillis
March 15, 11:10 a.m. EDT
WATCH: FDA Seeks To Expand Treatment Options For Coronavirus
March 19, 20209:26 AM ET
Coronavirus: Grim toll as Italy’s Covid-19 deaths surpass those of China
- Italian authorities announce 427 new deaths, pushing the total to 3,405 and exceeding mainland China’s 3,242
- In Madrid, death rate is described by health authorities as ‘one case every 16 minutes’
Published: 12:08am, 20 Mar, 2020
What Two Months of Reporting Has Taught Caixin About the Coronavirus
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Mar 16, 2020 09:15 PMSOCIETY & CULTURE
Reporter’s Notebook: What Two Months of Reporting Has Taught Caixin About the Coronavirus
By Han Wei
How China’s military took a frontline role in the coronavirus crisis
- Chinese President Xi Jinping, who gave army medical teams the heaviest responsibilities, says virus is now ‘basically curbed’ thanks to their efforts
- PLA’s Academy of Military Medical Sciences personnel have decades of experience including tackling Sars, Ebola, and the earthquake that shattered Sichuan in 2008
Published: 6:00am, 17 Mar, 2020
Coronavirus: China’s economy suffers dramatic collapse in January, February in warning to rest of world
- Combined data for January and February showed that industrial production, retail sales and asset investment all declined far more than analysts expected
- Lockdowns to control the coronavirus proved to be a constraint to economic growth, but with China now in recovery, data suggests what rest of the world could expect
Finbarr Bermingham and Orange Wang
Published: 10:00am, 16 Mar, 2020
Mar 16, 2020 08:58 PMBUSINESS & TECH
Restaurants in China Are Reopening, But Finding It Hard to Recover Business
By Shen Xinyue and Isabelle Li
COVID-19: Containing and conquering a global health threat
The Fatal Impact of Coronavirus Lockdown
One chart shows how the coronavirus is more deadly than the flu even in South Korea, where the COVID-19 death rate is low
Andy Kiersz Mar 12, 2020, 5:18 PM
https://www.businessinsider.com/coronavirus-death-rate-south-korea-compared-to-flu-2020-3
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents
https://www.journalofhospitalinfection.com/article/S0195-6701(20)30046-3/pdf
The incompetence pandemic
- The first victim of the coronavirus? Leadership
Published: 12:49pm, 16 Mar, 2020
https://www.scmp.com/news/world/united-states-canada/article/3075336/incompetence-pandemic
This story is published in a content partnership with POLITICO. It was originally reported by Matthew Karnitschnig on
on March 16, 2020.
The incompetence pandemic
The first victim of the coronavirus? Leadership.
https://www.politico.com/news/2020/03/16/coronavirus-pandemic-leadership-131540
Coronavirus: US officials overruled expert advice on listing places visited by Patient 1
- Emails reveal that Washington state health officials ignored an earlier plan by a senior epidemiologist to name locations
- Hong Kong, South Korea and Singapore have been credited with slowing the outbreak by disclosing details about the movements of infected patients
Published: 8:00pm, 23 Mar, 2020
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update U.S., Trump administration response under scrutiny
Coronavirus update: 82,550 cases, 2,810 deaths, 1 possible case of spread in the U.S., Trump administration response under scrutiny
142Published: Feb. 27, 2020 at 3:26 p.m. ETBy
A woman in Northern California who tested positive for COVID-19 had not traveled to an affected country or likely been in contact with another confirmed case
Mar 06, 2020 06:39 AMSOCIETY & CULTURE
Coronavirus Live Updates (Thursday): As Domestic Outbreak Ebbs, China Faces Waves of Cases Imported From Iran, Italy
10 measures to help control epidemic, restart work
chinadaily.com.cn | Updated: 2020-03-05 20:37
http://global.chinadaily.com.cn/a/202003/05/WS5e60f294a31012821727caf7.html
Coronavirus: global infections could increase tenfold every 19 days, Chinese study says
- Nation’s leading geneticist Jin Li calls on the world to ‘take strong actions on public health, using experiences learned from China and Singapore’
- Chilling forecast based on simple linear model, though research has yet to be peer-reviewed
Stephen Chen in Beijing
Published: 6:11pm, 7 Mar, 2020
Coronavirus
LAST UPDATED: MAR 7, 9
Source: China's NHC, state media, other authorities
https://multimedia.scmp.com/widgets/china/wuhanvirus/
How It All Started: China’s Early Coronavirus Missteps
China’s errors, dating back to the very first patients, were compounded by political leaders who dragged their feet to inform the public of the risks and to take decisive control measures
By Jeremy Page, Wenxin Fan and Natasha KhanMarch 6, 2020 10:36 am ET
Mar 16, 2020 01:14 PM
Coronavirus Live Updates (Monday): Fed Cuts Rate to Near Zero; Deaths Outside China Hit More Than 3,200
China CDC Weekly > 2020, 2(4): 61-62
Notes from the Field: A Novel Coronavirus Genome Identified in a Cluster of Pneumonia Cases — Wuhan, China 2019−2020
http://weekly.chinacdc.cn/en/article/id/a3907201-f64f-4154-a19e-4253b453d10c
Younger adults less immune to Covid-19 health risks than thought, US agency’s study suggests
- A top American health official and US President Donald Trump urged the country’s millennials to heed social distancing guidelines
- Data from Centres for Disease Control and Prevention showed that a fifth of 705 people aged 20-44 were hospitalised, with 2-4 per cent requiring intensive care
Published: 6:01am, 19 Mar, 2020
Mar 20, 2020 05:00 AMSOCIETY & CULTURE
Coronavirus Live Updates (Thursday): Italy’s Death Toll Surpasses China’s; India Bars Inbound Flights
When You Die of the Coronavirus, You Die Alone
Containing a pandemic means keeping visitors out of the I.C.U. My patients will suffer in solitary confinement.
By Daniela J. Lamas
Dr. Lamas is critical care doctor.
- March 24, 2020, 5:00 a.m. ET
https://www.nytimes.com/2020/03/24/opinion/coronavirus-hospital-visits.html
number of people tested in US on 3/10/2020 for coronavirus = 8
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Testing in the U.S.
Updated March 11, 2020
This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.
CDC is responding to an outbreak of respiratory illness caused by a novel (new) coronavirus. The outbreak first started in Wuhan, China, but cases have been identified in a growing number of other locations internationally, including the United States.
number of people tested in US on 3/10/2020 for coronavirus = 8
INFECTIOUS DISEASES CORONAVIRUS (COVID-19)PRINT
A Timeline of Coronavirus (COVID-19)
How It Started and Where It's Spreading
By Team Verywell Fact checked by James Lacy Updated on March 12, 2020
https://www.verywellhealth.com/coronavirus-covid-19-timeline-4798671
QIAGEN Gains BARDA Funding for Approval Process of QIAstat-Dx Test Kit for SARS-CoV-2 Coronavirus
Fri March 13, 2020 9:01 AM|Business Wire|About: QGEN
- First syndromic testing solution to get U.S. agency’s development support in novel coronavirus response
- QIAstat-Dx Respiratory SARS-CoV-2 Panel test kit will rapidly differentiate novel coronavirus from 21 other pathogens implicated in respiratory syndromes
- Further expanding QIAGEN’s global mobilization to scale up testing supplies for the COVID-19 response
HILDEN, Germany & GERMANTOWN, Md.--(BUSINESS WIRE)-- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA)
https://seekingalpha.com/symbol/QGEN
Roche’s cobas SARS-CoV-2 Test to detect novel coronavirus receives FDA Emergency Use Authorization and is available in markets accepting the CE mark
- First commercial test for SARS-CoV-2 will enable expedited coronavirus testing to meet urgent medical needs
- Testing on widely available, high-volume cobas 6800/8800 will significantly increase available testing capacity
- Roche expedites test development to support urgent need for patient testing during pandemic outbreak to avoid a further spread of the virus at an early stage of infection
Basel, 13 March 2020 - Roche (SIX: RO, ROG; OTCQX: RHHBY)
https://www.roche.com/media/releases/med-cor-2020-03-13.htm
https://seekingalpha.com/symbol/RHHBY
FDA Issues Emergency Use Authorization to Thermo Fisher Scientific for Diagnostic Test Used to Detect COVID-19
Fri March 13, 2020 10:09 PM|PR Newswire|About: TMO
WALTHAM, Mass., March 13, 2020 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO)
TaqPath COVID-19 Multiplex Diagnostic Solution
Roche begins shipments of first 400,000 COVID-19 tests to laboratories across US to begin patient testing under FDA Emergency Use Authorization
- Broad network of labs will use automated cobas SARS-CoV-2 Test to process high volume of patient samples sent from across US
- First available commercial test kit for novel coronavirus will enable labs to expand and expedite testing to meet urgent medical needs
cobas® SARS-CoV-2 Test
https://diagnostics.roche.com/global/en/products/params/cobas-sars-cov-2-test.html
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit
Coronavirus: China’s ravaged manufacturing heartlands force international firms to speed up exit strategies
- Some multinationals are increasingly fleeing China, having seen the coronavirus outbreak as validation of exit strategies made during the US trade war
- While some bemoan the lack of alternatives, others will stay for the domestic market as the supply chain debate rages on
Published: 12:00pm, 5 Mar, 2020
Opinion
Minxin Pei
How China’s coronavirus crisis exposes the Achilles’ heel of Communist Party power
- The party’s initial mishandling of the outbreak has eroded support among China’s urban middle class
- The brief but intense eruption of public criticism is a taste of how such missteps can threaten the social contract on which the party’s legitimacy is built
Published: 12:30am, 6 Mar, 2020
Coronavirus: US Secretary of State Mike Pompeo switches disease name to ‘Wuhan virus’ as it spreads in the US
- Top US diplomat ignores pleas from Beijing and world health officials over the use of names for the Covid-19 disease that incite racial discrimination
- New nomenclature comes with President Donald Trump’s administration under fire over its response to community transmission of the virus in the US
Published: 4:58am, 7 Mar, 2020
Coronavirus COVID-19 Global Cases by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU)
https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Addressing the potential impact of novel coronavirus disease (COVID-19) on medicines supply in the EU
ShareNews 10/03/2020
Prognosis
Coronavirus Outbreak Likely Began With Bats, an Omen for Next Epidemic
Scientists say future pandemics are inevitable as cities and villages encroach on wild habitats
February 3, 2020, 3:38 PM EST Updated on February 3, 2020, 4:09 PM EST\
Facts about novel coronavirus and how to prevent COVID-19
March 6, 2020 at 7:19 am Updated March 12, 2020 at 4:12 pm
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Hong Kong / Health & Environment
Coronavirus: some recovered patients may have reduced lung function and are left gasping for air while walking briskly, Hong Kong doctors find
- Hospital Authority releases its findings after observing the first group of discharged coronavirus patients
- Some patients might have a drop of about 20 to 30 per cent in lung function, says medical director of Infectious Disease Centre at Princess Margaret Hospital
Published: 12:04am, 13 Mar, 2020
Johnson & Johnson Announces Collaboration with the Beth Israel Deaconess Medical Center to Accelerate COVID-19 Vaccine Development
Fri March 13, 2020 9:41 AM|PR Newswire|About: JNJPR Newswire
NEW BRUNSWICK, N.J., March 13, 2020 /PRNewswire/ -- Johnson & Johnson (JNJ)
https://seekingalpha.com/symbol/JNJ
Can old drugs take down a new coronavirus?
Several approved and well-studied small molecules could be repurposed as treatments for COVID-19
by Lisa M. Jarvis
MARCH 12, 2020
C&EN has made this story and all of its coverage of the coronavirus epidemic freely available during the outbreak to keep the public informed. To support our journalism, become a member of ACS or sign up for C&EN's weekly newsletter.
Coronavirus: US infections likely to surge as mobile testing gets underway, officials say
- Following in the footsteps of South Korea, ‘drive-through’ coronavirus diagnostic testing will be rolled out across the US in the coming days
- President Donald Trump has told Americans who have been panic-buying supplies at grocery stores to ‘relax’ and ‘take it easy’
Published: 7:12am, 16 Mar, 2020
Mar 16, 2020 04:17 AMWORLD
In Depth: How the U.S. Missed Its Window for Taming the Covid-19 Virus
By Zeng Jia, Ma Danmeng, Zhang Qi and Denise Jia
Mar 18, 2020 01:56 PMBUSINESS & TECH
China Says Japan-Developed Drug Avigan Works Against Coronavirus
Japanese-Developed Flu Drug Avigan Seems Effective Against COVID-19
Early studies show the influenza treatment significantly shortens coronavirus illnesses and improves lung function in patients.
https://www.fool.com/investing/2020/03/19/flu-drug-avigan-covid19-coronavirus.aspx
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
Coronavirus: some recovered patients - reduced lung function & are gasping for air walking, HK docs
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
MARCH 3, 2020
Senior Writer, Science and Discovery
Sharon covers science and discovery.
sharon.begley@statnews.com @sxbegle
Mar 07, 2020 03:15 AMSOCIETY & CULTURE
In Depth: How Shanghai Handled the Coronavirus Better Than Most of China
By Ma Danmeng, Di Ning and Sun Huixia
Gilead Analyst Sees Only 50% Chance That Coronavirus Drug Works
By Cristin FlanaganMarch 5, 2020, 9:19 AM EST
https://www.bloomberg.com/quote/GILD:US
https://www.mayoclinic.org/diseases-conditions/coronavirus/symptoms-causes/syc-20479963
coronavirus treatments or vaccines
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
Remdesivir (GS-5734, Nuc inhibitor)
These nine companies are working on coronavirus treatments or vaccines — here’s where things stand
141Published: March 8, 2020 at 10:45 a.m. ETBy
The list includes Gilead Sciences Inc. and Moderna Inc. along with smaller biotechs
https://www.worldometers.info/coronavirus/coronavirus-cases/#case-dayly-outchina
https://www.worldometers.info/coronavirus/#news
CBS NEWS March 8, 2020, 11:47 AM
Transcript: Scott Gottlieb on "Face the Nation," March 8, 2020
https://www.cbsnews.com/news/transcript-scott-gottlieb-on-face-the-nation-march-8-2020/
Remdesivir (GS-5734, Nuc inhibitor)
Who is getting sick, and how sick? A breakdown of coronavirus risk by demographic factors
Remdesivir (GS-5734, Nuc inhibitor)
Gilead’s coronavirus treatment is already being used in Washington state
BY SY MUKHERJEE
March 10, 2020 4:34 PM EST
6,249 views|Mar 10, 2020,01:19pm EST
Buy Gilead...But Not Because Of Remdesivir
James BermanContributorInvestingI look for value wherever I can find it, both in stocks and in life.
Experimental Drug Helps Some Americans Ride Out Coronavirus, NIH Doctor Says
Antiviral drug remdesivir appeared to have an effect in American cruise passengers treated in Japan, although data are limited
By Suryatapa BhattacharyaUpdated March 13, 2020 7:52 am ET
YOUNG AND UNAFRAID OF THE CORONAVIRUS PANDEMIC? GOOD FOR YOU. NOW STOP KILLING PEOPLE | OPINION
A DOCTOR IN WESTERN EUROPE
ON 3/11/20 AT 2:29 PM EDT
Mild/Moderate 2019-nCoV Remdesivir RCT
https://clinicaltrials.gov/ct2/show/NCT04252664?term=Remdesivir&draw=2&rank=2
Severe 2019-nCoV Remdesivir RCT
https://clinicaltrials.gov/ct2/show/NCT04257656
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
IPhone Maker Projects China Plants to Return to Normal in Coming Weeks
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Mar 04, 2020 06:24 AMBUSINESS & TECH
IPhone Maker Projects China Plants to Return to Normal in Coming Weeks
(Bloomberg) — Hon Hai Precision Industry Co., Apple Inc.’s most important manufacturing partner, said it expects its Chinese plants to begin operating normally by the end of March after resolving severe labor shortages brought on by the coronavirus outbreak.
Coronavirus could cause global medicine shortages as China’s factory closures hit supply chains
- Factory activity in China – the top producer of active pharmaceutical ingredients – hit all-time low in February after measures to halt outbreak
- US and Europe monitoring short-term delay to supplies, with antibiotics, diabetes medications, HIV drugs and ibuprofen among those heavily reliant on China
Published: 3:46pm, 4 Mar, 2020
Coronavirus: ‘Recovered’ patient dies as China reports discharged cases falling ill again
- A 36-year-old man has died in Wuhan from respiratory failure days after being discharged from hospital
- Latest data from the mainland shows most new infections continue to occur at epidemic’s epicentre
Published: 9:23am, 5 Mar, 2020
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
- Any hope that the US-China phase one trade deal would salvage the superpower relationship have been scotched by the coronavirus
- Epidemic set to hit US economy and has led to rising discord among Washington figures, some of whom call for decoupling between the world’s two largest economies
Published: 6:00am, 4 Mar, 2020
Mar 03, 2020 08:53 PM OPINION
Opinion: A Pandemic of Deglobalization?
By Harold James
https://www.caixinglobal.com/2020-03-03/opinion-a-pandemic-of-deglobalization-101523519.html
Mar 05, 2020 08:08 PMOPINION
Opinion: Make Careful Supply Chain Decisions for the Future, Not the Past
By Edward Tse
Are temperature checks effective in stopping the spread of the coronavirus?
Coronavirus outbreak fans the flames of US-China decoupling debate in Washington
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Are temperature checks effective in stopping the spread of the coronavirus?
- Use of ‘temperature guns’ is increasingly common as authorities and companies screen people entering buildings
- Questions remain over transmission by people who have not shown symptoms
Published: 7:45am, 4 Mar, 2020
06:26 AMSOCIETY & CULTURE
Five Provinces Find Recovered Patients Testing Positive for Covid-19
By Cui Xiankang and Denise Jia 0-03-04/covid-19-virus-found-in-two-more-recovered-patients-in-tianjin-101523652.html
Coronaviruses: an overview of their replication and pathogenesis.
https://www.ncbi.nlm.nih.gov/pubmed/25720466
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Mar 04, 2020 08:28 PMBUSINESS & TECH
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
By Yuan Ruiyang and Isabelle Li
Mar 04, 2020 09:52 PMSOCIETY & CULTURE
Coronavirus Live Updates (Wednesday): Iran Furloughs 54,000 Prisoners to Stop Spread in Jails; Chinese Car Sales Crushed
Coronavirus/COVID-19
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Remdesivir (GS-5734, Nuc inhibitor)
The Trump Administration’s Many Vacancies Could Complicate its Coronavirus Response
BY VERA BERGENGRUEN AND BRIAN BENNETT
UPDATED: FEBRUARY 27, 2020 8:59 PM EST | ORIGINALLY PUBLISHED: FEBRUARY 27, 2020 5:05 PM EST
Trump defends huge cuts to the CDC's budget by saying the government can hire more doctors 'when we need them' during crises
Joseph Zeballos-Roig Feb. 27, 2020, 10:45 AM
Welcome to the2019 Global Health Security Index
GLOBAL MONITORING OF DISEASE OUTBREAK PREPAREDNESS Preventing the Next Pandemic A Shared Framework
© 2018 Harvard Global Health Ins6tute 42 Church Street Cambridge, MA 02138 This work is the product of faculty and staff from the Harvard Global Health Ins6tute with major contribu6ons from Georgetown University Center for Global Health Science and Security and the John F. Kennedy School of Government at Harvard University. Suggested cita,on Harvard Global Health Ins6tute. 2018. Global Monitoring of Disease Outbreak Preparedness: Preven7ng the Next Pandemic. Harvard University, Cambridge, MA.
https://globalhealth.harvard.edu/files/hghi/files/global_monitoring_report.pdf
Remdesivir (GS-5734, Nuc inhibitor)
Lights Are On but No One’s Working: How Local Governments Are Faking Coronavirus Recovery
Remdesivir (GS-5734, Nuc inhibitor)
The antiviral compound remdesivir potently inhibits RNA-dependent RNA polymerase from Middle East respiratory syndrome coronavirus
+Author Affiliations
- Received February 14, 2020.
- Accepted February 24, 2020.
- Published under license by The American Society for Biochemistry and Molecular Biology, Inc.
Mechanism of action revealed for remdesivir, potential coronavirus drug
Researchers have demonstrated how the drug known as remdesivir works, presenting the viral RNA polymerase of coronaviruses as a target for these conditions.
25 FEBRUARY 2020 NEWS
WHO says Gilead’s remdesivir may help treat coronavirus
https://www.pharmaceutical-technology.com/news/who-gilead-remdesivir-coronavirus/
A closer look at the Ebola drug that's become the top hope for a coronavirus treatment
AUTHOR
Ned Pagliarulo@NedPagliarulo https://www.biopharmadive.com/news/coronavirus-remdesivir-gilead-antiviral-drug-covid-19/573261/
Mild/Moderate 2019-nCoV Remdesivir RCT
Sponsor:Capital Medical UniversityCollaborator:Chinese Academy of Medical SciencesInformation provided by (Responsible Party):Bin Cao, China-Japan Friendship Hospital https://clinicaltrials.gov/ct2/show/NCT04252664?intr=GS-5734&draw=2&rank=5
What the new phase of the coronavirus outbreak in the U.S. means for you
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
What the new phase of the coronavirus outbreak in the U.S. means for you
What the new phase of the coronavirus outbreak in the U.S. means for you
Health experts warn there are probably many undetected COVID-19 cases already here
By Tina Hesman Saey, Aimee Cunningham and Erin Garcia de Jesus
FEBRUARY 28, 2020 AT 1:25 PM
UPDATED FEBRUARY 28, 2020 AT 8:45 PM
Coronavirus: first Chinese province that declared top-level emergency downgrades alert status
- Zhejiang province, which is China’s key export and manufacturing base, declared a Grade I emergency on January 23, a day before the epicentre of Hubei
- According to the Zhejiang Health Commission, there have been no new confirmed cases of the coronavirus in the province for nine days
Published: 5:45pm, 2 Mar, 20
Coronavirus/COVID-19
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
What the new phase of the coronavirus outbreak in the U.S. means for you
Coronavirus: Xi Jinping focuses on long-term battle as more countries report cases
- Number of new infections in mainland China falls to lowest level since it locked down cities at centre of epidemic in January
- EU raises risk level to ‘moderate to high’ as death toll in Europe from Covid-19 reaches 38
Teddy Ng, Gigi Choy, Simone McCarthy and Jevans Nyabiage
Published: 11:25pm, 2 Mar, 2020
Mar 02, 2020 08:45 PMSOCIETY & CULTURE
Coronavirus Live Updates (Monday): Top Iranian Official Dies as South Korea Caseload Keeps Growing
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
Graphic: Report of the WHO-China joint mission on COVID-19
chinadaily.com.cn | Updated: 2020-03-02 06:30
http://global.chinadaily.com.cn/a/202003/02/WS5e5c376aa31012821727b644.html
How Does the Coronavirus Compare With the Flu?
As new cases appear on the West Coast, some — including the president — are comparing it to the seasonal flu. Here’s a close look at the differences.
By Denise Grady Feb. 29, 2020
Remdesivir (GS-5734, Nuc inhibitor)
Remdesivir (GS-5734, Nuc inhibitor)
Report of the WHO-China joint mission on COVID-19 chinadaily.com.cn | Updated: 2020-03-02 06:30
Chinese biotech firm censured for false claim on Gilead’s virus drug
- BrightGene Bio-Medical Technology has not been licensed by Gilead to make its experimental drug known as remdesivir
Published: 7:01pm, 2 Mar, 2020
Look Out for Coronavirus-Related Investment Scams - Investor Alert
Feb. 4, 2020
The SEC’s Office of Investor Education and Advocacy is issuing this Investor Alert to warn investors about investment frauds involving claims that a company’s products or services will be used to help stop the coronavirus outbreak.
https://www.sec.gov/oiea/investor-alerts-and-bulletins/ia_coronavirus
Chinese Biotech Censured for False Claim on Gilead’s Virus Drug
Bloomberg NewsBloombergMarch 1, 2020
https://finance.yahoo.com/news/chinese-biotech-censured-false-claim-040207427.html
- COVID-19
- CHINESE BIOTECH COMPANY CENSURED FOR CLAIMING IT COULD MAKE EXPERIMENTAL CORONAVIRUS DRUG
Chinese Biotech Company Censured for Claiming It Could Make Experimental Coronavirus Drug
BY BLOOMBERG
MARCH 2, 2020 1:47 AM EST
https://time.com/5793357/china-company-censured-coronavirus/
First Case of 2019 Novel Coronavirus in the United States
ORIGINAL ARTICLEBRIEF REPORT
https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
Biotech-Wars™ – Hunger + Thirst
Remdesivir (GS-5734, Nuc inhibitor)
Biotech-Wars™ – Hunger + Thirst
Biotech-Wars™ – Hunger + Thirst
Feb. 29, 2020 12:46 PM ET|About: AbbVie Inc. (ABBV), GILD, JNJ, MRNA, REGN, VIR, WXXWY
long only, Deep Value, dividend growth investing, healthcare
Summary
the news coming from China since January 11, 2020 was never positive even if the actual reported statistical data was suspect.
everyone, including everyone in China, has a right to be angry about COVID-19.
too much single source product manufacturing located in China.
politicos are now creating “Anti-Endorsements” lists that identify successful USA citizens.
Covid-19
Remdesivir (GS-5734, Nuc inhibitor)
Biotech-Wars™ – Hunger + Thirst
.
Covid-19 — Navigating the Uncharted
List of authors.
- Anthony S. Fauci, M.D.,
- H. Clifford Lane, M.D.,
- and Robert R. Redfield, M.D.
February 28, 2020
DOI: 10.1056/NEJMe2002387
What You Should Know About Flu Antiviral Drugs
https://www.cdc.gov/flu/treatment/whatyoushould.htm
Content source: Centers for Disease Control and Prevention, National Center for Immunization and Respiratory Diseases (NCIRD)
https://www.cdc.gov/flu/treatment/whatyoushould.htm
| VOLUME 395, ISSUE 10223, P507-513, FEBRUARY 15, 2020
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
- Prof Nanshan Chen, MD †
- Prof Min Zhou, MD †
- Xuan Dong, PhD †
- Prof Jieming Qu, MD †
- Fengyun Gong, MD
- Yang Han, PhD
- et al.
- Show all authors
- Show footnotes
Published:January 30, 2020
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
First death from coronavirus in the United States
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
First death from coronavirus in the United States confirmed in Washington state, officials say
By Christina Maxouris and Dakin Andone, CNN
Updated 4:12 PM ET, Sat February 29, 2020
Washington State Is Investigating Potential Outbreak at Facility
2/29/2020, 4:39:25 PM
COVID-19 CORONAVIRUS OUTBREAK
Last updated: March 01, 2020, 01:32 GMT
https://www.worldometers.info/coronavirus/
Coronavirus disease 2019 (COVID-19) Situation Report – 31
As CDC warns of US COVID-19 spread, labs frustrated over lack of tests
Filed Under: COVID-19Stephanie Soucheray | News Reporter | CIDRAP News | Feb 25, 2020
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
The scientific director of the Spallanzani hospital: "Less infections out of Italy because the method is different"
Giuseppe Ippolito: «The administration of the test to patients who do not show symptoms does not comply with European guidelines»
You made a new miracle with the two Chinese patients. Are the medications you used the weapon to fight the virus?
« We used two drugs: lopinavir / ritonavir, an antiviral commonly used for HIV infection and which also shows antiviral activity on coronaviruses; and remdesivir, an antiviral already used for Ebola, potentially active against new coronavirus infection. Our patients have recovered from pneumonia and have become negative compared to the virus, but more in-depth studies will be needed to verify whether this therapeutic approach can be extended ".
Remdesivir (GS-5734, Nuc inhibitor)
https://www.gilead.com/science-and-medicine/pipeline
https://seekingalpha.com/symbol/GILD
What are KALETRA® (lopinavir/ritonavir) tablets and oral solution?2
KALETRA is a prescription medicine that is used with other antiretroviral medicines to treat human immunodeficiency virus-1 (HIV-1) infection in adults and children 14 days of age and older. HIV is the virus that causes AIDS (acquired immune deficiency syndrome). It is not known if KALETRA is safe and effective in children under 14 days old.
https://www.kaletra.com/?cid=ppc_ppd_kaletra_ggl_br_0140
https://seekingalpha.com/symbol/ABBV
AbbVie Products List
Biotech-Wars™ – Hunger + Thirst
We used two drugs: lopinavir / ritonavir, an antiviral used for HIV infection; and remdesivir
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Politico’s continue to attack biotech/pharma companies even in the face of a pandemic with COVID-19
Summary
the news coming from China since January 11, 2020 was never positive even if the actual reported statistical data was suspect.
everyone, including everyone in China, has a right to be angry about COVID-19.
too much single source product manufacturing located in China.
politicos are now creating “Anti-Endorsements” lists that identify successful USA citizens.
Feb. 29, 2020 12:46 PM ET|About: AbbVie Inc.
long only, Deep Value, dividend growth investing, healthcare
GILD
Gilead Sciences, Inc.
, JNJ, MRNA, REGN, VIR, WXXWY
Gilead Sciences Update On The Company’s Ongoing Response To COVID-19
https://www.gilead.com/purpose/advancing-global-health/covid-19
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
- Total cases in South Korea reach 3,526, but estimates of 4,200 infections among Shincheonji church members alone
- Cases rise in Hubei epicentre, but 3 new infections in the rest of mainland China is the lowest figure since lockdowns began on January 23
Teddy Ng and Amanda Lee in Beijing
Published: 9:55am, 1 Mar, 2020
Prisons, retirement homes are weak links: Hubei chief
Hubei’s new Communist Party chief Ying Yong told a local virus response meeting he chaired on Saturday that the outbreak was still at a “critical” stage in the province, despite some progress in containing the epidemic.
He said the government needed to improve efforts to prevent new infections in prisons and pensioners’ homes, where there have been outbreaks in recent days.
Feb 25, 2020 08:50 PMSOCIETY & CULTURE
Guangzhou Family Cluster Appears to Experience Extra-Long Covid-19 Incubation
By Huang Shulun and Dave Yin
"Coronavirus is a moving target"
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Coronavirus: Hong Kong expert claims outbreak is now a pandemic
Uncertainty in a Time of Coronavirus
Here’s why communicating public health risk during an epidemic is so challenging
- By Amitha Kalaichandran on February 26, 2020
" Coronavirus is a moving target, as most epidemics are."
GLOBAL HEALTH
Wuhan Coronavirus Looks Increasingly Like a Pandemic, Experts Say
Rapidly rising caseloads alarm researchers, who fear the virus may make its way across the globe. But scientists cannot yet predict how many deaths may result.
https://www.nytimes.com/2020/02/02/health/coronavirus-pandemic-china.html
Is It a Pandemic Yet?
It’s now clear that the coronavirus epidemic was never going to be contained. What’s next?
By Michael T. Osterholm and Mark Olshaker
Mr. Osterholm is an infectious disease expert. Mark Olshaker is a writer and documentary filmmaker.
- Feb. 24, 2020
https://www.nytimes.com/2020/02/24/opinion/coronavirus-pandemic.html
As work resumes in outbreak, brand-new 'normal' emerges
By Cao Zinan and Li Danqing | chinadaily.com.cn | Updated: 2020-03-01 06:30
http://global.chinadaily.com.cn/a/202003/01/WS5e5ae5e8a31012821727b4c1.html
Coronavirus: Hong Kong expert claims outbreak is now a pandemic
Coronavirus: baby in South Korea infected as US, Australia and Thailand report first deaths
Coronavirus: Hong Kong expert claims outbreak is now a pandemic
Hong Kong / Health & Environment
Coronavirus: Hong Kong expert claims outbreak is now a pandemic and US death could be ‘tip of the iceberg’
- University of Hong Kong’s medical faculty dean Gabriel Leung says only reason WHO has not used word is ‘public fear’
- First wave of outbreak outside China could just be starting, says Leung
Published: 12:47pm, 1 Mar, 2020
FEB. 28, 2020, AT 10:13 AM
Quarantines Won’t Save Us From Coronavirus
Filed under Coronavirus
https://fivethirtyeight.com/features/quarantines-wont-save-us-from-coronavirus/
POLITICSMARCH 1, 2020 / 10:00 AM / UPDATED 2 HOURS AGO
Coronavirus spurs U.S. to screen travelers, ramp up mask production after first death
China’s coronavirus epidemic shows strengths, flaws of one country, one system
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
China’s coronavirus epidemic shows strengths, flaws of one country, one system
China’s coronavirus epidemic shows strengths, flaws of one country, one system
- The system allows Beijing to mobilise vast resources and take steps that would be unthinkable in the West
- But critics say the top-down system encourages cover-ups and repeated missteps in the face of a crisis
Published: 7:30am, 28 Feb, 2020
Feb 27, 2020 08:56 PMSOCIETY & CULTURE
Coronavirus Thursday Update: WHO Says Coronavirus Outbreak at ‘Decisive Point’; Iran Vice President Tested Positive
Will COVID-19 go away on its own in warmer weather?
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
China’s coronavirus epidemic shows strengths, flaws of one country, one system
Will COVID-19 go away on its own in warmer weather?
Marc Lipsitch, DPhil
Professor of Epidemiology and Director, Center for Communicable Disease Dynamics, Harvard T.H. Chan School of Public Health
(tl;dr) No.
The Coronavirus Scare: This Time Is Different
Even if health authorities get a grip on the outbreaks, counting on an economic and market recovery may be wishful thinking
By Spencer Jakab,
Stephen Wilmot and Justin LahartFeb. 25, 2020 7:00 am ET
Feb 28, 2020 06:25 PMSOCIETY & CULTURE
In Depth: How Early Signs of a SARS-Like Virus Were Spotted, Spread, and Throttled
By Gao Yu, Peng Yanfeng, Yang Rui, Feng Yuding, Ma Danmeng, Flynn Murphy, Han Wei and Timmy Shen
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
Opinion: If the coronavirus isn’t contained, a severe global recession is almost certain
Published: Feb 25, 2020 9:09 a.m. ET
By
COLUMNIST
Coronavirus: China, Japan, South Korea supply chains under threat from ‘second wave’ of disruptions
- The three Asian countries contribute around 24 per cent of the entire world economy, but have been hit hard by the coronavirus outbreak
- China was attempting to boost trade and investment with Japan and South Korea to offset risks of decoupling from the United States
Published: 9:15pm, 27 Feb, 2020
Feb 29, 2020 04:25 PMOPINION
Opinion: Five Lessons for Other Nations from China’s Fight Against Covid-19
By Wang Shuo
Health experts warned of a epidemic = ‘threatening to the world and socially disrupting’.
Health experts warned of a epidemic = ‘threatening to the world and socially disrupting’.
Economists try to estimate the impact of a pandemic, but we just don’t know how bad it could get
How Disease X, the epidemic-in-waiting, erupted in China
Health experts warned of a future epidemic that would be ‘threatening to the world and socially disrupting’. The new virus may fit the description
PUBLISHED 27 FEBRUARY, 2020
ILLUSTRATIONS BY KALIZ LEE
By Simone McCarthy, Linda Lew, William Zheng, Echo Xie and Phoebe Zhang
South China Morning Post
https://multimedia.scmp.com/infographics/news/china/article/3052721/wuhan-killer/index.html?src=pm
Infections across world now top WHO's concerns
By CHEN WEIHUA in Brussels | China Daily | Updated: 2020-02-29 03:44
http://global.chinadaily.com.cn/a/202002/29/WS5e596da8a31012821727b304.html
Epidemic's impact on China's place in supply chains should be minimal: MoC
Health experts warned of a epidemic = ‘threatening to the world and socially disrupting’.
Epidemic's impact on China's place in supply chains should be minimal: MoC
Epidemic's impact on China's place in supply chains should be minimal: MoC
By Zhong Nan | chinadaily.com.cn | Updated: 2020-02-27 17:37
http://global.chinadaily.com.cn/a/202002/27/WS5e578ddfa31012821727ad99.html
Coronavirus: Vietnam lured factories during trade war, but now faces big hit as parts from China stop flowing
- Vietnam became the destination of choice for firms looking to avoid trade war tariffs, but the coronavirus has left many cut off from their suppliers
- The Southeast Asian nation is more exposed to China’s supply chain than any other country in region, research shows, with companies across the board set to take a hit
Published: 1:02pm, 28 Feb, 2020
'Smart hospital' plays important role in virus prevention
Health experts warned of a epidemic = ‘threatening to the world and socially disrupting’.
Epidemic's impact on China's place in supply chains should be minimal: MoC
Novel heroes: 'Smart hospital' plays important role in virus prevention
chinadaily.com.cn | Updated: 2020-02-28 13:09
http://global.chinadaily.com.cn/a/202002/28/WS5e58a073a31012821727b129.html
Statement in support of the scientists, public health professionals, and medical professionals of China combatting COVID-19
- Charles Calisher
- Dennis Carroll
- Rita Colwell
- Ronald B Corley
- Peter Daszak
- Christian Drosten
- et al.
- Show all authors
Published:February 19, 2020DOI:https://doi.org/10.1016/S0140-6736(20)30418-9
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30418-9/fulltext
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
Remdesivir (GS-5734, Nuc inhibitor)
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
February 25, 2020 09:11 AM EST Jason Mast R&DCoronavirus
First US Covid-19 trials set to get underway in Nebraska and Washington, backed by NIH
Tuesday, February 25, 2020
NIH clinical trial of remdesivir to treat COVID-19 begins
Study enrolling hospitalized adults with COVID-19 in Nebraska.
https://www.nih.gov/news-events/news-releases/nih-clinical-trial-remdesivir-treat-covid-19-begins
8 OF 10
READ ALL TODAY'S ISSUE IN FULL
TODAY'S ISSUE
NIH starts testing Gilead’s remdesivir as treatment for COVID-19
26-02-2020
Gilead to Expand Coronavirus Drug Trials to Other Countries
The drug maker said that in March it would begin two more clinical trials of remdesivir, an experimental antiviral drug, in more nations outside China.
https://www.nytimes.com/2020/02/26/health/coronavirus-gilead-drug-trials.html
Gilead Sciences Update On The Company’s Ongoing Response To COVID-19
https://www.gilead.com/purpose/advancing-global-health/covid-19
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
Posted onFebruary 23, 2020AuthorIan M Mackay, PhD (EIC)107 Comments
by Jody Lanard and Peter M. Sandman
Big unknowns for millions as they return to work in China’s economic powerhouse
- Some people are struggling to get back to their workplaces while those who can face quarantine and financial uncertainties
- Businesses are also feeling the squeeze as they try to absorb the cost of extra protective equipment and measures.
Published: 8:00am, 26 Feb, 2020
14% of Recovered Covid-19 Patients in Guangdong Tested Positive Again
Past Time to Tell the Public: “It Will Probably Go Pandemic, and We Should All Prepare Now”
TNX-1800* (live modified horsepox virus vaccine for percutaneous administration)
Feb 26, 2020 06:47 AMSOCIETY & CULTURE
14% of Recovered Covid-19 Patients in Guangdong Tested Positive Again
By Li Liuqian, Huang Shulun and Han Wei
Coronavirus far more likely than Sars to bond to human cells due to HIV-like mutation, scientists say
- Research by team from Nankai University shows new virus has mutated gene similar to those found in HIV and Ebola
- Finding may help scientists understand how the infection spreads and where it came from
Stephen Chen in Beijing
Published: 12:30am, 27 Feb, 2020
TNX-1800* (live modified horsepox virus vaccine for percutaneous administration)
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
TNX-1800* (live modified horsepox virus vaccine for percutaneous administration)
Tonix Pharmaceuticals Announces Research Collaboration with Southern Research to Develop a Potential Vaccine to Protect Against New Coronavirus Disease 2019 (COVID-19) Based on Horsepox Virus (TNX-1800)
Wed February 26, 2020 7:00 AM|GlobeNewswire|About: TNXP
NEW YORK, Feb. 26, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (TNXP)
https://www.tonixpharma.com/pipeline/overview
SOUTHERN RESEARCH, TONIX TEAM TO DEVELOP POTENTIAL VACCINE AGAINST NEW CORONAVIRUS
FEBRUARY 26, 2020 | BY JERRY UNDERWOOD | DRUG DEVELOPME
https://seekingalpha.com/symbol/TNXP
Gilead Granted Three Chinese Patents for Antiviral Drug Remdesivir (GS-5734, Nuc inhibitor)
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
Feb 26, 2020 10:24 PMSOCIETY & CULTURE
Coronavirus Wednesday Update: Another 284 Cases Reported in South Korea; Gilead Granted Three Chinese Patents for Antiviral Drug Remdesivir
Antiviral drug Remdesivir gains 3 patents in China
Xinhua, February 26, 2020
http://www.china.org.cn/china/2020-02/26/content_75745874.htm
Antiviral drug Remdesivir gains three patents in China: official
Source: Xinhua| 2020-02-25 19:05:41|Editor: huaxia
http://www.xinhuanet.com/english/2020-02/25/c_138817801.htm
Gilead Sciences Initiates Two Phase 3 Studies of Investigational Antiviral Remdesivir for the Treatment of COVID-19
Wed February 26, 2020 5:00 PM|Business Wire|About: GILD
-- U.S. FDA Grants Investigational New Drug Authorization to Study Remdesivir for the Treatment of COVID-19 --
FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (GILD)
https://seekingalpha.com/symbol/GILD
Feb 27, 2020 06:30 AMBUSINESS & TECH
China Grants Three Patents to Gilead’s Remdesivir as Hopes Rise for Effective Treatment
By Yu Dawei and Denise Jia
https://www.gilead.com/purpose/advancing-global-health/covid-19
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
Vir Biotechnology & WuXi Biologics Collaboration for Development of Antibodies to Treat COVID-19
Vir Biotechnology and WuXi Biologics Announce Collaboration for Global Development of Antibodies to Treat COVID-19
Tue February 25, 2020 8:30 AM|GlobeNewswire|About: VIR, WXXWY
SAN FRANCISCO and SHANGHAI, China, Feb. 25, 2020 (GLOBE NEWSWIRE) -- Vir Biotechnology (VIR), Inc. (Nasdaq: VIR) and WuXi Biologics (WXXWY) (stock code: 2269.HK)
https://www.wuxibiologics.com/
https://www.vir.bio/pipeline/#focus
https://seekingalpha.com/symbol/WXXWY
https://seekingalpha.com/symbol/VIR
WUXI BIOLOGICS AND VIR BIOTECHNOLOGY ANNOUNCE COLLABORATION FOR GLOBAL DEVELOPMENT OF ANTIBODIES TO TREAT COVID-19
WuXi Biologics and Vir Biotechnology Announce Collaboration for Global Development of Antibodies to Treat COVID-19
2020/02/25
SAN FRANCISCO and SHANGHAI, February 25, 2020 – WuXi Biologics (“WuXi Bio”) (2269.HK)
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
Coronavirus: the new disease Covid-19 explained
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Iran lawmaker says 50 dead from new virus in city of Qom
Coronavirus: the new
disease Covid-19 explained
Despite China's best efforts the coronavirus outbreak has spread rapidly around the world. Many cities in Hubei province remain in lockdown and an increasing number of international flights to China have been suspended.
BY SCMP GRAPHICS UPDATED FEBRUARY 18, 2020
Article Navigation > China CDC Weekly > 2020, 2(8): 113-122
Vital Surveillances: The Epidemiological Characteristics of an Outbreak of 2019 Novel Coronavirus Diseases (COVID-19) — China, 2020
- The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team
http://weekly.chinacdc.cn/en/article/id/e53946e2-c6c4-41e9-9a9b-fea8db1a8f51
Iran lawmaker says 50 dead from new virus in city of Qom
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Iran lawmaker says 50 dead from new virus in city of Qom
Iran lawmaker says 50 dead from new virus in city of Qom
By AYA BATRAWYan hour ago
DUBAI, United Arab Emirates (AP) — A staggering 50 people have died in the Iranian city of Qom from the new coronavirus this month, a lawmaker was quoted as saying on Monday, even as the Health Ministry insisted only 12 deaths have been recorded to date in the country.
The lawmaker said the 50 deaths date as far back as Feb. 13. Iran first officially reported cases of the virus and its first deaths in Qom on Feb. 19.
Feb 24, 2020 08:22 PMSOCIETY & CULTURE
Coronavirus Monday Update: China Postpones Annual Legislature Meeting as Overseas Case Numbers Rocket
http://china.caixin.com/2020-02-24/101519629.html
Coronavirus: how Iran’s death toll came to be the highest behind only China
- Iran’s health minister says the infections are believed to be linked to a merchant who bypassed travel restrictions by making indirect flights to China
- Qom, south of the capital Tehran, has been identified as the centre of contagion, but authorities have warned it is possible the virus is present in all cities
Published: 8:17pm, 24 Feb, 2020
Fact Checked
How Long Will It Take to Develop a Vaccine for Coronavirus?
Share on PinterestMultiple companies are working on a vaccine to fight the new coronavirus. Getty Images
- Several groups are working on a vaccine for the new coronavirus, but there’s no guarantee that it will be ready before the end of the current outbreak.
- One group says they may have an experimental vaccine ready for initial testing in just a month.
- But experts caution this expedited timeline doesn’t always allow for careful evaluation of the safety and effectiveness of the vaccines.
https://www.healthline.com/health-news/how-long-will-it-take-to-develop-vaccine-for-coronavirus
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
Richard StainesFebruary 21, 2020
A Chinese research foundation has awarded $2.1m to four teams from Columbia University to identify antiviral drugs that work against the COVID-19 coronavirus – including a project investigating whether compounds based on Gilead’s hepatitis C drug Sovaldi could be used against the outbreak.
The funding was awarded by the Jack Ma Foundation, based in Hangzhou City, in China’s Zhejiang Province.
https://pharmaphorum.com/news/could-gileads-sovaldi-be-the-answer-to-coronavirus/
SOVALDI is sofosbuvir
Early trial results from an unapproved Gilead drug, remdesivir, are expected in the next three weeks.
Results are also expected from a trial combining AbbVie’s HIV drugs lopinavir and ritonavir.
KALETRA® (lopinavir/ritonavir)
7 Biotech Stocks to Buy That Could Beat the Coronavirus
Stocks fell sharply in the days following the outbreak,
so these companies may save the day
By Chris Lau, InvestorPlace Contributor Feb 6, 2020, 10:50 am EST
https://investorplace.com/2020/02/7-biotech-stocks-to-buy-that-could-beat-thee companies may save the day-coronavirus/
February 25, 2020 09:11 AM EST Jason Mast R&DCoronavirus
First US Covid-19 trials set to get underway in Nebraska and Washington, backed by NIH
The Bad; The Worse; The Ugly; and The Unthinkable
The Bad; The Worse; The Ugly; and The Unthinkable
Could Gilead’s Sovaldi be the answer to COVID-19 coronavirus?
RaboResearch - Economic Research
Coronavirus: Outbreak of uncertainty
Special
February 14, 2020, by Michael Every et al.
https://economics.rabobank.com/publications/2020/february/coronavirus-outbreak-of-uncertainty/
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
NIAID Now | February 19, 2020
https://www.niaid.nih.gov/news-events/atomic-structure-novel-coronavirus-protein
CDC is closely monitoring the novel coronavirus outbreak.
Coronavirus Disease 2019 (COVID-19)
How COVID-19 Spreads
https://www.cdc.gov/coronavirus/2019-ncov/about/transmission.html
mRNA-1273
The Bad; The Worse; The Ugly; and The Unthinkable
Remdesivir (GS-5734, Nuc inhibitor)
Moderna Ships mRNA Vaccine Against Novel Coronavirus (mRNA-1273) for Phase 1 Study
Mon February 24, 2020 6:04 PM|Business Wire|About: AZN, MRK, MRNA
mRNA-1273 delivered from Company’s cGMP facility in 42 days from sequence selection
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Moderna, Inc. (MRNA)
NIH Scientists Identify Atomic Structure of Novel Coronavirus Protein
NIAID Now | February 19, 2020
https://www.niaid.nih.gov/news-events/atomic-structure-novel-coronavirus-protein
Moderna Receives FDA Fast Track Designation for Zika Vaccine mRNA-1893
August 19, 2019 at 4:01 PM EDTPDF Version
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Aug. 19, 2019-- Moderna, Inc., (Nasdaq: MRNA)
https://www.businesswire.com/news/home/20200224005955/en/
https://seekingalpha.com/symbol/MRNA
Moderna, Inc. 2019 Q4 - Results - Earnings Call Presentation
Feb. 26, 2020 9:13 AM ET | About: Moderna, Inc. (MRNA)
https://seekingalpha.com/article/4327317-moderna-inc-2019-q4-results-earnings-call-presentation
Remdesivir (GS-5734, Nuc inhibitor)
The Bad; The Worse; The Ugly; and The Unthinkable
Remdesivir (GS-5734, Nuc inhibitor)
Gilead's Remdesivir May Be Effective Against Coronavirus, WHO Says
Gilead Sciences' antiviral remdesivir may be effective against the coronavirus, the World Health Organization says.TONY OWUSUUPDATED:FEB 24, 2020 10:05 AM ESTORIGINAL:FEB 24, 2020
https://www.thestreet.com/investing/gilead-remdesivir-coronavirus
Gilead gains 4.8% as WHO sees potential in its antiviral drug
Feb. 24, 2020 9:57 AM ET|About: Gilead Sciences, Inc. (GILD)|By: Liz Kiesche, SA News Editor
https://seekingalpha.com/news/3544811-gilead-gains-4_8-who-sees-potential-in-antiviral-drug
https://www.gilead.com/science-and-medicine/pipeline
Gilead Sciences drug remdesivir may help treat coronavirus symptoms, according to WHO
By Paul R. La Monica, CNN Business
Updated 6:04 AM ET, Tue February 25, 2020
https://www.cnn.com/2020/02/24/investing/gilead-sciences-coronavirus-who-remdesivir/index.html
February 25, 2020 09:11 AM EST Jason Mast R&DCoronavirus
First US Covid-19 trials set to get underway in Nebraska and Washington, backed by NIH
Adaptive COVID-19 Treatment Trial
https://clinicaltrials.gov/ct2/show/NCT04280705?cond=covid-19&cntry=US&draw=2&rank=1
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
from bats to pangolins to humans
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
Coronavirus traces found in recovered patients
Feb 21, 2020 06:29 AMSOCIETY & CULTURE
Coronavirus Thursday Update: Pangolin Again Linked to Coronavirus; Ministry Expects Consumer Market to Bottom Out by March
Thursday, Feb. 20 11:45 p.m.
Recent research again linked an endangered mammal, the pangolin, to the novel coronavirus that has sickened more than 75,000 people worldwide, as scientists strive to determine the intermediate host of the deadly virus.
http://www.caixin.com/2020-02-20/101518165.html
Wait, What’s a Pangolin?
This highly endangered and frequently trafficked creature might be the source of COVID-19.
By SHANNON PALUS FEB 19, 2020 4:52 PM
https://slate.com/technology/2020/02/coronavirus-origin-pangolins-trafficking-endangered.html
Coronavirus traces found in recovered patients
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
Coronavirus traces found in recovered patients
Coronavirus traces found in recovered patients as Hubei cases rise slightly
- Chinese respiratory expert warns numbers could rise again as tests show people who have recovered may still be infectious
- Globally there have been 75,773 confirmed cases and 2,129 deaths
Published: 7:21am, 21 Feb, 2020
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
Coronavirus pneumonia might exist for long time, says expert
By Wang Keju | chinadaily.com.cn | Updated: 2020-02-20 11:47
https://www.chinadaily.com.cn/a/202002/20/WS5e4e0160a310128217278fb1.html
There was no vaccine for Sars or Mers. Will there be one for the new coronavirus?
There was no vaccine for Sars or Mers. Will there be one for the new coronavirus?
The pneumonia caused by the novel coronavirus might exist for a long time, like the flu
There was no vaccine for Sars or Mers. Will there be one for the new coronavirus?
- A month has passed since China locked down millions of people in Wuhan and other cities in Hubei at the heart of the epidemic
- In the first part of a series, the Post looks at how the race to find a vaccine may be different than for other coronaviruses
Josephine Ma and Simone McCarthy
Published: 6:15am, 22 Feb, 2020
Feb 22, 2020 10:06 PMSOCIETY & CULTURE
Coronavirus Saturday Update: Global Spread Accelerates as South Korea Reports 142 New Cases; Xi Jinping Thanks Bill & Melinda Gates Foundation
Remdesivir (GS-5734, Nuc inhibitor)
There was no vaccine for Sars or Mers. Will there be one for the new coronavirus?
Remdesivir (GS-5734, Nuc inhibitor)
Chinese trials for Gilead’s antiviral drug to treat coronavirus still far from reaching patient recruitment goals
- Antiviral remdesivir is being trialled as a treatment for the novel coronavirus in 10 hospitals in Wuhan
- Researchers have recruited more than 230 patients for the trials so far, short of the 760 targeted
Coco Feng in Beijing
Published: 7:30pm, 21 Feb, 2020
Clinical trials of an experimental antiviral drug said to “
” in treating the
are still far from fulfilling patient recruitment targets more than two weeks in, raising questions about whether they can be completed within previously projected timelines.
- Preliminary results from two clinical trials testing potential treatments for the COVID-19 coronavirus are expected in three weeks, WHO says.
- One trial combines HIV drugs Lopinavir and Ritonavir, while the other is testing U.S.-based biotech Gilead Sciences’ antiviral Remdesivir.
https://www.cnbc.com/quotes/?symbol=GILD
BiotecHeart™ - See The Light
There was no vaccine for Sars or Mers. Will there be one for the new coronavirus?
Remdesivir (GS-5734, Nuc inhibitor)
BiotecHeart™ - See The Light
Feb. 20, 2020 10:20 AM ET
The political and socio-economic environment in America, is both depressing and disconcerting.
The hostility increases towards everyone connected with the biotech/drug industry during this highly politically charged season.
Politicos still see little to no value in biotech companies and continue to vilify them.
There continues to be much encouraging news and positive clinical tests in the biotech world, including on the coronavirus situation, for the first 2 months of 2020.
https://seekingalpha.com/instablog/5205071-danwatson888/5411014-biotecheart-see-light
https://seekingbiotechalpha.com/biotecheart
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Biological Sciences
RESEARCH ARTICLE
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
View ORCID ProfileEmmie de Wit, Friederike Feldmann, Jacqueline Cronin, Robert Jordan, Atsushi Okumura, Tina Thomas, Dana Scott, Tomas Cihlar, and Heinz FeldmannPNAS first published February 13, 2020 https://doi.org/10.1073/pnas.1922083117
- Edited by Michael B. A. Oldstone, Scripps Research Institute, La Jolla, CA, and approved February 7, 2020 (received for review December 16, 2019)
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs when administered either before or after animals were infected with MERS-CoV. Our data show that remdesivir is a promising antiviral treatment against MERS that could be considered for implementation in clinical trials. It may also have utility for related coronaviruses such as the novel coronavirus 2019-nCoV emerging from Wuhan, China.
China’s BrightGene Manufactures APIs of Gilead’s Remdesivir
By Alex Philippidis -February 12, 2020
Chinese drug developer BrightGene Bio-Medical Technology Co., said it has successfully manufactured the active pharmaceutical ingredients (APIs) of remdesivir (GS-5734), the Gilead Sciences antiviral candidate being tested in China human clinical trials as a treatment for 2019-nCoV novel coronavirus. [BrightGene Bio-Medical Technology]
https://www.genengnews.com/news/coronavirus-chinas-brightgene-manufactures-apis-of-gileads-remdesivir/
Chinese firm copies Gilead's remdesivir, the most promising drug against the new coronavirus
by Angus Liu | Feb 12, 2020 10:28am
BrightGene Bio-Medical Technology Co.,Ltd.
http://www.bright-gene.com/en/product_category.php
Remdesivir (GS-5734, Nuc inhibitor)
https://www.gilead.com/science-and-medicine/pipeline
COVID-19 Severity of 2019-novel coronavirus (nCoV)
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Coronavirus likely now ‘gathering steam’
BY Alvin PowellHarvard Staff Writer
DATEFebruary 11, 2020
In China, the number of confirmed cases of the coronavirus reached 42,700 on Feb. 11, according to the World Health Organization. To accommodate the growing number, an exhibition center was turned into a temporary hospital in Wuhan.
10 February 2020 - Imperial College London
Report 4: Severity of 2019-novel coronavirus (nCoV)
https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/news--wuhan-coronavirus/
Coronavirus fatality rate estimated by Imperial scientists
by Kate Wighton, Dr Sabine L. van Elsland11 February 2020
https://www.imperial.ac.uk/news/195217/coronavirus-fatality-rate-estimated-imperial-scientists/
The Novel Coronavirus, 2019-nCoV, is Highly Contagious and More Infectious Than Initially Estimated
Steven Sanche, Yen Ting Lin, Chonggang Xu, Ethan Romero-Severson, Nick Hengartner, View ORCID ProfileRuian Kedoi: https://doi.org/10.1101/2020.02.07.20021154
https://www.medrxiv.org/content/10.1101/2020.02.07.20021154v1
Feb 18, 2020 08:10 PMSOCIETY & CULTURE
Evidence Mounts of Japan’s Mishandling of Coronavirus Epidemic
By Dave Yin and Chen Lixiong
WuXi Biologics' Subsidiary WuXi Vaccines Signed Long-Term Vaccine Manufacturing Contract with a Global Vaccine Leader
Tue February 18, 2020 5:42 AM|PR Newswire|About: WXXWY
SHANGHAI, Feb. 18, 2020 /PRNewswire/ -- WuXi Biologics (WXXWY)
Coronavirus outbreak
Remdesivir reduced the severity of disease, virus replication, and damage to the lungs
Remdesivir (GS-5734, Nuc inhibitor)
Economy / China Economy
China struggles to balance coronavirus containment with economic cost as millions return to work
- Most Chinese companies will resume operations this week, but the coronavirus outbreak is still raging and it’s far from business as usual
- Transport restrictions, supply chain disruptions and new workplace rules to minimise the risk of transmission all cloud the short-term economic outlook
Topic | Coronavirus outbreak
Published: 6:00am, 13 Feb, 2020
To work or not to work – that is proving a crucial question for Chinese officials, companies and employees as the world’s second largest economy struggles to balance the risk of the deadly coronavirus with the need to resume business.
Experts envision two scenarios if the new coronavirus isn’t contained
FEBRUARY 4, 2020
https://www.statnews.com/2020/02/04/two-scenarios-if-new-coronavirus-isnt-contained/
National Health Commission of the
People's Republic of China
中华人民共和国国家卫生健康委员会
Feb 12: Daily briefing on novel coronavirus cases in China
Updated: 2020-02-12
|en.nhc.gov.cn
http://en.nhc.gov.cn/2020-02/12/c_76463.htm
Coronavirus death toll in China rises to 1,868 as epicentre reports 93 new fatalities
- Majority of new cases and deaths have been reported from the province at the heart of the outbreak
- China postpones annual parliamentary meeting scheduled for early March
Published: 7:02am, 18 Feb, 2020
The View by Mark Clifford
The coronavirus was no black swan. Hong Kong and China just weren’t ready for a crisis
- Lessons that should have been learned after the harrowing Sars experience were not: diseases like Covid-19 will happen from time to time in a hyper-connected world, and the trust and transparency that will fortify a society’s response to such a crisis is lacking
Published: 3:00am, 19 Feb, 2020
Remdesivir (GS-5734, Nuc inhibitor)
World Health Organisation says it is impossible to predict the future path of the epidemic,
Remdesivir (GS-5734, Nuc inhibitor)
Nouveau coronavirus: le patient de Bordeaux a reçu du remdesivir
AFPPublié le 14/02/2020 à 14:33 | AFP
Feb 16, 2020 11:16 AM
Second Batch of Experimental Gilead Coronavirus Drug Arrives in Wuhan
By Jia Tianqiong, Di Ning, Lu Yutong and Flynn Murphy
New drug tested in fight against coronavirus
By Liu Kun in Wuhan and Zhao Lei in Beijing | chinadaily.com.cn | Updated: 2020-02-07 23:21
https://www.chinadaily.com.cn/a/202002/07/WS5e3d8068a310128217275e9d.html
chloroquine diphosphate, favipiravir and remdesivir
World Health Organisation says it is impossible to predict the future path of the epidemic,
World Health Organisation says it is impossible to predict the future path of the epidemic,
Drugs with potential against coronavirus in human trials
By Wang Xiaoyu | chinadaily.com.cn | Updated: 2020-02-15 17:33
https://www.chinadaily.com.cn/a/202002/15/WS5e47bad4a310128217277c96.html
three drugs that hold great promise - chloroquine diphosphate, favipiravir and remdesivir - are undergoing human trials in the country.
Home / China / The fight against novel coronavirus
Latest on the novel coronavirus outbreak
chinadaily.com.cn | Updated: 2020-02-16 06:30
https://www.chinadaily.com.cn/a/202002/16/WS5e2a95d9a310128217273202.html
World Health Organisation says it is impossible to predict the future path of the epidemic,
World Health Organisation says it is impossible to predict the future path of the epidemic,
World Health Organisation says it is impossible to predict the future path of the epidemic,
Coronavirus: China reports 105 more deaths, taking global toll to 1,775, as some cases throw 14-day incubation into doubt
- Hubei province’s new Communist Party chief calls for less bureaucracy as number of new infections rises again
- World Health Organisation says it is impossible to predict the future path of the epidemic, which has spread to at least 25 other countries
Cissy Zhou, Gigi Choy and Wendy Wu
Published: 7:27am, 17 Feb, 2020
Rethinking media coverage of COVID-19: A call to humanize people's suffering
By Hodan Osman Abdi | cgtn | Updated: 2020-02-17 11:24
https://global.chinadaily.com.cn/a/202002/17/WS5e4a0780a3101282172780e9.html
COVID-19
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
WHO Director-General's remarks at the media briefing on 2019-nCoV on 11 February 2020
11 February 2020
Feb 12, 2020 09:21 PMDAILY CHART
Charts of the Day: How Deadly Is New Coronavirus?
By Tang Ziyi, Lin Jinbing, Ye Xueming and Wang Xintong
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
Audrey Jiajia Li
Coronavirus crisis: How the death of Li Wenliang, a doctor and ordinary citizen, sparked Chinese demands for freedom of speech
- A reluctant hero, the doctor who was reprimanded for warning about the coronavirus has, in death, become a lightning rod for public unhappiness with the government’s tight control of information
Published: 9:00am, 12 Feb, 2020
Beijing battles ‘crisis of Chernobyl proportions’ in coronavirus outbreak
- Public fury is growing, with calls for more freedom of speech, but observers don’t expect any dramatic changes
- Xi Jinping has been mostly absent from view, as heads start to roll in Hubei province
Published: 6:00pm, 13 Feb, 2020
Andy Xie
How the coronavirus crisis is exposing the ills of the China model
- An all-powerful government means a swift and effective quarantine but the same hierarchical system caused critical delays in containing the coronavirus
- Likewise, the China model, so effective when the economy was nascent, has outlived its usefulness in a country now trying to beat the middle-income trap
Published: 9:00am, 31 Jan, 2020
two monoclonal antibodies (mAbs) that bind to SARS-CoV-2 (previously known as “2019-nCoV”)
How the death of Li Wenliang, a doctor/ordinary citizen, sparked demands for freedom of speech
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
Vir Biotechnology Identifies Two Antibodies That Bind to the Spike Protein of 2019-nCoV, Newly Named as SARS-CoV-2
Wed February 12, 2020 8:30 AM|GlobeNewswire|About: VIR
https://seekingalpha.com/symbol/VIR
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
South China Morning Post
Coronavirus: Everything you need to know in a visual explainer
The coronavirus which was first reported in Wuhan late last year has quickly spread around the world. The Chinese authorities have locked down many cities in China's Hubei province, and some international flights to China have been suspended.
BY SCMP GRAPHICS UPDATED FEBRUARY 11, 2020
https://multimedia.scmp.com/infographics/news/china/article/3047038/wuhan-virus/index.html
Feb 13, 2020 12:53 PMSOCIETY & CULTURE
Coronavirus Latest: Wuhan Infections Jump By More Than 13,000, Hubei Party Chief Removed
FEBRUARY 13, 2020 / 12:24 AM / UPDATED AN HOUR AGO
Factbox: Latest on coronavirus spreading in China and beyond
(Reuters) - Here are the latest developments around the coronavirus outbreak:
Remdesivir
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV)
Foster City, Calif., January 31, 2020
Remdesivir has demonstrated in vitro and in vivo activity in animal models against the viral pathogens MERS and SARS, which are coronaviruses that are structurally similar to 2019-nCoV.
Coronavirus-Drug Development Becomes a Top Focus at Gilead
Drugmaker sprints to build up capacity to produce its promising antiviral remdesivir should it prove effective in studies in China
A Chinese Drugmaker Has Started Mass-Producing an Experimental Drug for COVID-19
Suzhou-based BrightGene Bio-Medical Technology
https://time.com/5782633/covid-19-drug-remdesivir-china/
BrightGene Bio-Medical Technology Co. Ltd. (Suzhou, China)
http://www.bright-gene.com/en/
Chinese firm copycats Gilead's remdesivir, the most promising drug against the new coronavirus
by Angus Liu | Feb 12, 2020 10:28am
BrightGene Bio-Medical Technology Co Ltd
https://www.bloomberg.com/quote/688166:CH
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- Manli Wang,
- Ruiyuan Cao,
- Leike Zhang,
- Xinglou Yang,
- Jia Liu,
- Mingyue Xu,
- Zhengli Shi,
- Zhihong Hu,
- Wu Zhong &
- Gengfu Xiao
Cell Research (2020)
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Coronavirus: Everything you need to know in a visual explainer = South China Morning Post
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Johnson & Johnson Announces Collaboration with U.S. Department of Health & Human Services to Accelerate Development of a Potential Novel Coronavirus Vaccine
Tue February 11, 2020 4:30 PM|PR Newswire|About: JNJPR Newswire
NEW BRUNSWICK, N.J., Feb. 11, 2020 /PRNewswire/ -- Johnson & Johnson (JNJ)
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Initiating Vaccine Development and Providing Supplies of Antiviral Medicines to China for Investigational Use
Johnson & Johnson Announces Collaboration with U.S. Department of Health and Human Services to Fight InfluenzaJanssen and Biomedical Advanced Research and Development Authority (BARDA) join forces to accelerate new therapies and vaccines to protect communities against the threat of a pandemic
NEW BRUNSWICK, N.J., – September 15, 2017 – Johnson & Johnson (NYSE: JNJ)
https://www.jnj.com/coronavirus
What You Need to Know About the Latest on the Coronavirus—and a Potential Preventive Vaccine
The coronavirus has made headlines as it has spread from China to other parts of the world. To help stop the global outbreak in its tracks, Johnson & Johnson is already hard at work on a potential preventive vaccine.By Johnson & JohnsonJanuary 28, 2020
https://www.jnj.com/innovation
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
Remdesivir (GS-5734, Nuc inhibitor)
Arbidol and Darunavir, could effectively inhibit replication of the new strain
Arbidol and Darunavir, could effectively inhibit replication of the new strain
US drug cleared for trials in Wuhan
By Liu Zhihua | China Daily | Updated: 2020-02-05 09:07
http://www.chinadaily.com.cn/a/202002/05/WS5e3a156ca310128217274f36.html
Antiviral drug Remdesivir arrives in China for clinical trial: official
Source: Xinhua| 2020-02-04 23:47:08|Editor: Mu Xuequan
http://www.xinhuanet.com/english/2020-02/04/c_138755837.htm
Prognosis
Trials of Gilead Coronavirus Drug in China Could Start Next Week
By Robert Langreth February 4, 2020, 3:44 PM EST
Remdesivir is being rushed into trials for the new virus because it previously showed promise in laboratory tests against SARS, a virus similar to the current coronavirus. It’s already been used on the first U.S. coronavirus patient in Washington state, who improved after getting the drug, as well as a handful of other coronavirus patients in the West.
China Wants to Patent Gilead’s Experimental Coronavirus Drug
Bloomberg News February 5, 2020, 12:00 AM EST Updated on February 5, 2020, 6:47 AM EST
- Wuhan’s virology institute has applied for remdesivir’s patent
- Gilead said human trials on the drug have begun in China
Cell Research
ISSN 1748-7838 (online)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
https://www.nature.com/articles/s41422-020-0282-0
Experimental drug offers silver lining
By ZHANG ZHIHAO | China Daily | Updated: 2020-02-06 11:15
Clinical trials begin for remdesivir, which has shown promise in studies
https://www.chinadaily.com.cn/a/202002/06/WS5e3b84d5a310128217275700.html
Arbidol and Darunavir, could effectively inhibit replication of the new strain
Arbidol and Darunavir, could effectively inhibit replication of the new strain
Arbidol and Darunavir, could effectively inhibit replication of the new strain
China’s health officials say priority is to stop mild coronavirus cases from getting worse
- National Health Commission admits Wuhan lacked intensive care facilities at start of the outbreak, but more beds and staff have now been provided
- And an epidemiologist says preliminary tests have shown two drugs, Arbidol and Darunavir, could effectively inhibit replication of the new strain
Published: 11:46pm, 4 Feb, 2020
Arbidol, commonly available as Umifenovir, is a potent antiviral used to treat and prevent influenza, while Darunavir is used to treat and prevent HIV/Aids.
Umifenovir in treatment of influenza and acute respiratory viral infections in outpatient care
https://www.ijidonline.com/article/S1201-9712(18)34836-7/fulltext
PREZISTA® (darunavir) is a prescription HIV-1 (Human Immunodeficiency Virus type-1) medicine used with NORVIR® (ritonavir) and other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
PREZISTA® (darunavir) is a prescription HIV‑1 (Human Immunodeficiency Virus type‑1) medicine used with NORVIR® (ritonavir) and other antiretroviral medicines to treat HIV-1 infection in adults. HIV is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
PREZISTA® should not be used in children under 3 years of age.
When used with other antiretroviral medicines to treat HIV‑1 infection, PREZISTA® may help:
- reduce the amount of HIV-1 in your blood. This is called "viral load."
- increase the number of CD4+ (T) cells in your blood that help fight off other infections.
PREZISTA® is always taken with and at the same time as NORVIR® (ritonavir) in combination with other HIV‑1 medicines for the treatment of HIV‑1 infection in adults. PREZISTA® should also be taken with food.
https://www.janssencarepath.com/patient/prezista/cost-support
NORVIR® (ritonavir) tablets and oral solution are prescription medicines each used with other antiviral medicines to treat people with human immunodeficiency virus (HIV-1) infection.
NORVIR® (ritonavir) oral powder is a prescription medicine that is used with other antiviral medicines to treat children with HIV-1 infection.
HIV-1 is the virus that causes AIDS (Acquired Immune Deficiency Syndrome).
Remdesivir (GS-5734, Nuc inhibitor)
Arbidol and Darunavir, could effectively inhibit replication of the new strain
Life and Death in a Wuhan Coronavirus ICU
Who owns the coronavirus cure? China’s move to patent Gilead’s experimental drug for the novel virus could lead to legal wrangle
Institute of Virology in Wuhan, the epicentre of the global coronavirus outbreak, filed a patent for Gilead’s remdesivir antiviral drug on January 21
In a statement to the Post, California-based Gilead said it applied for a global patent in 2016, including in China, for using the drug to treat all coronavirus-linked illnesses
Eric Ng Published: 8:00am, 6 Feb, 2020
China wants to patent Gilead's experimental coronavirus drug
BEIJING (BLOOMBERG) - Chinese researchers have applied for a local patent on an experimental Gilead Sciences drug that they believe might fight the novel coronavirus.
https://www.straitstimes.com/wuhan-virus-outbreak
FEBRUARY 5, 2020 / 2:21 AM /
China lab seeks patent on use of Gilead's coronavirus treatment
BEIJING/SHANGHAI (Reuters)
“Even if the Wuhan Institute’s application gets authorized, the role is very limited because Gilead still owns the fundamental patent of the drug,” said Zhao Youbin, a Shanghai-based intellectual property counsel at Purplevine IP Service Co.
https://www.reuters.com/article/us-china-health-patent-idUSKBN1ZZ0RL
Remdesivir (GS-5734, Nuc inhibitor)
Potential Indication: Ebola Virus Infection
PHASE 2
https://www.gilead.com/science-and-medicine/pipeline
Feb 06, 2020 03:35 AMBUSINESS & TECH
China Wants to Patent Gilead’s Experimental Coronavirus Drug
Who owns the coronavirus cure? China’s move to patent Gilead’s experimental drug for the novel virus could lead to legal wrangle
- Institute of Virology in Wuhan, the epicentre of the global coronavirus outbreak, filed a patent for Gilead’s remdesivir antiviral drug on January 21
- In a statement to the Post, California-based Gilead said it applied for a global patent in 2016, including in China, for using the drug to treat all coronavirus-linked illnesses
Published: 8:00am, 6 Feb, 2020
“We are aware of reports of the Wuhan Institute for Virology’s patent application,” said Sonia Choi, Gilead’s vice president of public affairs in a telephone interview with South China Morning Post. “Our focus at this time is on rapidly determining the potential for remdesivir as a treatment for [the novel coronavirus] and accelerating manufacturing in anticipation of potential future supply needs.”
“In theory, a patent owner may be able to use its patent to stop other companies from manufacturing, importing or selling that drug in China,” he said. “But a patent cannot stop doctors from prescribing the drug to treat a patient.”
Life and Death in a Wuhan Coronavirus ICU
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
Life and Death in a Wuhan Coronavirus ICU
Feb 06, 2020 07:40 AM SOCIETY & CULTURE
Reporter’s Notebook: Life and Death in a Wuhan Coronavirus ICU
By Xiao Hui
Translated By Sun Huixia and Dave Yin
Feb 12, 2020 03:36 AM SOCIETY & CULTURE
Coronavirus Latest: Oxygen Supplies Run Short on Front Lines as Disease Is Named COVID-19
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
Moderna Announces Progress in Prophylactic Vaccines Modality with CMV Vaccine Phase 2 Study Data Now Expected in Third Quarter 2020 and Expands Investment in This Core Modality with Three New Development Candidates
February 10, 2020 at 5:11 PM EST PDF Version
Phase 2 CMV vaccine dose-confirmation study more than sixty percent enrolled
mRNA-1189 to prevent infectious mononucleosis and Epstein-Barr virus (EBV) infection
mRNA-1345 to prevent respiratory syncytial virus (RSV) disease in young children, with the intent to combine with mRNA-1653 to create a pediatric respiratory vaccine against RSV, hMPV and PIV3
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the National Institutes of Health; physical manufacturing of first batch complete, awaiting analytical testing
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 10, 2020-- Moderna, Inc. (Nasdaq: MRNA)
Coronavirus Study Finds Incubation Period of Up to 24 Days
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
mRNA-1273 to prevent novel coronavirus (2019-nCoV) disease, in collaboration with the NIH
Feb 11, 2020 06:05 AMSOCIETY & CULTURE
Coronavirus Study Finds Incubation Period of Up to 24 Days
By Liu Denghui and Denise Jia
https://www.medrxiv.org/content/10.1101/2020.02.06.20020974v1.full.pdf
Coronavirus death toll reaches 1,018 as China reports 2,478 new cases
- New deaths hit a daily record for Hubei – epicentre of the epidemic – and for mainland China as a whole
- Chinese authorities have partially locked down more than 80 cities in nearly 20 provinces since the epidemic began
Published: 6:23am, 11 Feb, 2020
antiviral drug, Remdesivir
Hong Kong’s first death was the second outside mainland China.
Hong Kong’s first death was the second outside mainland China.
China starts clinical trials for new antiviral drug to treat coronavirus
- Remdesivir, developed by Gilead Sciences, was last week given to US patient whose condition appeared to improve within a day
- Tests are being carried out at multiple hospitals in Wuhan, ground zero of the outbreak
Published: 5:04pm, 3 Feb, 2020
The experimental antiviral drug, Remdesivir, developed by US-based Gilead Sciences, is aimed at infectious diseases such Ebola and Sars. It was
last week – a 35-year-old man whose condition appeared to improve within a day.
Gilead Might Have a Coronavirus Treatment.
On Friday, The Wall Street Journal reported that Chinese officials had reached an agreement with Gilead (ticker: GILD) to test remdesivir in patients with coronavirus. The same day, the New England Journal of Medicine published a case report on a man sickened with the coronavirus in Washington state who was given remdesivir, and whose condition began to improve the following day.
Cell Research
ISSN 1748-7838 (online)
- Letter to the Editor
- Open Access
- Published: 04 February 2020
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- Manli Wang,
- Ruiyuan Cao,
- Leike Zhang,
- Xinglou Yang,
- Jia Liu,
- Mingyue Xu,
- Zhengli Shi,
- Zhihong Hu,
- Wu Zhong &
- Gengfu Xiao
Hong Kong’s first death was the second outside mainland China.
Hong Kong’s first death was the second outside mainland China.
Hong Kong’s first death was the second outside mainland China.
Coronavirus Live Updates: Hong Kong Reports First Death From Outbreak
By The New York Times
https://www.nytimes.com/2020/02/03/world/asia/coronavirus-china.html
Coronavirus: US should help ‘as soon as possible’ as China death toll hits 425 and cases rise to 20,438
- New cases in Hubei province, the epicentre of the outbreak, reach 2,345 for a total of 13,522
- Deaths in the province rose by 64 to 414, another record high
Published: 7:27am, 4 Feb, 2020
Feb 04, 2020 10:45 AMPODCAST
Caixin-Sinica Podcast: Coronavirus
By Tanner Brown
https://www.caixinglobal.com/2020-02-04/caixin-sinica-podcast-coronavirus-101511269.html
Feb 04, 2020 06:41 PMPODCAST
Caixin China Biz Roundup: New Coronavirus Recovery Rates Begin Outstripping Fatalities
Coronavirus death toll in China jumps 65, another daily record, raising global total to 492
- China also registers another 3,971 confirmed cases, raising total to 24,324
- Majority of the new cases are in Hubei province
Published: 6:31am, 5 Feb, 2020
Feb 05, 2020 07:43 AMSOCIETY & CULTURE
Hong Kong Coronavirus Death Reveals Young May Be More Vulnerable Than Previously Thought
By Wen Simin, Gao Yu, Zhao Jinzhao and Han Wei
coronavirus (2019-nCoV)
Hong Kong’s first death was the second outside mainland China.
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
A lethal new virus that originated in the central China city of Wuhan has spread to the rest of the country and is fast infecting the world, creating one of the biggest global health crises since Ebola and SARS. Beijing has shut down huge swaths of the country and other nations are rapidly cutting travel links and taking other drastic measures that could send a chill through the global economy.
Editor: Lin Jinbing. Producer: Yu Zhuyangyang
Coronavirus Latest: Economy Feels the Pinch as Death Toll Reaches 362
Human trials of coronavirus drug begin
Chinese authorities have fast tracked a clinical trial by pharmaceutical giant Gilead of a drug to treat the novel coronavirus.
Antiviral drug remdesivir, a failed Ebola treatment, will be tested by a medical team from Beijing's China-Japan Friendship Hospital to treat coronavirus patients, Bloomberg reported, as well as in Wuhan. In all, 270 patients will participate in the randomized double-blinded placebo controlled study. Gilead rival AbbVie's HIV medicine Kaletra has also been recommended by China's health regulator for ad-hoc treatment of the new virus, for which there is as yet no approved drug treatment.
Full development and commercialization of a coronavirus vaccine could be years away.
Testing of Gilead's remdesivir in coronavirus patients to start tomorrow in China
Feb. 5, 2020 11:24 AM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
Chinese authorities have OK'd the start of clinical trials.
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
Regeneron Announces Expanded Collaboration with HHS to Develop Antibody Treatments for New Coronavirus
Tue February 4, 2020 9:00 AM|PR Newswire|About: REGN
TARRYTOWN, N.Y., Feb. 4, 2020 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (REGN)
https://www.regeneron.com/pipeline
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform which uses a unique genetically-engineered mouse with a humanized immune system
https://www.regeneron.com/technology
REGN-EB3 (also known as REGN3470-3471-3479) was invented by Regeneron using its VelociSuite® technologies; the therapy combines three fully-human monoclonal antibodies.
"REGN-EB3 is a three-antibody cocktail designed with the goal of enhancing efficacy, reducing the development of viral sequences that lead to resistance, and increasing potential utility in future outbreaks as viruses continually evolve," said Christos Kyratsous, Ph.D., Vice President of Research, Infectious Diseases and Viral Vector Technologies at Regeneron. "The Regeneron rapid response infectious disease platform has the opportunity to accelerate our response to future epidemics and pandemics, and we continue to work on additional diseases that may pose a threat to public health."
https://www.regeneron.com/technology
Feb 04, 2020 08:30 PM Coronavirus Latest
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
Feb 04, 2020 08:30 PM Coronavirus Latest
Feb 04, 2020 08:30 PMSOCIETY & CULTURE
Coronavirus Latest: Total Cases Soar Past 20,000, Singapore Confirms Six More
Coronavirus: are cocktail therapies for flu and HIV the magic cure? Bangkok and Hangzhou hospitals put combination remedies to the test
- Arbidol, an antiviral drug used for treating influenza in China and Russia, could be combined with the anti-HIV drug Darunavir for treating coronavirus
- Hospitals in Bangkok, and the Zhejiang provincial capital of Hangzhou, are reporting successes in reducing viral loads with ‘cocktail therapies’
Published: 2:24pm, 4 Feb, 2020
https://www.cochranelibrary.com/es/cdsr/doi/10.1002/14651858.CD011489/full/es
https://www.cochranelibrary.com/es/
Arbidol, an antiviral drug used for treating influenza in Russia and China, could be combined with the anti-HIV drug Darunavir for treating patients afflicted with the novel coronavirus, according to China Business News, citing a proposal on Tuesday by China’s National Health Commission expert Li Lanjuan.
In Thailand, a combination of anti-influenza medication Oseltamivir and HIV drugs Lopinavir and Ritonavir have been used on three patients with severe symptoms, according to Thai media reports, citing the Rajavithi Hospital’s director Somkiat Lalitwongsa in Bangkok. One of the patients, a 71-year-old woman, showed signs of improvement 48 hours after being administered the cocktail of drugs, the reports said.
China
China coverage from Reuters.
https://www.reuters.com/places/china
Latest numbers on the novel coronavirus
By CAO YIN | chinadaily.com.cn | Updated: 2020-02-03 09:05
https://www.chinadaily.com.cn/a/202002/03/WS5e3771e1a310128217274451.html
State pharma firms step in to curb spread of deadly pathogens
By Liu Zhihua | China Daily | Updated: 2020-02-04 08:48
https://www.chinadaily.com.cn/a/202002/04/WS5e38bf5fa31012821727498a.html
病毒：新型冠状病毒 2019-nCoV
Regeneron's proprietary VelociSuite® technologies – including the VelocImmune® platform
Feb 04, 2020 08:30 PM Coronavirus Latest
病毒：新型冠状病毒 2019-nCoV
传染源：新型冠状病毒感染的肺炎患者
传播途径：经呼吸道飞沫传播，亦可通过接触传播，存在粪-口传播可能性
截至 2020-02-04 09:48 全国数据统计
疑似病例数来自国家卫健委数据，目前为全国数据，未分省市自治区等
Virus: New Coronavirus 2019-nCoV
Source of infection: New coronavirus-infected pneumonia patients
Transmission: It can be transmitted through respiratory droplets or through contact. There is a possibility of fecal-oral transmission
As of 2020-02-04 10:36 National Statistics
The number of suspected cases comes from the data of the National Health and Health Commission, which is currently national data, not divided into provinces, municipalities and autonomous regions http://ncov.dxy.cn/ncovh5/view/pneumonia?scene=2&clicktime=1579582238&enterid=1579582238&from=singlemessage&isappinstalled=0
Cell Research
ISSN 1748-7838 (online)
- Letter to the Editor
- Open Access
- Published: 04 February 2020
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
- Manli Wang,
- Ruiyuan Cao,
- Leike Zhang,
- Xinglou Yang,
- Jia Liu,
- Mingyue Xu,
- Zhengli Shi,
- Zhihong Hu,
- Wu Zhong &
- Gengfu Xiao
Cell Research (2020)Cite this article
https://www.nature.com/articles/s41422-020-0282-0
Recently, the Wuhan Institute of Virology, Chinese Academy of Sciences / National Institute of Biosafety and the National Academy of Military Medical Research Institute of Emergency Medicine for Prevention and Control of Drugs have jointly conducted research on the screening of 2019 new coronavirus ( 2019-nCoV ) drugs Important progress. Relevant research results to "Remdesivir and chloroquine Effectively INHIBIT at The Recently Logs in emerged Novel coronavirus (2019-nCoV) in vitro " ( "Reed Western Wei and chloroquine phosphate can inhibit the in vitro novel coronavirus ( 2019-nCoV )") was published In Cell Research, a well-known international academic journal with independent intellectual property rights in China .
http://www.whiov.cas.cn/kyjz_105338/202002/t20200204_5497136.html
近日，中国科学院武汉病毒研究所/生物安全大科学研究中心与军事科学院军事医学研究院国家应急防控药物工程技术研究中心开展联合研究，在抑制2019新型冠状病毒（2019-nCoV）药物筛选方面取得重要进展。相关研究成果以“Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro”（《瑞得西韦和磷酸氯喹能在体外有效抑制新型冠状病毒（2019-nCoV）》）为题发表在中国自主知识产权的国际知名学术期刊Cell Research（《细胞研究》）上。
http://www.whiov.cas.cn/kyjz_105338/202002/t20200204_5497136.html
novel coronavirus (2019-nCoV) 病毒：新型冠状病毒 2019-nCoV
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
(1/31/19 2019-nCoV Global Confirmed Cases - John Hopkins University)
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
Coronavirus
Source: China's NHC, state media, other authorities
SCMP
https://multimedia.scmp.com/widgets/china/wuhanvirus/#
WUHAN CORONAVIRUS OUTBREAK
https://www.worldometers.info/coronavirus/
病毒: 新型冠状病毒 2019-nCoV
Virus: New Coronavirus 2019-nCoV
sources used By Johns Hopkins Database
CDC, WHO, NHC. ECDC and DXY
Where Coronaviruses Come From
EcoHealth Alliance President Peter Daszak speaks with The Scientist about how pathogens like 2019-nCoV jump species, and how to head off the next pandemic.
Jan 24, 2020
SHAWNA WILLIAMS
https://www.the-scientist.com/news-opinion/where-coronaviruses-come-from-67011
Quarantine centres set up for coronavirus patients in Wuhan
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
Quarantine centres set up for coronavirus patients in Wuhan
- People showing pneumonia symptoms, and those who have had close contact with confirmed cases, will be given free accommodation and medical treatment in centralised zones
- First overseas fatalities reported in the Philippines as death toll rises to 305, with more than 14,500 confirmed cases
Published: 6:42am, 2 Feb, 2020
HEALTH NEWS FEBRUARY 2, 2020 / 8:01 AM /
Cocktail of flu, HIV drugs appears to help fight coronavirus: Thai doctors
BANGKOK (Reuters)
The drug treatment includes a mixture of anti-HIV drugs lopinavir and ritonavir, in combination with flu drug oseltamivir in large doses.
lopinavir and ritonavir =
www.kaletra.com/... ($ABBV)
oseltamivir (Tamiflu) =
https://www.tamiflu.com/ ($RHHBY)
Thailand 'cures' coronavirus with anti-HIV drug cocktail in 48 hours
FRENCH PRESS AGENCY - AFPBANGKOKPublished02.02.202021:15
Coronavirus: Philippines reports first death outside China
novel coronavirus (2019-nCoV) Global Confirmed Cases - John Hopkins University) 病毒: 新型冠状病毒 2019-nCoV
Transmission of 2019-nCoV Infection from an Asymptomatic Contact
Coronavirus: Philippines reports first death outside China as Duterte orders travel ban on visitors from mainland, Hong Kong
- The victim was a 44-year-old male Chinese national who was the companion of a 38-year-old Chinese woman who arrived in the Philippines on January 21
- A new Philippine travel ban could apply to all travellers from China, including Hong Kong
Compiled by SCMP’s Asia desk,Sum Lok-kei,Phila Siu
Published: 9:51am, 2 Feb, 2020
Feb 03, 2020 04:58 AM SOCIETY & CULTURE
In Depth: How Wuhan Lost the Fight to Contain the Coronavirus
By Gao Yu, Xiao Hui, Ma Danmeng, Cui Xiankang and Han Wei
Transmission of 2019-nCoV Infection from an Asymptomatic Contact
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
Transmission of 2019-nCoV Infection from an Asymptomatic Contact
Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany
January 30, 2020
DOI: 10.1056/NEJMc2001468
Metrics This letter was published on January 30, 2020, at NEJM.org.
https://www.nejm.org/doi/full/10.1056/NEJMc2001468
Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam
This letter was published on January 28, 2020, at NEJM.org.
https://www.nejm.org/doi/full/10.1056/NEJMc2001272?query=RP
RESEARCH ARTICLE
mbio.asm.org
March/April 2018 Volume 9 Issue 2 e00221-18
Coronavirus Susceptibility to the Antiviral Remdesivir (GS5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Department of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee, USA
Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
Department of Biology, the University of the South, Sewanee, Tennessee, USA
Gilead Sciences, Inc., Foster City, California, USA
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5844999/pdf/mBio.00221-18.pdf
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
Latest on the novel coronavirus outbreak
chinadaily.com.cn | Updated: 2020-02-02 07:55
https://www.chinadaily.com.cn/index.html
Import tax lifted on foreign material donations for outbreak response
By Zhong Nan | chinadaily.com.cn | Updated: 2020-02-02 10:01
https://www.chinadaily.com.cn/a/202002/02/WS5e362d5ca310128217274260.html
Coronavirus vaccine will take months
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
Latest on the novel coronavirus outbreak chinadaily.com.cn | Updated: 2020-02-02 07:55
THE JAKARTA POST
Coronavirus vaccine will take months: Biotech exec
MARIE-MORGANE LE MOEL
AGENCE FRANCE-PRESSE
Paris / Sat, February 1, 2020 / 10:15 am
Moderna is working in coordination with the US National Institutes of Health, while Inovio Pharmaceuticals and the University of Queensland in Australia are pursuing alternative tracks. (Shutterstock/Parilov)
Moderna Announces Funding Award from CEPI to Accelerate Development of Messenger RNA (mRNA) Vaccine Against Novel Coronavirus
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Jan. 23, 2020-- Moderna, Inc., (Nasdaq: MRNA)
Johnson & Johnson Launches Multi-Pronged Response to Coronavirus Global Public Health Threat
Initiating Vaccine Development and Providing Supplies of Antiviral Medicines to China for Investigational Use
NEW BRUNSWICK, N.J., January 29, 2020
https://www.jnj.com/johnson-johnson-launches-multi-pronged-response-to-coronavirus-global-public-health-threat THE JAKARTA POST
The slow race to make a coronavirus vaccine is on as nations try to speed yearlong process
PUBLISHED FRI, JAN 31 20202:31 PM ESTUPDATED FRI, JAN 31 20203:18 PM ESTBerkeley Lovelace Jr.@BERKELEYJR
https://www.cnbc.com/2020/01/31/coronavirus-why-it-takes-at-least-a-year-to-make-a-vaccine.html
Coronavirus: 'Significant breakthrough' in race for vaccine made by UK scientists
A vaccine may be close to being tested on animals and then humans, depending on the level of funding researchers get.
Health correspondent @ashishskynews
Wednesday 5 February 2020 19:50, UK
This article was published on January 31, 2020, at NEJM.org.
Novel Coronavirus : What We Know So Far
Novel Coronavirus : What We Know So Far
First Case of 2019 Novel Coronavirus in the United States
Summary
An outbreak of novel coronavirus (2019-nCoV) that began in Wuhan, China, has spread rapidly, with cases now confirmed in multiple countries. We report the first case of 2019-nCoV infection confirmed in the United States and describe the identification, diagnosis, clinical course, and management of the case, including the patient’s initial mild symptoms at presentation with progression to pneumonia on day 9 of illness. This case highlights the importance of close coordination between clinicians and public health authorities at the local, state, and federal levels, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
Copyright © 2020 Massachusetts Medical Society
Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV.
December 10, 2019
Two drugs reduce risk of death from Ebola
What are KALETRA® (lopinavir/ritonavir) tablets and oral solution?2
KALETRA is a prescription medicine that is used with other antiretroviral medicines to treat human immunodeficiency virus-1 (HIV-1) infection in adults and children 14 days of age and older. HIV is the virus that causes AIDS (acquired immune deficiency syndrome). It is not known if KALETRA is safe and effective in children under 14 days old.
Novel Coronavirus : What We Know So Far
Novel Coronavirus : What We Know So Far
Novel Coronavirus : What We Know So Far
Jan 29, 2020 08:56 PMSOCIETY & CULTURE
Novel Coronavirus: What We Know So Far
By Guo Yingzhe
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Summary
Background
A recent cluster of pneumonia cases in Wuhan, China, was caused by a novel betacoronavirus, the 2019 novel coronavirus (2019-nCoV). We report the epidemiological, clinical, laboratory, and radiological characteristics and treatment and clinical outcomes of these patients.
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext
2019 新型冠状病毒疫情进展和风险评估 Epidemic update and risk assessment of 2019 Novel Coronavirus 中国疾病预防控制中心新型冠状病毒感染的肺炎疫情一级响应 态势分析与风险评估组 2020 年 1 月 28 日
http://www.chinacdc.cn/yyrdgz/202001/P020200128523354919292.pdf
What is a coronavirus and why is a new virus strain making people in China so sick?
By Tegan Taylor
Updated Saturday at 23:51First posted 20 January 2020 at 12:55 am
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Published:January 30, 2020
https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext
This article was published on January 24, 2020, and updated on January 29, 2020, at NEJM.org.
Novel Coronavirus : What We Know So Far
This article was published on January 24, 2020, and updated on January 29, 2020, at NEJM.org.
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Summary
In December 2019, a cluster of patients with pneumonia of unknown cause was linked to a seafood wholesale market in Wuhan, China. A previously unknown betacoronavirus was discovered through the use of unbiased sequencing in samples from patients with pneumonia. Human airway epithelial cells were used to isolate a novel coronavirus, named 2019-nCoV, which formed a clade within the subgenus sarbecovirus, Orthocoronavirinae subfamily. Different from both MERS-CoV and SARS-CoV, 2019-nCoV is the seventh member of the family of coronaviruses that infect humans. Enhanced surveillance and further investigation are ongoing. (Funded by the National Key Research and Development Program of China and the National Major Project for Control and Prevention of Infectious Disease in China.)
2019-nCoV Global Cases by Johns Hopkins CSSE
https://gisanddata.maps.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6
2019 Novel Coronavirus (2019-nCoV)
The CDC is closely monitoring an outbreak of respiratory illness caused by a novel (new) coronavirus first identified in Wuhan, Hubei Province, China. Infections with 2019-nCoV also are being reported in a growing number of countries internationally, including the United States. There are ongoing investigations to learn more.
https://www.cdc.gov/media/dpk/diseases-and-conditions/coronavirus/coronavirus-2020.html
Coronavirus Latest: China Infections Reach 11,890, Apple Closes All Mainland Stores
Coronavirus Latest: China Infections Reach 11,890, Apple Closes All Mainland Stores
This article was published on January 24, 2020, and updated on January 29, 2020, at NEJM.org.
Feb 01, 2020 10:42 PMSOCIETY & CULTURE
Coronavirus Latest: China Infections Reach 11,890, Apple Closes All Mainland Stores
By Flynn Murphy, Lin Jinbing, Han Wei, Dave Yin, Matthew Walsh, Denise Jia, Mo Yelin and Timmy Shen
Feb 01, 2020 10:18 PMFINANCE
China’s Central Bank Offers More Aid Amid Virus Fallout
By Guo Yingzhe
People’s Daily published (link in Chinese) a story hours later asking for caution and discouraging panic buying.
The New England Journal of Medicine, a U.S. medical journal, published a study Friday on the first coronavirus infection in the U.S. The case highlights an experimental drug remdesivir developed by Gilead Sciences Inc. It was given to the first U.S. case whose clinical condition improved the next day, the study showed. The report also stressed the importance of close coordination between clinicians and public health authorities at all levels of government, as well as the need for rapid dissemination of clinical information related to the care of patients with this emerging infection.
https://www.nejm.org/doi/full/10.1056/NEJMoa2001191
Gilead Assesses Ebola Drug as Possible Coronavirus Treatment (1)
Jan. 23, 2020, 1:35 PM; Updated: Jan. 23, 2020, 2:06 PM
Remdesivir is an experimental antiviral drug that grew out of a collaboration with the Centers for Disease Control and Prevention and the U.S. Army Medical Research Institute of Infectious Diseases in 2014. It works by blocking a key enzyme the virus needs for replication, the company explained in a statement.
https://www.gilead.com/purpose/advancing-global-health
Xinhua News Agency, China’s state run press agency, is reporting nearly 600 cases of pneumonia linked to the new strain of coronavirus in an outbreak that began last month in Wuhan City in China. That’s almost double the number of cases the World Health Organization had reported on Jan. 21
Novel Coronavirus (2019-nCoV) SITUATION REPORT - 1 21 JANUARY 2020
Remdesivir (GS-5734)
https://stm.sciencemag.org/content/11/494/eaau9242.full
Gilead advancing experimental antiviral to treat coronavirus infection
Feb. 1, 2020 1:25 PM ET|About: Gilead Sciences, Inc. (GILD)|By: Douglas W. House, SA News Editor
numbers of new infections and deaths set daily records
Coronavirus Latest: China Infections Reach 11,890, Apple Closes All Mainland Stores
numbers of new infections and deaths set daily records
Coronavirus: Wuhan may be home to 75,815 infected people, report says
- Findings by scientists at Hong Kong University based on the assumption that each infected patient could have infected 2.68 others
- Meanwhile, numbers of new infections and deaths set daily records
Cissy Zhou,Josephine Ma,Stephen Chen in Beijing,Phoebe Zhang
Published: 8:17am, 1 Feb, 2020
World / United States & Canada
Coronavirus: US bars entry to foreigners travelling from mainland China, declares public health emergency
- Foreign nationals arriving in the US from mainland China will be denied entry starting Sunday
- US citizens who have been in Hubei province will be quarantined for two weeks
Published: 5:23am, 1 Feb, 2020
Source: China's NHC, state media, other authorities
SCMP
https://multimedia.scmp.com/widgets/china/wuhanvirus/#
Feb 01, 2020 08:40 PMSOCIETY & CULTURE
Airlines Cut Flights and Routes to China as Virus Fears Grow
By Lu Yutong, Ye Xueming, Wang Xintong and Flynn Murphy
Some 40 airlines in 29 countries and regions have suspended flights to the Chinese mainland amid fears about the deadly coronavirus that has infected thousands and killed hundreds.
Remdesivir (GS-5734)
Coronavirus Latest: China Infections Reach 11,890, Apple Closes All Mainland Stores
numbers of new infections and deaths set daily records
Gilead Sciences Statement on the Company’s Ongoing Response to the 2019 Novel Coronavirus (2019-nCoV)
Foster City, Calif., January 31, 2020 — Gilead Sciences today issued the following statement from Merdad Parsey, MD, PhD, Chief Medical Officer, Gilead Sciences:
Remdesivir (GS-5734)
https://www.gilead.com/purpose/advancing-global-health
Gilead mulls repositioning failed Ebola drug in China virus
by Nick Paul Taylor | Jan 24, 2020 8:22am
https://www.fiercebiotech.com/biotech/gilead-mulls-repositioning-failed-ebola-drug-china-virus
December 10, 2019
Two drugs reduce risk of death from Ebola
Gilead Sciences Offers Experimental Drug for Coronavirus Treatments, Testing
The U.S. biotech firm has formalized agreement with China to conduct clinical trial of remdesivir
By Joseph Walker
Updated Jan. 31, 2020 8:33 pm ET
Gilead Sciences Inc. GILD -1.30%
U.S. Drugmakers Ship Therapies to China, Seeking to Treat Coronavirus
AbbVie, Gilead, others respond to Chinese authorities’ requests for antiviral drugs to test effectiveness against deadly respiratory illness
Washington state coronavirus patient treated with investigational, unapproved Ebola drug
UPDATED: Fri., Jan. 31, 2020
https://www.spokesman.com/stories/2020/jan/31/washington-state-coronavirus-patient-treated-with-/
By Arielle Dreher arielled@spokesman.com (509)459-5467
remdesivir and combination lopinavir, ritonavir, and interferon